INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum.
Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen.
INFLAMMATION of the LIVER in humans caused by HEPATITIS B VIRUS lasting six months or more. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
Vaccines or candidate vaccines containing inactivated hepatitis B or some of its component antigens and designed to prevent hepatitis B. Some vaccines may be recombinantly produced.
Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens.
The hepatitis B antigen within the core of the Dane particle, the infectious hepatitis virion.
A closely related group of antigens found in the plasma only during the infective phase of hepatitis B or in virulent chronic hepatitis B, probably indicating active virus replication; there are three subtypes which may exist in a complex with immunoglobulins G.
INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally, and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.
INFLAMMATION of the LIVER in humans caused by a member of the HEPATOVIRUS genus, HUMAN HEPATITIS A VIRUS. It can be transmitted through fecal contamination of food or water.
Antigens of the virion of the HEPATITIS B VIRUS or the Dane particle, its surface (HEPATITIS B SURFACE ANTIGENS), core (HEPATITIS B CORE ANTIGENS), and other associated antigens, including the HEPATITIS B E ANTIGENS.
INFLAMMATION of the LIVER.
INFLAMMATION of the LIVER in humans due to infection by VIRUSES. There are several significant types of human viral hepatitis with infection caused by enteric-transmission (HEPATITIS A; HEPATITIS E) or blood transfusion (HEPATITIS B; HEPATITIS C; and HEPATITIS D).
INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS.
A species in the genus HEPATOVIRUS containing one serotype and two strains: HUMAN HEPATITIS A VIRUS and Simian hepatitis A virus causing hepatitis in humans (HEPATITIS A) and primates, respectively.
A DNA virus that closely resembles human hepatitis B virus. It has been recovered from naturally infected ducks.
INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors.
Immunoglobulins raised by any form of viral hepatitis; some of these antibodies are used to diagnose the specific kind of hepatitis.
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.
A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species.
Vaccines or candidate vaccines used to prevent infection with hepatitis A virus (HEPATOVIRUS).
Antibodies to the HEPATITIS C ANTIGENS including antibodies to envelope, core, and non-structural proteins.
Deoxyribonucleic acid that makes up the genetic material of viruses.
INFLAMMATION of the LIVER in animals due to viral infection.
INFLAMMATION of the LIVER in humans caused by HEPATITIS DELTA VIRUS, a defective RNA virus that can only infect HEPATITIS B patients. For its viral coating, hepatitis delta virus requires the HEPATITIS B SURFACE ANTIGENS produced by these patients. Hepatitis D can occur either concomitantly with (coinfection) or subsequent to (superinfection) hepatitis B infection. Similar to hepatitis B, it is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
Any of the viruses that cause inflammation of the liver. They include both DNA and RNA viruses as well viruses from humans and animals.
Any vaccine raised against any virus or viral derivative that causes hepatitis.
A reverse transcriptase inhibitor and ZALCITABINE analog in which a sulfur atom replaces the 3' carbon of the pentose ring. It is used to treat HIV disease.
Acute INFLAMMATION of the LIVER in humans; caused by HEPATITIS E VIRUS, a non-enveloped single-stranded RNA virus. Similar to HEPATITIS A, its incubation period is 15-60 days and is enterically transmitted, usually by fecal-oral transmission.
A defective virus, containing particles of RNA nucleoprotein in virion-like form, present in patients with acute hepatitis B and chronic hepatitis. It requires the presence of a hepadnavirus for full replication. This is the lone species in the genus Deltavirus.
Antibodies to the HEPATITIS A ANTIGENS including antibodies to envelope, core, and non-structural proteins.
A positive-stranded RNA virus species in the genus HEPEVIRUS, causing enterically-transmitted non-A, non-B hepatitis (HEPATITIS E).
A chronic self-perpetuating hepatocellular INFLAMMATION of unknown cause, usually with HYPERGAMMAGLOBULINEMIA and serum AUTOANTIBODIES.
A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
A strain of HEPATITIS A VIRUS which causes hepatitis in humans. The virus replicates in hepatocytes and is presumed to reach the intestine via the bile duct. Transmission occurs by the fecal-oral route.
Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
Tumors or cancer of the LIVER.
INFLAMMATION of the LIVER in non-human animals.
An enzyme that catalyzes the conversion of L-alanine and 2-oxoglutarate to pyruvate and L-glutamate. (From Enzyme Nomenclature, 1992) EC 2.6.1.2.
The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host.
An ORTHOHEPADNAVIRUS causing chronic liver disease and hepatocellular carcinoma in woodchucks. It closely resembles the human hepatitis B virus.
Ribonucleic acid that makes up the genetic material of viruses.
A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances.
One of the type I interferons produced by peripheral blood leukocytes or lymphoblastoid cells. In addition to antiviral activity, it activates NATURAL KILLER CELLS and B-LYMPHOCYTES, and down-regulates VASCULAR ENDOTHELIAL GROWTH FACTOR expression through PI-3 KINASE and MAPK KINASES signaling pathways.
A genus of PICORNAVIRIDAE causing infectious hepatitis naturally in humans and experimentally in other primates. It is transmitted through fecal contamination of food or water. HEPATITIS A VIRUS is the type species.
The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle.
Antigens of the virions of HEPACIVIRUS, their surface, core, or other associated antigens.
A species of the CORONAVIRUS genus causing hepatitis in mice. Four strains have been identified as MHV 1, MHV 2, MHV 3, and MHV 4 (also known as MHV-JHM, which is neurotropic and causes disseminated encephalomyelitis with demyelination as well as focal liver necrosis).
"Ducks" is not a recognized medical term or condition in human health; it may refer to various anatomical structures in animals, such as the ducks of the heart valves, but it does not have a standalone medical definition.
Antigens from any of the hepatitis viruses including surface, core, and other associated antigens.
Antigens produced by various strains of HEPATITIS D VIRUS.
Carbon-containing phosphonic acid compounds. Included under this heading are compounds that have carbon bound to either OXYGEN atom or the PHOSPHOROUS atom of the (P=O)O2 structure.
EPIDEMIOLOGIC STUDIES based on the detection through serological testing of characteristic change in the serum level of specific ANTIBODIES. Latent subclinical infections and carrier states can thus be detected in addition to clinically overt cases.
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
Antigens produced by various strains of HEPATITIS A VIRUS such as the human hepatitis A virus (HEPATITIS A VIRUS, HUMAN).
The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS.
A genus of Sciuridae consisting of 14 species. They are shortlegged, burrowing rodents which hibernate in winter.
Proteins found mainly in icosahedral DNA and RNA viruses. They consist of proteins directly associated with the nucleic acid inside the NUCLEOCAPSID.
Virus diseases caused by the HEPADNAVIRIDAE.
INFLAMMATION of the LIVER due to ALCOHOL ABUSE. It is characterized by NECROSIS of HEPATOCYTES, infiltration by NEUTROPHILS, and deposit of MALLORY BODIES. Depending on its severity, the inflammatory lesion may be reversible or progress to LIVER CIRRHOSIS.
A purine base and a fundamental unit of ADENINE NUCLEOTIDES.
'Blood donors' are individuals who voluntarily and safely donate a specific amount of their own blood, which can be further separated into components, to be used for transfusion purposes or for manufacturing medical products, without receiving remuneration that is intended to reward them financially.
A nucleoside antimetabolite antiviral agent that blocks nucleic acid synthesis and is used against both RNA and DNA viruses.
The transference of a part of or an entire liver from one human or animal to another.
The quantity of measurable virus in a body fluid. Change in viral load, measured in plasma, is sometimes used as a SURROGATE MARKER in disease progression.
The complete genetic complement contained in a DNA or RNA molecule in a virus.
The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence.
Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis.
The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time.
INFLAMMATION of the LIVER in humans caused by HEPATITIS DELTA VIRUS in conjunction with HEPATITIS B VIRUS and lasting six months or more.
The main structural component of the LIVER. They are specialized EPITHELIAL CELLS that are organized into interconnected plates called lobules.
The ability of viruses to resist or to become tolerant to chemotherapeutic agents or antiviral agents. This resistance is acquired through gene mutation.
Proteins encoded by a VIRAL GENOME that are produced in the organisms they infect, but not packaged into the VIRUS PARTICLES. Some of these proteins may play roles within the infected cell during VIRUS REPLICATION or act in regulation of virus replication or VIRUS ASSEMBLY.
Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS.
A family of hepatotropic DNA viruses which contains double-stranded DNA genomes and causes hepatitis in humans and animals. There are two genera: AVIHEPADNAVIRUS and ORTHOHEPADNAVIRUS. Hepadnaviruses include HEPATITIS B VIRUS, duck hepatitis B virus (HEPATITIS B VIRUS, DUCK), heron hepatitis B virus, ground squirrel hepatitis virus, and woodchuck hepatitis B virus (HEPATITIS B VIRUS, WOODCHUCK).
Blood tests that are used to evaluate how well a patient's liver is working and also to help diagnose liver conditions.
Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template.
The common chimpanzee, a species of the genus Pan, family HOMINIDAE. It lives in Africa, primarily in the tropical rainforests. There are a number of recognized subspecies.
Pathological processes of the LIVER.
Disease having a short and relatively severe course.
In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships.
An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.
Proteins prepared by recombinant DNA technology.
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
Retroviral proteins coded by the pol gene. They are usually synthesized as a protein precursor (POLYPROTEINS) and later cleaved into final products that include reverse transcriptase, endonuclease/integrase, and viral protease. Sometimes they are synthesized as a gag-pol fusion protein (FUSION PROTEINS, GAG-POL). pol is short for polymerase, the enzyme class of reverse transcriptase.
Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).
Schedule giving optimum times usually for primary and/or secondary immunization.
Severe inability of the LIVER to perform its normal metabolic functions, as evidenced by severe JAUNDICE and abnormal serum levels of AMMONIA; BILIRUBIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASES; and albumin/globulin ratio. (Blakiston's Gould Medical Dictionary, 4th ed)
Simultaneous infection of a host organism by two or more pathogens. In virology, coinfection commonly refers to simultaneous infection of a single cell by two or more different viruses.
Layers of protein which surround the capsid in animal viruses with tubular nucleocapsids. The envelope consists of an inner layer of lipids and virus specified proteins also called membrane or matrix proteins. The outer layer consists of one or more types of morphological subunits called peplomers which project from the viral envelope; this layer always consists of glycoproteins.
The transmission of infectious disease or pathogens from one generation to another. It includes transmission in utero or intrapartum by exposure to blood and secretions, and postpartum exposure via breastfeeding.
A clinical manifestation of HYPERBILIRUBINEMIA, characterized by the yellowish staining of the SKIN; MUCOUS MEMBRANE; and SCLERA. Clinical jaundice usually is a sign of LIVER dysfunction.
The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION.
A country spanning from central Asia to the Pacific Ocean.
Immunoglobulins produced in response to VIRAL ANTIGENS.
Established cell cultures that have the potential to propagate indefinitely.
Therapy with two or more separate preparations given for a combined effect.
Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care. (Dictionary of Health Services Management, 2d ed)
Enzymes of the transferase class that catalyze the conversion of L-aspartate and 2-ketoglutarate to oxaloacetate and L-glutamate. EC 2.6.1.1.
Abuse, overuse, or misuse of a substance by its injection into a vein.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
The co-occurrence of pregnancy and an INFECTION. The infection may precede or follow FERTILIZATION.
Organized services to administer immunization procedures in the prevention of various diseases. The programs are made available over a wide range of sites: schools, hospitals, public health agencies, voluntary health agencies, etc. They are administered to an equally wide range of population groups or on various administrative levels: community, municipal, state, national, international.
Diffusible gene products that act on homologous or heterologous molecules of viral or cellular DNA to regulate the expression of proteins.
Any of the processes by which cytoplasmic factors influence the differential control of gene action in viruses.
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
Infectious organisms in the BLOOD, of which the predominant medical interest is their contamination of blood-soiled linens, towels, gowns, BANDAGES, other items from individuals in risk categories, NEEDLES and other sharp objects, MEDICAL WASTE and DENTAL WASTE, all of which health workers are exposed to. This concept is differentiated from the clinical conditions of BACTEREMIA; VIREMIA; and FUNGEMIA where the organism is present in the blood of a patient as the result of a natural infectious process.
Guanine is a purine nucleobase, one of the four nucleobases in the nucleic acid of DNA and RNA, involved in forming hydrogen bonds between complementary base pairs in double-stranded DNA molecules.
The indelible marking of TISSUES, primarily SKIN, by pricking it with NEEDLES to imbed various COLORING AGENTS. Tattooing of the CORNEA is done to colorize LEUKOMA spots.
A family of RNA viruses, many of which cause disease in humans and domestic animals. There are three genera FLAVIVIRUS; PESTIVIRUS; and HEPACIVIRUS, as well as several unassigned species.
Protein precursors, also known as proproteins or prohormones, are inactive forms of proteins that undergo post-translational modification, such as cleavage, to produce the active functional protein or peptide hormone.
The functional hereditary units of VIRUSES.
The mechanism by which latent viruses, such as genetically transmitted tumor viruses (PROVIRUSES) or PROPHAGES of lysogenic bacteria, are induced to replicate and then released as infectious viruses. It may be effected by various endogenous and exogenous stimuli, including B-cell LIPOPOLYSACCHARIDES, glucocorticoid hormones, halogenated pyrimidines, IONIZING RADIATION, ultraviolet light, and superinfecting viruses.
Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed)
Unassigned species, in the family PICORNAVIRIDAE, causing high mortality in ducklings 3 days to 3 weeks old.
An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed.
Elements of limited time intervals, contributing to particular results or situations.
The return of a sign, symptom, or disease after a remission.
The introduction of whole blood or blood component directly into the blood stream. (Dorland, 27th ed)
Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions.
The presence of viruses in the blood.
A form of rapid-onset LIVER FAILURE, also known as fulminant hepatic failure, caused by severe liver injury or massive loss of HEPATOCYTES. It is characterized by sudden development of liver dysfunction and JAUNDICE. Acute liver failure may progress to exhibit cerebral dysfunction even HEPATIC COMA depending on the etiology that includes hepatic ISCHEMIA, drug toxicity, malignant infiltration, and viral hepatitis such as post-transfusion HEPATITIS B and HEPATITIS C.
Small synthetic peptides that mimic surface antigens of pathogens and are immunogenic, or vaccines manufactured with the aid of recombinant DNA techniques. The latter vaccines may also be whole viruses whose nucleic acids have been modified.
Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses.
Diagnostic procedures involving immunoglobulin reactions.
The infective system of a virus, composed of the viral genome, a protein core, and a protein coat called a capsid, which may be naked or enclosed in a lipoprotein envelope called the peplos.
The relationships of groups of organisms as reflected by their genetic makeup.
Removal and pathologic examination of specimens in the form of small pieces of tissue from the living body.
The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES.
A protein-nucleic acid complex which forms part or all of a virion. It consists of a CAPSID plus enclosed nucleic acid. Depending on the virus, the nucleocapsid may correspond to a naked core or be surrounded by a membranous envelope.
Proteins found in any species of virus.
Sites on an antigen that interact with specific antibodies.
A genus of HEPADNAVIRIDAE infecting birds but rarely causing clinical problems. Transmission is predominantly vertical. HEPATITIS B VIRUS, DUCK is the type species.
A genus of HEPADNAVIRIDAE causing hepatitis in humans, woodchucks (HEPATITIS B VIRUS, WOODCHUCK) and ground squirrels. hepatitis b virus is the type species.
An enzyme that synthesizes DNA on an RNA template. It is encoded by the pol gene of retroviruses and by certain retrovirus-like elements. EC 2.7.7.49.
A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, and chemicals from the environment.
A human liver tumor cell line used to study a variety of liver-specific metabolic functions.
A multistage process that includes cloning, physical mapping, subcloning, determination of the DNA SEQUENCE, and information analysis.
The transmission of infectious disease or pathogens from health professional or health care worker to patients. It includes transmission via direct or indirect exposure to bacterial, fungal, parasitic, or viral agents.
Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc.
A pyrimidine nucleoside formed in the body by the deamination of CYTARABINE.
Studies which start with the identification of persons with a disease of interest and a control (comparison, referent) group without the disease. The relationship of an attribute to the disease is examined by comparing diseased and non-diseased persons with regard to the frequency or levels of the attribute in each group.
I'm sorry for any confusion, but "Taiwan" is not a medical term and does not have a medical definition. It is a country located in East Asia. If you have any questions related to healthcare or medical terms, I would be happy to help with those!
I'm sorry for any confusion, but "Brazil" is not a medical term or concept, it is a country located in South America, known officially as the Federative Republic of Brazil. If you have any questions related to health, medicine, or science, I'd be happy to help answer those!
An infant during the first month after birth.
Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation.
Penal institutions, or places of confinement for war prisoners.
Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS.
Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.
Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)
A country in northern Africa, bordering the Mediterranean Sea, between Libya and the Gaza Strip, and the Red Sea north of Sudan, and includes the Asian Sinai Peninsula Its capital is Cairo.
A condition characterized by the presence of abnormal quantities of CRYOGLOBULINS in the blood. Upon cold exposure, these abnormal proteins precipitate into the microvasculature leading to restricted blood flow in the exposed areas.
The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases, new or old, in the population at a given time.
A genus of tree shrews of the family TUPAIIDAE which consists of about 12 species. One of the most frequently encountered species is T. glis. Members of this genus inhabit rain forests and secondary growth areas in southeast Asia.
Any immunization following a primary immunization and involving exposure to the same or a closely related antigen.
Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.
A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally being called a macroglobulin.
Substances elaborated by viruses that have antigenic activity.
Any DNA sequence capable of independent replication or a molecule that possesses a REPLICATION ORIGIN and which is therefore potentially capable of being replicated in a suitable cell. (Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed)
A family of the order Rodentia which contains 49 genera. Some of the more common genera are MARMOTA, which includes the marmot and woodchuck; Sciurus, the gray squirrel, S. carolinensis, and the fox squirrel, S. niger; Tamias, the eastern and western chipmunk; and Tamiasciurus, the red squirrel. The flying squirrels, except the scaly-tailed Anomaluridae, also belong to this family.
Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.
The transmission of infectious disease or pathogens. When transmission is within the same species, the mode can be horizontal or vertical (INFECTIOUS DISEASE TRANSMISSION, VERTICAL).
A subclass of enzymes of the transferase class that catalyze the transfer of an amino group from a donor (generally an amino acid) to an acceptor (generally a 2-keto acid). Most of these enzymes are pyridoxyl phosphate proteins. (Dorland, 28th ed) EC 2.6.1.
I'm sorry for any confusion, but "Pakistan" is a country located in South Asia and it does not have a medical definition. If you have any medical question or term that you would like me to define, please provide it and I will be happy to help.
Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time.
Short sequences (generally about 10 base pairs) of DNA that are complementary to sequences of messenger RNA and allow reverse transcriptases to start copying the adjacent sequences of mRNA. Primers are used extensively in genetic and molecular biology techniques.
The assembly of VIRAL STRUCTURAL PROTEINS and nucleic acid (VIRAL DNA or VIRAL RNA) to form a VIRUS PARTICLE.
A potent hepatotoxic and hepatocarcinogenic mycotoxin produced by the Aspergillus flavus group of fungi. It is also mutagenic, teratogenic, and causes immunosuppression in animals. It is found as a contaminant in peanuts, cottonseed meal, corn, and other grains. The mycotoxin requires epoxidation to aflatoxin B1 2,3-oxide for activation. Microsomal monooxygenases biotransform the toxin to the less toxic metabolites aflatoxin M1 and Q1.
Immunologic techniques based on the use of: (1) enzyme-antibody conjugates; (2) enzyme-antigen conjugates; (3) antienzyme antibody followed by its homologous enzyme; or (4) enzyme-antienzyme complexes. These are used histologically for visualizing or labeling tissue specimens.
The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B.
The outer protein protective shell of a virus, which protects the viral nucleic acid.
'Prisoners,' in a medical context, refer to individuals who are incarcerated and may face challenges in accessing adequate healthcare services due to various systemic and individual barriers, which can significantly impact their health status and outcomes.
DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes.
I'm sorry for any confusion, but "Moldova" is not a medical term and does not have a medical definition. It is the name of a country located in Eastern Europe, bordered by Romania to the west and Ukraine to the north, east, and south. If you have any questions related to healthcare or medical topics, I would be happy to help with those!
Genotypic differences observed among individuals in a population.
Penetrating stab wounds caused by needles. They are of special concern to health care workers since such injuries put them at risk for developing infectious disease.
The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.
A bile pigment that is a degradation product of HEME.
The first alpha-globulins to appear in mammalian sera during FETAL DEVELOPMENT and the dominant serum proteins in early embryonic life.
Organized periodic procedures performed on large groups of people for the purpose of detecting disease.
Viral diseases which are transmitted or propagated by sexual conduct.
The sexual attraction or relationship between members of the same SEX.
Any of the covalently closed DNA molecules found in bacteria, many viruses, mitochondria, plastids, and plasmids. Small, polydisperse circular DNA's have also been observed in a number of eukaryotic organisms and are suggested to have homology with chromosomal DNA and the capacity to be inserted into, and excised from, chromosomal DNA. It is a fragment of DNA formed by a process of looping out and deletion, containing a constant region of the mu heavy chain and the 3'-part of the mu switch region. Circular DNA is a normal product of rearrangement among gene segments encoding the variable regions of immunoglobulin light and heavy chains, as well as the T-cell receptor. (Riger et al., Glossary of Genetics, 5th ed & Segen, Dictionary of Modern Medicine, 1992)
Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow).
DNA-dependent DNA polymerases found in bacteria, animal and plant cells. During the replication process, these enzymes catalyze the addition of deoxyribonucleotide residues to the end of a DNA strand in the presence of DNA as template-primer. They also possess exonuclease activity and therefore function in DNA repair.
The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
Tetraspanin proteins that are involved in a variety of cellular functions including BASEMENT MEMBRANE assembly, and in the formation of a molecular complexes on the surface of LYMPHOCYTES.
A species of virus (unassigned to a genus) in the family FLAVIVIRIDAE. It is genetically heterogeneous, of human origin, and transmitted by blood or blood products. Despite its alternate name (Hepatitis G virus), its pathogenicity remains controversial.
Commercially prepared reagent sets, with accessory devices, containing all of the major components and literature necessary to perform one or more designated diagnostic tests or procedures. They may be for laboratory or personal use.
The degree to which the blood supply for BLOOD TRANSFUSIONS is free of harmful substances or infectious agents, and properly typed and crossmatched (BLOOD GROUPING AND CROSSMATCHING) to insure serological compatibility between BLOOD DONORS and recipients.
The study of the structure, growth, function, genetics, and reproduction of viruses, and VIRUS DISEASES.
I'm sorry for any confusion, but "India" is not a medical term that can be defined in a medical context. It is a geographical location, referring to the Republic of India, a country in South Asia. If you have any questions related to medical topics or definitions, I would be happy to help with those!
A malignant neoplasm occurring in young children, primarily in the liver, composed of tissue resembling embryonal or fetal hepatic epithelium, or mixed epithelial and mesenchymal tissues. (Stedman, 25th ed)
Infections with viruses of the family FLAVIVIRIDAE.
Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely.
The term "United States" in a medical context often refers to the country where a patient or study participant resides, and is not a medical term per se, but relevant for epidemiological studies, healthcare policies, and understanding differences in disease prevalence, treatment patterns, and health outcomes across various geographic locations.
Further or repeated use of equipment, instruments, devices, or materials. It includes additional use regardless of the original intent of the producer as to disposability or durability. It does not include the repeated use of fluids or solutions.
The biosynthesis of RNA carried out on a template of DNA. The biosynthesis of DNA from an RNA template is called REVERSE TRANSCRIPTION.
Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it.
The transmission of infectious disease or pathogens from patients to health professionals or health care workers. It includes transmission via direct or indirect exposure to bacterial, fungal, parasitic, or viral agents.
Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION.
A cell line derived from cultured tumor cells.

Hepatitis B--are surgeons putting patients at risk? (1/4232)

The 1993 Department of Health guidelines permit a surgeon who is hepatitis B surface antigen (HBsAg) positive but e-antigen (HBeAg) negative to perform exposure prone procedures, unless demonstrated to have infected patients. However, there is increasing evidence of transmission of hepatitis B to patients from health care workers in this supposedly low infectivity category. The Occupational Physician must decide whether existing guidelines represent an adequate risk assessment and indeed whether this is an acceptable risk for patients. If an NHS Trust continues to follow these guidelines it may be in breach of its duty of care to patients. Yet refusing to allow such carriers to operate without testing for additional serological markers may be unlawful discrimination. Further research is clearly needed as well as an urgent review of the guidelines.  (+info)

Third component, HBeAg/3, of hepatitis B e antigen system, identified by three different double-diffusion techniques. (2/4232)

A third component, HB(e)AG/3, of the hepatitis B e antigen system has been detected, and it was consistently detected in three variations of the double-diffusion technique.  (+info)

Hepatitis virus infection in haemodialysis patients from Moldavia. (3/4232)

BACKGROUND: Although the epidemiology of hepatitis B (HBV) and C (HCV) now seems well established for Western European countries, in Central and Eastern Europe < 50% of all dialysis centres routinely test for hepatitis C antibodies since testing is not available or is not applied to all patients. This study describes the prevalence, risk factors and clinical significance of HBV and HCV infection for the haemodialysis population of the North Eastern region of Romania, Moldavia. METHODS: The presence of HBV antigens was determined with an ELISA kit (Wellcome, Abbot) and HCV antibodies with the ELISA-3 Ortho-HCV, third generation test. The following individual data were collected: gender, age, duration of dialysis, rural/urban domicile, actual and previous HBV status, actual HCV status, known acute, clinically evident hepatitis episodes in the last 3 years, monthly alanine aminotransferase (ALAT) and aspartate aminotransferase (ASAT) levels, complete biochemical hepatic assessment at the time of the study, transfusions for the past 3 years and family history. RESULTS: HBV and HCV prevalences were 17% (stable over the last 3 years) and 75%, respectively; co-infection was seen in 10% of the subjects. Hospitalization (nosocomial infection) for HBV, blood transfusions and duration on dialysis for HCV, emerged as the main risk factors for hepatitis infection. Socio-economic conditions appear to be equally important for HCV infection, since the prevalence was significantly higher among patients from rural, underdeveloped areas than urban areas (80.8 vs 60.3%), and infection was already present in a large proportion of patients (47%) before starting dialysis, without being related to previous disease duration or blood transfusions. HBV and/or HCV was not associated with a worse clinical or biochemical profile at the time of the study. However, infected patients had significantly more previous cytolytic episodes, with higher, transient increases in ALAT and ASAT levels. CONCLUSIONS: HCV infection is endemic among dialysis centres in Moldavia. Apart from previously well-known risk factors for hepatitis infection, our study demonstrates the negative impact of socio-economic underdevelopment. Simple measures such as enforced general asepsia rules, careful disinfection and equipment sterilization, routine testing of patients from economically disadvantaged areas and monthly, serial determination of hepatic enzymes should be the common practice in dialysis centres in Romania.  (+info)

Candidate viral diseases for elimination or eradication. (4/4232)

This article discusses the possibilities for elimination or eradication of four viral diseases--measles, hepatitis B, rubella and yellow fever.  (+info)

Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers. (5/4232)

Virus load and liver damage, as measured by quantitative polymerase chain reaction and histology activity index, were related to genotype and core promoter mutations in 43 chronic hepatitis B virus (HBV) carriers of East Asian origin. T-1762 mutants were more frequent in genotype C strains and were associated with more inflammation (P=.0036) and fibrosis (P=.0088) of the liver but not with hepatitis B e antigen (HBeAg) status or virus load. Conversely, precore mutations were associated with less liver inflammation (P=. 08), which was linked to HBeAg negativity and lower viral replication. Carriers with genotype C were more often HBeAg positive (P=.03) with precore wild type strains and more-severe liver inflammation (P=.009) than were those with genotype B. These findings suggest that pathogenic differences between genotypes may exist and that the T-1762 mutation may be useful as a marker for progressive liver damage but seem to contradict that down-regulation of HBeAg production is the major effect of this mutation.  (+info)

Class II HLA alleles and hepatitis B virus persistence in African Americans. (6/4232)

Persistence of hepatitis B virus (HBV) infection is likely due to the interplay of the virus and host immune response. Given its critical role in antigen presentation, allelic differences in the HLA complex may affect HBV persistence. In a prospectively followed African American cohort, molecular class I and class II HLA typing was done on 31 subjects with persistent HBV infection and 60 controls who cleared the infection. HBV persistence was significantly associated with two class II alleles, DQA1 *0501 (odds ratio [OR], 2.6; P=.05) and DQB1 *0301 (OR, 3.9; P=.01), the two-locus haplotype consisting of these same two alleles (OR, 3; P=. 005) and the three-locus haplotype, DQA1 *0501, DQB1 *0301, and DRB1 *1102 (OR, 10.7; P=.01). In addition, HBV persistence was associated with class II allelic homozygosity. Several class I associations with persistence were also noted but were not statistically significant after correction for multiple comparisons. These results underscore the importance of the class II-mediated immune response in recovery from HBV infection.  (+info)

Home delivery of heat-stable vaccines in Indonesia: outreach immunization with a prefilled, single-use injection device. (7/4232)

Extending immunization coverage to underserved populations will require innovative immunization strategies. This study evaluated one such strategy: the use of a prefilled, single-use injection device for outreach immunization by village midwives. The device, UniJect, is designed to prevent refilling or reuse. Stored at ambient temperatures for up to 1 month in midwives' homes, vaccine-filled UniJect devices were immediately available for outreach. Between July 1995 and April 1996, 110 midwives on the Indonesia islands of Lombok and Bali visited the homes of newborn infants to deliver hepatitis B vaccine to the infants and tetanus toxoid to their mothers. Observations and interviews showed that the midwives used the device properly and safely to administer approximately 10,000 sterile injections in home settings. There were no problems with excessive heat exposure during the storage or delivery of vaccine. Injection recipients and midwives expressed a strong preference for the UniJect device over a standard syringe. Use of the prefilled device outside the cold chain simplified the logistics and facilitated the speed and efficiency of home visits, while the single-dose format minimized vaccine wastage.  (+info)

Hepadnavirus evolution and molecular strategy of adaptation in a new host. (8/4232)

In order to elucidate the mechanisms of hepadnavirus evolution in vivo and to trace the fate of known quasispecies in a single animal during the acute phase of infection, a woodchuck (Marmota monax) was infected with the hepadnavirus woodchuck hepatitis B virus (WHV). Woodchuck 197 (W197) was injected intravenously with pooled sera collected from a chronic carrier that had been infected originally with a molecular clone of known genome sequence (WHV7). Viral genome variants from both the inoculum and the follow-up sera from W197 were characterized for the presence of quasispecies related to the WHV7 sequence. Interestingly, WHV7-related genomes were predominant 6 weeks post-infection (p.i.), whereas a highly heterogeneous virus population was present in the first viraemic serum (4 weeks p.i.). Using WHV7 as the prototype, the variability of the Pol and PreS/S regions in the first 11 weeks p.i. has been calculated. The sequence population in serum collected 6 weeks p.i. was highly homogeneous, with a mean variability of 0.36% in the region analysed. Mean variability values ranging from 0.82% to 1.61% were found in quasispecies from the other sera. The presence of possible selective pressure was analysed by means of the non-synonymous versus synonymous variation ratio (dn/d5). We found that the dn/d5 values were stable for the S ORF (ranging from 2.6 to 3.0), whereas a wider range was observed for the Pol ORF (from 1.4 to 3.0). Furthermore, from the analysis of the variability of the codon positions for the two overlapping ORFs it was found that, in most cases, non-synonymous mutations at position 1 of the Pol ORF (position 3 of the S ORF) corresponded to synonymous variation in the S (Pol) ORF, indicating independent evolution of the encoded proteins.  (+info)

Hepatitis B is a viral infection that attacks the liver and can cause both acute and chronic disease. The virus is transmitted through contact with infected blood, semen, and other bodily fluids. It can also be passed from an infected mother to her baby at birth.

Acute hepatitis B infection lasts for a few weeks to several months and often causes no symptoms. However, some people may experience mild to severe flu-like symptoms, yellowing of the skin and eyes (jaundice), dark urine, and fatigue. Most adults with acute hepatitis B recover completely and develop lifelong immunity to the virus.

Chronic hepatitis B infection can lead to serious liver damage, including cirrhosis and liver cancer. People with chronic hepatitis B may experience long-term symptoms such as fatigue, joint pain, and depression. They are also at risk for developing liver failure and liver cancer.

Prevention measures include vaccination, safe sex practices, avoiding sharing needles or other drug injection equipment, and covering wounds and skin rashes. There is no specific treatment for acute hepatitis B, but chronic hepatitis B can be treated with antiviral medications to slow the progression of liver damage.

Hepatitis B virus (HBV) is a DNA virus that belongs to the Hepadnaviridae family and causes the infectious disease known as hepatitis B. This virus primarily targets the liver, where it can lead to inflammation and damage of the liver tissue. The infection can range from acute to chronic, with chronic hepatitis B increasing the risk of developing serious liver complications such as cirrhosis and liver cancer.

The Hepatitis B virus has a complex life cycle, involving both nuclear and cytoplasmic phases. It enters hepatocytes (liver cells) via binding to specific receptors and is taken up by endocytosis. The viral DNA is released into the nucleus, where it is converted into a covalently closed circular DNA (cccDNA) form, which serves as the template for viral transcription.

HBV transcribes several RNAs, including pregenomic RNA (pgRNA), which is used as a template for reverse transcription during virion assembly. The pgRNA is encapsidated into core particles along with the viral polymerase and undergoes reverse transcription to generate new viral DNA. This process occurs within the cytoplasm of the hepatocyte, resulting in the formation of immature virions containing partially double-stranded DNA.

These immature virions are then enveloped by host cell membranes containing HBV envelope proteins (known as surface antigens) to form mature virions that can be secreted from the hepatocyte and infect other cells. The virus can also integrate into the host genome, which may contribute to the development of hepatocellular carcinoma in chronic cases.

Hepatitis B is primarily transmitted through exposure to infected blood or bodily fluids containing the virus, such as through sexual contact, sharing needles, or from mother to child during childbirth. Prevention strategies include vaccination, safe sex practices, and avoiding needle-sharing behaviors. Treatment for hepatitis B typically involves antiviral medications that can help suppress viral replication and reduce the risk of liver damage.

Hepatitis B Surface Antigens (HBsAg) are proteins found on the surface of the Hepatitis B virus. They are present in the blood of individuals infected with the Hepatitis B virus and are used as a marker for the presence of a current Hepatitis B infection. The detection of HBsAg in the blood indicates that an individual is infectious and can transmit the virus to others. It is typically used in diagnostic tests to detect and diagnose Hepatitis B infections, monitor treatment response, and assess the risk of transmission.

Chronic Hepatitis B is a persistent infection of the liver caused by the hepatitis B virus (HBV), which can lead to chronic inflammation and scarring of the liver over time. It is defined as the presence of hepatitis B surface antigen (HBsAg) in the blood for more than six months.

The infection can be asymptomatic or may cause nonspecific symptoms such as fatigue, loss of appetite, nausea, and joint pain. A small percentage of people with chronic HBV infection may develop serious complications, including cirrhosis, liver failure, and liver cancer. Treatment options for chronic hepatitis B include antiviral medications that can help to suppress the virus and reduce the risk of liver damage. Vaccination is available to prevent hepatitis B infection.

"Hepatitis B vaccines are vaccines that prevent infection caused by the hepatitis B virus. They work by introducing a small and harmless piece of the virus to your body, which triggers your immune system to produce antibodies to fight off the infection. These antibodies remain in your body and provide protection if you are exposed to the real hepatitis B virus in the future.

The hepatitis B vaccine is typically given as a series of three shots over a six-month period. It is recommended for all infants, children and adolescents who have not previously been vaccinated, as well as for adults who are at increased risk of infection, such as healthcare workers, people who inject drugs, and those with certain medical conditions.

It's important to note that hepatitis B vaccine does not provide protection against other types of viral hepatitis, such as hepatitis A or C."

Hepatitis B antibodies are proteins produced by the immune system in response to the presence of the Hepatitis B virus. There are two main types of Hepatitis B antibodies:

1. Hepatitis B surface antibody (anti-HBs): This is produced when a person has recovered from a Hepatitis B infection or has been successfully vaccinated against the virus. The presence of anti-HBs indicates immunity to Hepatitis B.
2. Hepatitis B core antibody (anti-HBC): This is produced during a Hepatitis B infection and remains present for life, even after the infection has been cleared. However, the presence of anti-HBC alone does not indicate immunity to Hepatitis B, as it can also be present in people who have a chronic Hepatitis B infection.

It's important to note that testing for Hepatitis B antibodies is typically done through blood tests and can help determine whether a person has been infected with the virus, has recovered from an infection, or has been vaccinated against it.

Hepatitis B core antigen (HBcAg) is a protein found in the core of the hepatitis B virus (HBV). It is present during active replication of the virus and plays a crucial role in the formation of the viral capsid or core. The antibodies produced against HBcAg (anti-HBc) can be detected in the blood, which serves as a marker for current or past HBV infection. It is important to note that HBcAg itself is not detectable in the blood because it is confined within the viral particle. However, during the serological testing of hepatitis B, the detection of anti-HBc IgM indicates a recent acute infection, while the presence of anti-HBc IgG suggests either a past resolved infection or an ongoing chronic infection.

Hepatitis B e antigen (HBeAg) is a protein produced by the hepatitis B virus (HBV) during its replication process. It can be found in the blood of individuals infected with HBV. The presence of HBeAg generally indicates that the virus is actively replicating in the liver and that the individual has high levels of viral load.

HBeAg is a serological marker used to assess the severity and activity of HBV infection, as well as the response to antiviral treatment. In particular, the disappearance of HBeAg from the blood (known as seroconversion) is often associated with a decrease in viral replication and an improvement in liver disease. However, the presence of HBeAg does not necessarily mean that the individual will develop symptoms or liver damage, as some people can remain asymptomatic carriers of the virus for many years.

It's important to note that not all HBV strains produce HBeAg, and some mutant strains may not produce detectable levels of this antigen even when the virus is actively replicating. Therefore, additional tests may be needed to confirm the presence or absence of HBV infection in these cases.

Hepatitis C is a liver infection caused by the hepatitis C virus (HCV). It's primarily spread through contact with contaminated blood, often through sharing needles or other equipment to inject drugs. For some people, hepatitis C is a short-term illness but for most — about 75-85% — it becomes a long-term, chronic infection that can lead to serious health problems like liver damage, liver failure, and even liver cancer. The virus can infect and inflame the liver, causing symptoms like jaundice (yellowing of the skin and eyes), abdominal pain, fatigue, and dark urine. Many people with hepatitis C don't have any symptoms, so they might not know they have the infection until they experience complications. There are effective treatments available for hepatitis C, including antiviral medications that can cure the infection in most people. Regular testing is important to diagnose and treat hepatitis C early, before it causes serious health problems.

Hepatitis A is a viral infection that specifically targets the liver, causing inflammation and impaired function. This disease is caused by the hepatitis A virus (HAV), which spreads primarily through the fecal-oral route, often due to poor sanitation and hygiene. Individuals can become infected by consuming food or water contaminated with HAV or by coming into direct contact with an infected person's stool.

The symptoms of hepatitis A may include fatigue, loss of appetite, nausea, vomiting, abdominal pain, dark urine, clay-colored bowel movements, joint pain, and jaundice (yellowing of the skin and eyes). However, in some cases, particularly in children under six years old, the infection may be asymptomatic.

While hepatitis A can be unpleasant and cause serious complications, it is rarely fatal and most people recover completely within a few months. Preventive measures include vaccination, practicing good hygiene, and avoiding potentially contaminated food and water.

Hepatitis B antigens are proteins or particles present on the surface (HBsAg) or inside (HBcAg, HBeAg) the hepatitis B virus.

1. HBsAg (Hepatitis B surface antigen): This is a protein found on the outer surface of the hepatitis B virus. Its presence in the blood indicates an active infection with hepatitis B virus. It's also used as a marker to diagnose hepatitis B infection and monitor treatment response.

2. HBcAg (Hepatitis B core antigen): This is a protein found inside the hepatitis B virus core. It's not usually detected in the blood, but its antibodies (anti-HBc) are used to diagnose past or present hepatitis B infection.

3. HBeAg (Hepatitis B e antigen): This is a protein found inside the hepatitis B virus core and is associated with viral replication. Its presence in the blood indicates high levels of viral replication, increased infectivity, and higher risk of liver damage. It's used to monitor disease progression and treatment response.

These antigens play a crucial role in the diagnosis, management, and prevention of hepatitis B infection.

Hepatitis is a medical condition characterized by inflammation of the liver, often resulting in damage to liver cells. It can be caused by various factors, including viral infections (such as Hepatitis A, B, C, D, and E), alcohol abuse, toxins, medications, and autoimmune disorders. Symptoms may include jaundice, fatigue, abdominal pain, loss of appetite, nausea, vomiting, and dark urine. The severity of the disease can range from mild illness to severe, life-threatening conditions, such as liver failure or cirrhosis.

Viral hepatitis in humans refers to inflammation of the liver caused by infection with viruses that primarily target the liver. There are five main types of human viral hepatitis, designated as Hepatitis A, B, C, D, and E virus (HAV, HBV, HCV, HDV, and HEV). These viruses can cause a range of illnesses, from acute self-limiting hepatitis to chronic hepatitis, which can lead to cirrhosis and liver cancer.

1. Hepatitis A virus (HAV) is typically spread through the fecal-oral route, often through contaminated food or water. It usually results in an acute self-limiting infection, but rarely can cause chronic hepatitis in individuals with weakened immune systems.
2. Hepatitis B virus (HBV) is primarily transmitted through contact with infected blood, semen, and other bodily fluids. It can lead to both acute and chronic hepatitis, which may result in cirrhosis and liver cancer if left untreated.
3. Hepatitis C virus (HCV) is predominantly spread through exposure to infected blood, such as through sharing needles or receiving contaminated blood transfusions. Chronic hepatitis C is common, and it can lead to serious liver complications like cirrhosis and liver cancer if not treated.
4. Hepatitis D virus (HDV) is an incomplete virus that requires the presence of HBV for its replication. HDV infection occurs only in individuals already infected with HBV, leading to more severe liver disease compared to HBV monoinfection.
5. Hepatitis E virus (HEV) is primarily transmitted through the fecal-oral route, often through contaminated food or water. It usually results in an acute self-limiting infection but can cause chronic hepatitis in pregnant women and individuals with weakened immune systems.

Prevention measures include vaccination for HAV and HBV, safe sex practices, avoiding sharing needles, and ensuring proper hygiene and sanitation to prevent fecal-oral transmission.

Chronic Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that lasts for more than six months. This long-term infection can lead to scarring of the liver (cirrhosis), which can cause serious health problems, such as liver failure or liver cancer, in some individuals. The infection is usually asymptomatic until complications arise, but it can be detected through blood tests that identify antibodies to the virus or viral RNA. Chronic hepatitis C is typically managed with antiviral therapy, which can help clear the virus from the body and reduce the risk of liver damage.

Hepatitis A virus (HAV) is the causative agent of hepatitis A, a viral infection that causes inflammation of the liver. It is a small, non-enveloped, single-stranded RNA virus belonging to the Picornaviridae family and Hepatovirus genus. The virus primarily spreads through the fecal-oral route, often through contaminated food or water, or close contact with an infected person. After entering the body, HAV infects hepatocytes in the liver, leading to liver damage and associated symptoms such as jaundice, fatigue, abdominal pain, and nausea. The immune system eventually clears the infection, providing lifelong immunity against future HAV infections. Preventive measures include vaccination and practicing good hygiene to prevent transmission.

Duck hepatitis B virus (DHBV) is not a medical definition related to human health, but it is a species of hepatitis B virus that primarily infects various species of ducks and other Anseriformes (waterfowl). It is closely related to the human hepatitis B virus (HBV), but it is not known to infect humans or other mammals.

DHBV, like HBV, is a DNA virus that targets the liver and can cause both acute and chronic infections. The virus is transmitted through the fecal-oral route and primarily affects young ducklings. Infection with DHBV can lead to liver damage and death in infected birds.

Researchers study DHBV as a model system for understanding HBV infection and pathogenesis, due to their similarities in viral structure, replication strategy, and host-virus interactions. However, it is important to note that DHBV is not a human health concern and does not pose a risk of infection to humans or other mammals.

Chronic hepatitis is a type of liver inflammation that lasts for more than six months and can lead to scarring of the liver (cirrhosis), liver failure, and even liver cancer in some cases. It can be caused by various factors, including viral infections such as Hepatitis B and C, autoimmune disorders, alcohol abuse, and non-alcoholic fatty liver disease. The symptoms of chronic hepatitis may include fatigue, loss of appetite, nausea, vomiting, abdominal pain, joint pain, dark urine, and jaundice (yellowing of the skin and eyes). Treatment for chronic hepatitis depends on the underlying cause and may include antiviral medications, immunosuppressive drugs, or lifestyle changes.

Hepatitis antibodies are proteins produced by the immune system in response to an infection caused by a hepatitis virus. There are several types of hepatitis viruses, including A, B, C, D, and E, each with their own specific antibodies.

The presence of hepatitis antibodies in the blood can indicate a current or past infection with the corresponding hepatitis virus. For example, the detection of anti-HAV (hepatitis A virus) antibodies indicates a past infection or immunization against hepatitis A, while the detection of anti-HBs (hepatitis B surface antigen) antibodies indicates immunity due to vaccination or recovery from a hepatitis B infection.

It's important to note that some hepatitis antibodies may not provide immunity to future infections, and individuals can still be infected with the virus even if they have previously produced antibodies against it. Therefore, regular testing and vaccination are essential for preventing the spread of hepatitis viruses and protecting public health.

Antiviral agents are a class of medications that are designed to treat infections caused by viruses. Unlike antibiotics, which target bacteria, antiviral agents interfere with the replication and infection mechanisms of viruses, either by inhibiting their ability to replicate or by modulating the host's immune response to the virus.

Antiviral agents are used to treat a variety of viral infections, including influenza, herpes simplex virus (HSV) infections, human immunodeficiency virus (HIV) infection, hepatitis B and C, and respiratory syncytial virus (RSV) infections.

These medications can be administered orally, intravenously, or topically, depending on the type of viral infection being treated. Some antiviral agents are also used for prophylaxis, or prevention, of certain viral infections.

It is important to note that antiviral agents are not effective against all types of viruses and may have significant side effects. Therefore, it is essential to consult with a healthcare professional before starting any antiviral therapy.

Hepacivirus is a genus of viruses in the family Flaviviridae. The most well-known member of this genus is Hepatitis C virus (HCV), which is a major cause of liver disease worldwide. HCV infection can lead to chronic hepatitis, cirrhosis, and liver cancer.

Hepaciviruses are enveloped viruses with a single-stranded, positive-sense RNA genome. They have a small icosahedral capsid and infect a variety of hosts, including humans, non-human primates, horses, and birds. The virus enters the host cell by binding to specific receptors on the cell surface and is then internalized through endocytosis.

HCV has a high degree of genetic diversity and is classified into seven major genotypes and numerous subtypes based on differences in its RNA sequence. This genetic variability can affect the virus's ability to evade the host immune response, making treatment more challenging.

In addition to HCV, other hepaciviruses have been identified in various animal species, including equine hepacivirus (EHCV), rodent hepacivirus (RHV), and bat hepacivirus (BtHepCV). These viruses are being studied to better understand the biology of hepaciviruses and their potential impact on human health.

Hepatitis A vaccines are inactivated or live attenuated viral vaccines that are administered to prevent infection and illness caused by the hepatitis A virus. The vaccine contains antigens that stimulate an immune response in the body, leading to the production of antibodies that protect against future infection with the virus.

The inactivated hepatitis A vaccine is made from viruses that have been chemically treated to destroy their ability to cause disease while preserving their ability to stimulate an immune response. This type of vaccine is typically given in two doses, six months apart, and provides long-term protection against the virus.

The live attenuated hepatitis A vaccine contains a weakened form of the virus that is unable to cause illness but can still stimulate an immune response. This type of vaccine is given as a single dose and provides protection against the virus for at least 20 years.

Hepatitis A vaccines are recommended for people who are at increased risk of infection, including travelers to areas where hepatitis A is common, men who have sex with men, people who use injection drugs, and people with chronic liver disease or clotting factor disorders. The vaccine is also recommended for children in certain states and communities where hepatitis A is endemic.

Hepatitis C antibodies are proteins produced by the immune system in response to an infection with the hepatitis C virus (HCV). Detection of these antibodies in the blood indicates a past or present HCV infection. However, it does not necessarily mean that the person is currently infected, as antibodies can persist for years even after the virus has been cleared from the body. Additional tests are usually needed to confirm whether the infection is still active and to guide treatment decisions.

Viral DNA refers to the genetic material present in viruses that consist of DNA as their core component. Deoxyribonucleic acid (DNA) is one of the two types of nucleic acids that are responsible for storing and transmitting genetic information in living organisms. Viruses are infectious agents much smaller than bacteria that can only replicate inside the cells of other organisms, called hosts.

Viral DNA can be double-stranded (dsDNA) or single-stranded (ssDNA), depending on the type of virus. Double-stranded DNA viruses have a genome made up of two complementary strands of DNA, while single-stranded DNA viruses contain only one strand of DNA.

Examples of dsDNA viruses include Adenoviruses, Herpesviruses, and Poxviruses, while ssDNA viruses include Parvoviruses and Circoviruses. Viral DNA plays a crucial role in the replication cycle of the virus, encoding for various proteins necessary for its multiplication and survival within the host cell.

I'm sorry for any confusion, but "Viral Hepatitis, Animal" is not a standard medical classification or definition. Hepatitis refers to inflammation of the liver, and viral hepatitis refers to inflammation caused by a virus. The term "animal" in this context doesn't provide a clear meaning.

However, it's worth noting that some animals can contract viral hepatitis, similar to humans. For instance, there are hepatitis A, B, and C-like viruses that have been identified in various animal species. These are typically not transmissible to humans.

If you're referring to a specific medical condition or context, could you please provide more details? I'd be happy to help further with more information.

Hepatitis D, also known as Delta hepatitis, is a viral infection of the liver that can only occur in people who have a current infection with the hepatitis B virus (HBV). It's caused by the hepatitis delta virus (HDV), which is a small, enveloped, single-stranded RNA virus.

HDV requires the presence of HBV for its replication and survival, so it can't infect someone who doesn't already have HBV. When both viruses are present, they can interact in ways that lead to more severe liver disease than either virus would cause alone.

Hepatitis D can be an acute or chronic infection, and it can range from mild to severe, with symptoms similar to those of other types of viral hepatitis, such as jaundice, fatigue, loss of appetite, nausea, vomiting, abdominal pain, and joint pain. In some cases, hepatitis D can lead to serious complications, including liver failure and death.

Hepatitis D is primarily spread through contact with infected blood or other bodily fluids, such as during sexual contact, sharing needles, or mother-to-child transmission during childbirth. It's preventable through vaccination against hepatitis B, which provides immunity to both viruses. There is no specific treatment for hepatitis D, but antiviral therapy for hepatitis B can help manage the infection and prevent complications.

Hepatitis viruses refer to a group of viral agents that primarily target the liver, causing inflammation and damage to hepatocytes (liver cells). This results in various clinical manifestations, ranging from an acute infection to a chronic, persistent infection. There are five main types of hepatitis viruses, named Hepatitis A, B, C, D, and E virus, each with distinct genetic material, modes of transmission, and disease severity.

1. Hepatitis A Virus (HAV): This is a single-stranded RNA virus that is primarily transmitted through the fecal-oral route, often via contaminated food or water. Infected individuals may experience symptoms such as jaundice, fatigue, abdominal pain, and loss of appetite. While most people recover completely within a few months, severe complications can occur in rare cases. A vaccine is available to prevent HAV infection.
2. Hepatitis B Virus (HBV): This is a double-stranded DNA virus that is primarily transmitted through contact with infected blood or bodily fluids, such as during sexual contact, sharing needles, or from mother to child during childbirth. HBV can cause both acute and chronic hepatitis, which may lead to severe liver complications like cirrhosis and liver cancer if left untreated. A vaccine is available to prevent HBV infection.
3. Hepatitis C Virus (HCV): This is a single-stranded RNA virus that is primarily transmitted through contact with infected blood, often through sharing needles or during medical procedures using contaminated equipment. Like HBV, HCV can cause both acute and chronic hepatitis, which may lead to severe liver complications if left untreated. No vaccine is currently available for HCV; however, antiviral treatments can cure the infection in many cases.
4. Hepatitis D Virus (HDV): This is a defective RNA virus that requires the presence of HBV to replicate and cause infection. HDV is primarily transmitted through contact with infected blood or bodily fluids, similar to HBV. Co-infection with both HBV and HDV can result in more severe liver disease compared to HBV infection alone. Antiviral treatments are available for HDV; however, a vaccine is not.
5. Hepatitis E Virus (HEV): This is a single-stranded RNA virus that primarily causes acute hepatitis and is usually transmitted through the fecal-oral route, often through contaminated food or water. In most cases, HEV infection resolves on its own without treatment. However, in pregnant women and individuals with weakened immune systems, HEV can cause severe liver complications. No vaccine is currently available for HEV in the United States; however, a vaccine has been approved in some countries.

Viral hepatitis vaccines are vaccines that prevent infection caused by various hepatitis viruses, including hepatitis A and B. These vaccines contain antigens that stimulate the immune system to produce antibodies that protect against infection with the corresponding virus. The vaccines are typically administered through injection and may require multiple doses for full protection.

The hepatitis A vaccine is made from inactivated hepatitis A virus, while the hepatitis B vaccine is made from recombinant hepatitis B surface antigen. Both vaccines have been shown to be highly effective in preventing infection and reducing the risk of complications associated with viral hepatitis, such as liver disease and liver cancer.

It's important to note that there are no vaccines available for other types of viral hepatitis, such as hepatitis C, D, or E. Prevention strategies for these types of viral hepatitis typically involve measures to reduce exposure to the virus, such as safe injection practices and avoiding high-risk behaviors like sharing needles or having unprotected sex with infected individuals.

Lamivudine is an antiretroviral medication used in the treatment and management of HIV (Human Immunodeficiency Virus) infection and HBV (Hepatitis B Virus) infection. It is a nucleoside reverse transcriptase inhibitor (NRTI), which means it works by blocking the action of the reverse transcriptase enzyme that the viruses need to multiply. By doing this, Lamivudine helps to reduce the amount of the virus in the body, which in turn helps to slow down or prevent the damage that the virus can cause to the immune system and improve the patient's quality of life.

The medical definition of Lamivudine is: "A synthetic nucleoside analogue with activity against both HIV-1 and HBV. It is used in the treatment of HIV infection and AIDS, as well as chronic hepatitis B."

Hepatitis E is a viral infection that specifically affects the liver, caused by the hepatitis E virus (HEV). The disease is primarily transmitted through the fecal-oral route, often through contaminated water or food. It can also be spread through blood transfusions and vertical transmission from mother to fetus.

The incubation period for hepatitis E ranges from 2 to 10 weeks. Symptoms of the disease are similar to other types of viral hepatitis and may include jaundice (yellowing of the skin and eyes), fatigue, loss of appetite, abdominal pain, nausea, vomiting, joint pain, and dark urine.

In most cases, hepatitis E is a self-limiting disease, meaning that it resolves on its own within a few weeks to months. However, in some individuals, particularly those with weakened immune systems, the infection can lead to severe complications such as acute liver failure and death. Pregnant women, especially those in the third trimester, are at higher risk of developing severe disease and have a mortality rate of up to 25%.

Prevention measures include maintaining good hygiene practices, practicing safe food handling and preparation, and ensuring access to clean water sources. Currently, there is no specific treatment for hepatitis E, but supportive care can help manage symptoms. Vaccines are available in some countries to prevent the disease.

Hepatitis Delta Virus (HDV) is not a traditional virus but rather a defective RNA particle that requires the assistance of the hepatitis B virus (HBV) to replicate. It's also known as delta agent or hepatitis D. HDV is a unique pathogen that only infects individuals who are already infected with HBV.

The virus causes a more severe form of viral hepatitis than HBV alone, leading to a higher risk of fulminant hepatitis (acute liver failure) and chronic hepatitis, which can progress to cirrhosis and hepatocellular carcinoma. HDV is primarily transmitted through percutaneous or sexual contact with infected blood or body fluids.

Prevention strategies include vaccination against HBV, which also prevents HDV infection, and avoiding high-risk behaviors such as intravenous drug use and unprotected sex with multiple partners. There is no specific treatment for HDV; however, antiviral therapy for HBV can help manage the infection.

Hepatitis A antibodies are proteins produced by the immune system in response to a Hepatitis A virus infection or after vaccination. There are two types of Hepatitis A antibodies:

1. IgM anti-HAV (Hepatitis A Virus) antibodies: These are the first type of antibodies produced by the immune system during a Hepatitis A infection. They appear in the blood within 2 to 4 weeks after exposure to the virus and remain detectable for up to 12 weeks. The presence of IgM anti-HAV antibodies indicates a recent or ongoing Hepatitis A infection.

2. IgG anti-HAV antibodies: These are the second type of antibodies produced by the immune system during a Hepatitis A infection, and they appear in the blood several weeks after the onset of illness. IgG anti-HAV antibodies remain detectable for many years, providing long-term immunity against future Hepatitis A infections. After vaccination, only IgG anti-HAV antibodies are produced, indicating immunity to Hepatitis A.

Testing for Hepatitis A antibodies is used to diagnose acute or past Hepatitis A infections and to assess immunity following vaccination.

Hepatitis E virus (HEV) is a single-stranded, positive-sense RNA virus that belongs to the family Hepeviridae and genus Orthohepevirus. It primarily infects the liver, causing acute hepatitis in humans. The virus is transmitted through the fecal-oral route, often through contaminated water or food sources. Ingestion of raw or undercooked pork or deer meat can also lead to HEV infection.

HEV infection typically results in self-limiting acute hepatitis, characterized by symptoms such as jaundice, fatigue, loss of appetite, abdominal pain, and dark urine. In some cases, particularly among pregnant women and individuals with weakened immune systems, HEV infection can lead to severe complications, including fulminant hepatic failure and death.

There are four main genotypes of HEV that infect humans: genotype 1 and 2 are primarily found in developing countries and are transmitted through contaminated water; genotype 3 and 4 are found worldwide and can be transmitted through both zoonotic and human-to-human routes.

Prevention measures include improving sanitation, access to clean water, and food safety practices. Currently, there is no specific antiviral treatment for HEV infection, but supportive care can help manage symptoms. A vaccine against HEV is available in China and has shown efficacy in preventing the disease.

Autoimmune hepatitis is a chronic (long-term) disease in which the body's immune system mistakenly attacks the liver, leading to inflammation and damage. This results in decreased liver function over time if not treated. The exact cause of autoimmune hepatitis is unknown, but it is believed to be associated with genetic factors and exposure to certain environmental triggers, such as viral infections or medications.

There are two main types of autoimmune hepatitis:

1. Type 1 (classic) autoimmune hepatitis: This form can affect both adults and children, and it is more common in women than men. People with this type may also have other autoimmune disorders, such as rheumatoid arthritis, thyroid disease, or ulcerative colitis.
2. Type 2 autoimmune hepatitis: This form primarily affects children and young women. It is less common than type 1 and tends to be more severe. People with this type may also have other autoimmune disorders, such as celiac disease or chronic candidiasis.

Symptoms of autoimmune hepatitis can vary widely, from mild to severe. They may include fatigue, loss of appetite, nausea, vomiting, abdominal pain, joint pain, jaundice (yellowing of the skin and eyes), dark urine, and light-colored stools.

Diagnosis typically involves blood tests, imaging studies, and sometimes a liver biopsy to assess the extent of damage. Treatment usually includes medications that suppress the immune system, such as corticosteroids and immunosuppressants, which can help reduce inflammation and slow or stop liver damage. In some cases, lifestyle changes and supportive care may also be necessary.

Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer in adults. It originates from the hepatocytes, which are the main functional cells of the liver. This type of cancer is often associated with chronic liver diseases such as cirrhosis caused by hepatitis B or C virus infection, alcohol abuse, non-alcoholic fatty liver disease (NAFLD), and aflatoxin exposure.

The symptoms of HCC can vary but may include unexplained weight loss, lack of appetite, abdominal pain or swelling, jaundice, and fatigue. The diagnosis of HCC typically involves imaging tests such as ultrasound, CT scan, or MRI, as well as blood tests to measure alpha-fetoprotein (AFP) levels. Treatment options for Hepatocellular carcinoma depend on the stage and extent of the cancer, as well as the patient's overall health and liver function. Treatment options may include surgery, radiation therapy, chemotherapy, targeted therapy, or liver transplantation.

Hepatitis A Virus, Human (HAV): A single-stranded, positive-sense RNA virus belonging to the Picornaviridae family, specifically the Hepatovirus genus. It is the causative agent of Hepatitis A, a viral infection that primarily affects the liver. The virus is typically transmitted through the fecal-oral route, often via contaminated food or water, or close contact with an infected individual. Following incubation (15-50 days), symptoms may include jaundice, fatigue, abdominal pain, loss of appetite, nausea, diarrhea, and fever. Most people recover completely within a few weeks; however, severe complications and death are possible, especially in individuals with preexisting liver disease. Prevention is primarily achieved through vaccination and practicing good hygiene.

Liver cirrhosis is a chronic, progressive disease characterized by the replacement of normal liver tissue with scarred (fibrotic) tissue, leading to loss of function. The scarring is caused by long-term damage from various sources such as hepatitis, alcohol abuse, nonalcoholic fatty liver disease, and other causes. As the disease advances, it can lead to complications like portal hypertension, fluid accumulation in the abdomen (ascites), impaired brain function (hepatic encephalopathy), and increased risk of liver cancer. It is generally irreversible, but early detection and treatment of underlying causes may help slow down its progression.

Liver neoplasms refer to abnormal growths in the liver that can be benign or malignant. Benign liver neoplasms are non-cancerous tumors that do not spread to other parts of the body, while malignant liver neoplasms are cancerous tumors that can invade and destroy surrounding tissue and spread to other organs.

Liver neoplasms can be primary, meaning they originate in the liver, or secondary, meaning they have metastasized (spread) to the liver from another part of the body. Primary liver neoplasms can be further classified into different types based on their cell of origin and behavior, including hepatocellular carcinoma, cholangiocarcinoma, and hepatic hemangioma.

The diagnosis of liver neoplasms typically involves a combination of imaging studies, such as ultrasound, CT scan, or MRI, and biopsy to confirm the type and stage of the tumor. Treatment options depend on the type and extent of the neoplasm and may include surgery, radiation therapy, chemotherapy, or liver transplantation.

I'm sorry for any confusion, but "Animal Hepatitis" is not a medical term used to describe a specific disease. Hepatitis refers to inflammation of the liver, and it can be caused by various factors, including viruses, alcohol, drugs, and certain medical conditions.

However, there are several viral hepatitis types that can infect animals, such as Hepatitis A, B, and C, which primarily affect humans. But there are also other hepatitis viruses that are species-specific and primarily infect animals, such as:

1. Canine Hepatitis (Adenovirus Type 1): This is a viral infection that affects dogs and causes liver damage, respiratory signs, and occasionally death.
2. Feline Infectious Peritonitis (FIP) Virus: While not strictly a hepatitis virus, this feline coronavirus can cause severe inflammation of the liver and other organs in cats.
3. Equine Infectious Anemia Virus (EIAV): This retrovirus affects horses and causes cyclic fever, anemia, and occasionally liver disease.
4. Avian Hepatitis E Virus: A recently discovered virus that infects birds and can cause hepatitis and other systemic signs in chickens and other avian species.

If you're looking for information on a specific animal hepatitis virus or a different medical term, please provide more context so I can give you a more accurate answer.

Alanine transaminase (ALT) is a type of enzyme found primarily in the cells of the liver and, to a lesser extent, in the cells of other tissues such as the heart, muscles, and kidneys. Its primary function is to catalyze the reversible transfer of an amino group from alanine to another alpha-keto acid, usually pyruvate, to form pyruvate and another amino acid, usually glutamate. This process is known as the transamination reaction.

When liver cells are damaged or destroyed due to various reasons such as hepatitis, alcohol abuse, nonalcoholic fatty liver disease, or drug-induced liver injury, ALT is released into the bloodstream. Therefore, measuring the level of ALT in the blood is a useful diagnostic tool for evaluating liver function and detecting liver damage. Normal ALT levels vary depending on the laboratory, but typically range from 7 to 56 units per liter (U/L) for men and 6 to 45 U/L for women. Elevated ALT levels may indicate liver injury or disease, although other factors such as muscle damage or heart disease can also cause elevations in ALT.

A carrier state is a condition in which a person carries and may be able to transmit a genetic disorder or infectious disease, but does not show any symptoms of the disease themselves. This occurs when an individual has a recessive allele for a genetic disorder or is infected with a pathogen, but does not have the necessary combination of genes or other factors required to develop the full-blown disease.

For example, in the case of cystic fibrosis, which is caused by mutations in the CFTR gene, a person who carries one normal allele and one mutated allele for the disease is considered a carrier. They do not have symptoms of cystic fibrosis themselves, but they can pass the mutated allele on to their offspring, who may then develop the disease if they inherit the mutation from both parents.

Similarly, in the case of infectious diseases, a person who is infected with a pathogen but does not show any symptoms may still be able to transmit the infection to others. This is known as being an asymptomatic carrier or a healthy carrier. For example, some people who are infected with hepatitis B virus (HBV) may not develop any symptoms of liver disease, but they can still transmit the virus to others through contact with their blood or other bodily fluids.

It's important to note that in some cases, carriers of certain genetic disorders or infectious diseases may have mild or atypical symptoms that do not meet the full criteria for a diagnosis of the disease. In these cases, they may be considered to have a "reduced penetrance" or "incomplete expression" of the disorder or infection.

Hepatitis B virus (Woodchuck) refers to the hepadnavirus that naturally infects North American woodchucks (Marmota monax). This virus is closely related to the human Hepatitis B virus (HBV), and it is used as a model for studying HBV infection and related liver diseases in woodchucks. The woodchuck hepatitis virus (WHV) can cause both acute and chronic hepatitis, liver fibrosis, cirrhosis, and liver cancer in its natural host. The virus-host interactions and the disease progression in woodchucks closely mimic those observed in humans with HBV infection. Therefore, studies of WHV infection in woodchucks have contributed significantly to our understanding of HBV biology, host immune responses, and the development of novel therapies for HBV infection in humans.

A viral RNA (ribonucleic acid) is the genetic material found in certain types of viruses, as opposed to viruses that contain DNA (deoxyribonucleic acid). These viruses are known as RNA viruses. The RNA can be single-stranded or double-stranded and can exist as several different forms, such as positive-sense, negative-sense, or ambisense RNA. Upon infecting a host cell, the viral RNA uses the host's cellular machinery to translate the genetic information into proteins, leading to the production of new virus particles and the continuation of the viral life cycle. Examples of human diseases caused by RNA viruses include influenza, COVID-19 (SARS-CoV-2), hepatitis C, and polio.

The liver is a large, solid organ located in the upper right portion of the abdomen, beneath the diaphragm and above the stomach. It plays a vital role in several bodily functions, including:

1. Metabolism: The liver helps to metabolize carbohydrates, fats, and proteins from the food we eat into energy and nutrients that our bodies can use.
2. Detoxification: The liver detoxifies harmful substances in the body by breaking them down into less toxic forms or excreting them through bile.
3. Synthesis: The liver synthesizes important proteins, such as albumin and clotting factors, that are necessary for proper bodily function.
4. Storage: The liver stores glucose, vitamins, and minerals that can be released when the body needs them.
5. Bile production: The liver produces bile, a digestive juice that helps to break down fats in the small intestine.
6. Immune function: The liver plays a role in the immune system by filtering out bacteria and other harmful substances from the blood.

Overall, the liver is an essential organ that plays a critical role in maintaining overall health and well-being.

Interferon-alpha (IFN-α) is a type I interferon, which is a group of signaling proteins made and released by host cells in response to the presence of viruses, parasites, and tumor cells. It plays a crucial role in the immune response against viral infections. IFN-α has antiviral, immunomodulatory, and anti-proliferative effects.

IFN-α is produced naturally by various cell types, including leukocytes (white blood cells), fibroblasts, and epithelial cells, in response to viral or bacterial stimulation. It binds to specific receptors on the surface of nearby cells, triggering a signaling cascade that leads to the activation of genes involved in the antiviral response. This results in the production of proteins that inhibit viral replication and promote the presentation of viral antigens to the immune system, enhancing its ability to recognize and eliminate infected cells.

In addition to its role in the immune response, IFN-α has been used as a therapeutic agent for various medical conditions, including certain types of cancer, chronic hepatitis B and C, and multiple sclerosis. However, its use is often limited by side effects such as flu-like symptoms, depression, and neuropsychiatric disorders.

Hepatovirus is a genus of viruses in the Picornaviridae family, and it's most notably represented by the Human Hepatitis A Virus (HAV). These viruses are non-enveloped, with a single-stranded, positive-sense RNA genome. They primarily infect hepatocytes, causing liver inflammation and disease, such as hepatitis. Transmission of hepatoviruses typically occurs through the fecal-oral route, often via contaminated food or water. The virus causes an acute infection that does not usually become chronic, and recovery is usually complete within a few weeks. Immunity after infection is solid and lifelong.

Virus replication is the process by which a virus produces copies or reproduces itself inside a host cell. This involves several steps:

1. Attachment: The virus attaches to a specific receptor on the surface of the host cell.
2. Penetration: The viral genetic material enters the host cell, either by invagination of the cell membrane or endocytosis.
3. Uncoating: The viral genetic material is released from its protective coat (capsid) inside the host cell.
4. Replication: The viral genetic material uses the host cell's machinery to produce new viral components, such as proteins and nucleic acids.
5. Assembly: The newly synthesized viral components are assembled into new virus particles.
6. Release: The newly formed viruses are released from the host cell, often through lysis (breaking) of the cell membrane or by budding off the cell membrane.

The specific mechanisms and details of virus replication can vary depending on the type of virus. Some viruses, such as DNA viruses, use the host cell's DNA polymerase to replicate their genetic material, while others, such as RNA viruses, use their own RNA-dependent RNA polymerase or reverse transcriptase enzymes. Understanding the process of virus replication is important for developing antiviral therapies and vaccines.

Hepatitis C antigens refer to the proteins present on the surface of the hepatitis C virus (HCV). The most commonly studied and clinically relevant antigen is the core protein, which plays a crucial role in the viral replication process. Detection of HCV antigens in serum or plasma can indicate an ongoing infection, as they appear during the early stages of infection and usually persist until the development of a humoral immune response, which leads to the production of antibodies against these antigens.

The detection of HCV core antigen (HCVcAg) has been used as an alternative diagnostic marker for HCV infection, especially in resource-limited settings where nucleic acid testing (NAT), such as polymerase chain reaction (PCR) for HCV RNA, might not be readily available. However, the sensitivity and specificity of HCVcAg detection are generally lower than those of NAT methods. Nonetheless, it remains a valuable tool in monitoring treatment response and disease progression in individuals with chronic hepatitis C infection.

Murine hepatitis virus (MHV) is a type of coronavirus that primarily infects laboratory mice. It is not related to the human hepatitis viruses A, B, C, D, or E. MHV causes a range of diseases in mice, including hepatitis (liver inflammation), encephalomyelitis (inflammation of the brain and spinal cord), and enteritis (inflammation of the intestine). The virus is transmitted through fecal-oral route and respiratory droplets. It's widely used in research to understand the pathogenesis, immunity, and molecular biology of coronaviruses.

"Ducks" is not a medical term. It is a common name used to refer to a group of birds that belong to the family Anatidae, which also includes swans and geese. Some ducks are hunted for their meat, feathers, or down, but they do not have any specific medical relevance. If you have any questions about a specific medical term or concept, I would be happy to help if you could provide more information!

Hepatitis antigens are proteins or molecules present on the surface or inside the hepatitis viruses (hepatitis A, B, C, D, and E) that can stimulate an immune response in the body. These antigens are targeted by the immune system to produce antibodies to fight against the infection.

For example, the Hepatitis B surface antigen (HBsAg) is a protein found on the surface of the hepatitis B virus and its presence in the blood indicates an ongoing infection or evidence of past infection/vaccination. Similarly, the core antigen (HBcAg) is a protein found inside the hepatitis B virus and is a marker of active viral replication.

Detection of these antigens in clinical samples such as blood is useful for diagnosing hepatitis infections and monitoring the effectiveness of treatment.

Hepatitis Delta Antigens (HDAg) are proteins found on the surface of the Hepatitis Delta Virus (HDV), a defective virus that requires the assistance of the Hepatitis B Virus (HBV) to replicate. There are two types of HDAg: small (S-HDAg) and large (L-HDAg). S-HDAg is a 195-amino acid protein that is essential for viral replication, while L-HDAg is a 214-amino acid protein that regulates the packaging of the viral genome into new virus particles. The presence of HDAg can be used to diagnose HDV infection and distinguish it from other forms of hepatitis.

Organophosphonates are a class of organic compounds characterized by the presence of a carbon-phosphorus bond. They contain a phosphonic acid group, which consists of a phosphorus atom bonded to four oxygen or nitrogen atoms, with one of those bonds being replaced by a carbon atom.

In a medical context, organophosphonates are commonly used as radiopharmaceuticals in diagnostic nuclear medicine procedures, such as bone scans. These compounds have the ability to bind to hydroxyapatite, the mineral component of bones, and can be labeled with radioactive isotopes for imaging purposes. They may also be used in therapeutic settings, including as treatments for conditions such as tumor-induced hypercalcemia and Paget's disease of bone.

It is important to note that organophosphonates are distinct from organophosphates, another class of compounds that contain a phosphorus atom bonded to three oxygen or sulfur atoms and one carbon atom. Organophosphates have been widely used as pesticides and chemical warfare agents, and can pose significant health risks due to their toxicity.

Seroepidemiologic studies are a type of epidemiological study that measures the presence and levels of antibodies in a population's blood serum to investigate the prevalence, distribution, and transmission of infectious diseases. These studies help to identify patterns of infection and immunity within a population, which can inform public health policies and interventions.

Seroepidemiologic studies typically involve collecting blood samples from a representative sample of individuals in a population and testing them for the presence of antibodies against specific pathogens. The results are then analyzed to estimate the prevalence of infection and immunity within the population, as well as any factors associated with increased or decreased risk of infection.

These studies can provide valuable insights into the spread of infectious diseases, including emerging and re-emerging infections, and help to monitor the effectiveness of vaccination programs. Additionally, seroepidemiologic studies can also be used to investigate the transmission dynamics of infectious agents, such as identifying sources of infection or tracking the spread of antibiotic resistance.

Molecular sequence data refers to the specific arrangement of molecules, most commonly nucleotides in DNA or RNA, or amino acids in proteins, that make up a biological macromolecule. This data is generated through laboratory techniques such as sequencing, and provides information about the exact order of the constituent molecules. This data is crucial in various fields of biology, including genetics, evolution, and molecular biology, allowing for comparisons between different organisms, identification of genetic variations, and studies of gene function and regulation.

Hepatitis A antigens refer to the proteins or molecules present on the surface of the Hepatitis A virus (HAV) that can stimulate an immune response in the body. There are two main types of HAV antigens:

1. Hepatitis A Virus Capsid Antigen (also known as HAV VP1): This is a structural protein that makes up the outer shell or capsid of the HAV particle. It contains several epitopes (regions that can be recognized by the immune system) that can induce the production of antibodies in infected individuals.
2. Hepatitis A Virus Non-structural Antigen (also known as HAV NS1): This is a non-structural protein produced during the replication of the HAV genome. It plays a crucial role in the replication and assembly of new HAV particles, but it is not present in the mature virion. However, its detection in serum or liver tissue can indicate an ongoing HAV infection.

The presence of antibodies against these antigens (anti-HAV antibodies) in a person's blood can be used to diagnose past or recent Hepatitis A infections and immunity acquired through vaccination.

Genotype, in genetics, refers to the complete heritable genetic makeup of an individual organism, including all of its genes. It is the set of instructions contained in an organism's DNA for the development and function of that organism. The genotype is the basis for an individual's inherited traits, and it can be contrasted with an individual's phenotype, which refers to the observable physical or biochemical characteristics of an organism that result from the expression of its genes in combination with environmental influences.

It is important to note that an individual's genotype is not necessarily identical to their genetic sequence. Some genes have multiple forms called alleles, and an individual may inherit different alleles for a given gene from each parent. The combination of alleles that an individual inherits for a particular gene is known as their genotype for that gene.

Understanding an individual's genotype can provide important information about their susceptibility to certain diseases, their response to drugs and other treatments, and their risk of passing on inherited genetic disorders to their offspring.

"Marmota" is a genus of large ground squirrels that are native to North America and Eurasia. These animals, also known as woodchucks or whistle pigs, are well-known for their ability to hibernate during the winter months. They typically live in burrows that they dig themselves, and their diet consists mainly of grasses, leaves, and shrubs. Marmotas are social creatures and often live in colonies with a dominant male and several females. While "Marmota" is a valid term in medical literature, it is more commonly found in the fields of biology and zoology rather than medicine.

Viral core proteins are the structural proteins that make up the viral capsid or protein shell, enclosing and protecting the viral genome. These proteins play a crucial role in the assembly of the virion, assist in the infection process by helping to deliver the viral genome into the host cell, and may also have functions in regulating viral replication. The specific composition and structure of viral core proteins vary among different types of viruses.

Hepadnaviridae is a family of viruses that primarily infect the liver of various species, including humans. The most well-known member of this family is the hepatitis B virus (HBV), which causes serious human disease.

Hepadnaviridae infections, specifically HBV infection, can lead to a range of clinical manifestations, from acute self-limiting hepatitis to chronic liver inflammation, fibrosis, cirrhosis, and even hepatocellular carcinoma (liver cancer). The virus is transmitted through contact with infected blood or other bodily fluids, as well as during childbirth from an infected mother to her newborn.

The infection process begins when the viral envelope proteins bind to specific receptors on the surface of hepatocytes, allowing the virus to enter the cell. Once inside, the viral DNA is released and converted into a covalently closed circular DNA (cccDNA) form, which serves as the template for viral replication. The host's immune response plays a crucial role in controlling the infection, but in some cases, it may also contribute to liver damage.

Prevention measures include vaccination against HBV and safe practices to avoid exposure to infected blood or bodily fluids. Treatment options for chronic HBV infection include antiviral medications that can suppress viral replication and reduce the risk of liver complications.

Alcoholic hepatitis is a medical condition characterized by inflammation and damage to the liver caused by excessive alcohol consumption. It is a type of hepatitis that specifically results from alcohol abuse, rather than from viral infections or other causes. The condition can vary in severity, and long-term heavy drinking increases the risk of developing alcoholic hepatitis.

The inflammation in alcoholic hepatitis can lead to symptoms such as jaundice (yellowing of the skin and eyes), abdominal pain, nausea, vomiting, loss of appetite, and fever. In severe cases, it can cause liver failure, which may be life-threatening. Treatment typically involves alcohol abstinence, supportive care, and medications to manage symptoms and prevent further liver damage. In some cases, hospitalization and more intensive treatments may be necessary.

Adenine is a purine nucleotide base that is a fundamental component of DNA and RNA, the genetic material of living organisms. In DNA, adenine pairs with thymine via double hydrogen bonds, while in RNA, it pairs with uracil. Adenine is essential for the structure and function of nucleic acids, as well as for energy transfer reactions in cells through its role in the formation of adenosine triphosphate (ATP), the primary energy currency of the cell.

A blood donor is a person who voluntarily gives their own blood or blood components to be used for the benefit of another person in need. The blood donation process involves collecting the donor's blood, testing it for infectious diseases, and then storing it until it is needed by a patient. There are several types of blood donations, including:

1. Whole blood donation: This is the most common type of blood donation, where a donor gives one unit (about 450-500 milliliters) of whole blood. The blood is then separated into its components (red cells, plasma, and platelets) for transfusion to patients with different needs.
2. Double red cell donation: In this type of donation, the donor's blood is collected using a special machine that separates two units of red cells from the whole blood. The remaining plasma and platelets are returned to the donor during the donation process. This type of donation can be done every 112 days.
3. Platelet donation: A donor's blood is collected using a special machine that separates platelets from the whole blood. The red cells and plasma are then returned to the donor during the donation process. This type of donation can be done every seven days, up to 24 times a year.
4. Plasma donation: A donor's blood is collected using a special machine that separates plasma from the whole blood. The red cells and platelets are then returned to the donor during the donation process. This type of donation can be done every 28 days, up to 13 times a year.

Blood donors must meet certain eligibility criteria, such as being in good health, aged between 18 and 65 (in some countries, the upper age limit may vary), and weighing over 50 kg (110 lbs). Donors are also required to answer medical questionnaires and undergo a mini-physical examination before each donation. The frequency of blood donations varies depending on the type of donation and the donor's health status.

Ribavirin is an antiviral medication used in the treatment of certain viral infections, including hepatitis C and respiratory syncytial virus (RSV) infection. It works by interfering with viral replication, preventing the virus from multiplying within infected cells. Ribavirin is often used in combination with other antiviral drugs for more effective treatment.

It's important to note that ribavirin can have serious side effects and should only be used under the supervision of a healthcare professional. Additionally, it is not effective against all types of viral infections and its use should be based on a confirmed diagnosis and appropriate medical evaluation.

Liver transplantation is a surgical procedure in which a diseased or failing liver is replaced with a healthy one from a deceased donor or, less commonly, a portion of a liver from a living donor. The goal of the procedure is to restore normal liver function and improve the patient's overall health and quality of life.

Liver transplantation may be recommended for individuals with end-stage liver disease, acute liver failure, certain genetic liver disorders, or liver cancers that cannot be treated effectively with other therapies. The procedure involves complex surgery to remove the diseased liver and implant the new one, followed by a period of recovery and close medical monitoring to ensure proper function and minimize the risk of complications.

The success of liver transplantation has improved significantly in recent years due to advances in surgical techniques, immunosuppressive medications, and post-transplant care. However, it remains a major operation with significant risks and challenges, including the need for lifelong immunosuppression to prevent rejection of the new liver, as well as potential complications such as infection, bleeding, and organ failure.

Viral load refers to the amount or quantity of virus (like HIV, Hepatitis C, SARS-CoV-2) present in an individual's blood or bodily fluids. It is often expressed as the number of virus copies per milliliter of blood or fluid. Monitoring viral load is important in managing and treating certain viral infections, as a higher viral load may indicate increased infectivity, disease progression, or response to treatment.

A viral genome is the genetic material (DNA or RNA) that is present in a virus. It contains all the genetic information that a virus needs to replicate itself and infect its host. The size and complexity of viral genomes can vary greatly, ranging from a few thousand bases to hundreds of thousands of bases. Some viruses have linear genomes, while others have circular genomes. The genome of a virus also contains the information necessary for the virus to hijack the host cell's machinery and use it to produce new copies of the virus. Understanding the genetic makeup of viruses is important for developing vaccines and antiviral treatments.

A base sequence in the context of molecular biology refers to the specific order of nucleotides in a DNA or RNA molecule. In DNA, these nucleotides are adenine (A), guanine (G), cytosine (C), and thymine (T). In RNA, uracil (U) takes the place of thymine. The base sequence contains genetic information that is transcribed into RNA and ultimately translated into proteins. It is the exact order of these bases that determines the genetic code and thus the function of the DNA or RNA molecule.

Vaccination is a simple, safe, and effective way to protect people against harmful diseases, before they come into contact with them. It uses your body's natural defenses to build protection to specific infections and makes your immune system stronger.

A vaccination usually contains a small, harmless piece of a virus or bacteria (or toxins produced by these germs) that has been made inactive or weakened so it won't cause the disease itself. This piece of the germ is known as an antigen. When the vaccine is introduced into the body, the immune system recognizes the antigen as foreign and produces antibodies to fight it.

If a person then comes into contact with the actual disease-causing germ, their immune system will recognize it and immediately produce antibodies to destroy it. The person is therefore protected against that disease. This is known as active immunity.

Vaccinations are important for both individual and public health. They prevent the spread of contagious diseases and protect vulnerable members of the population, such as young children, the elderly, and people with weakened immune systems who cannot be vaccinated or for whom vaccination is not effective.

Prevalence, in medical terms, refers to the total number of people in a given population who have a particular disease or condition at a specific point in time, or over a specified period. It is typically expressed as a percentage or a ratio of the number of cases to the size of the population. Prevalence differs from incidence, which measures the number of new cases that develop during a certain period.

Chronic Hepatitis D is a liver infection caused by the hepatitis delta virus (HDV). It is often considered a serious form of hepatitis because it can lead to more severe liver disease than hepatitis B alone. HDV is a defective virus that requires the presence of hepatitis B surface antigen (HBsAg) to replicate and cause infection. Therefore, chronic hepatitis D only occurs in individuals who have an underlying chronic hepatitis B infection.

Chronic hepatitis D is characterized by persistent inflammation and damage to the liver, which can lead to scarring (fibrosis), cirrhosis, liver failure, and increased risk of liver cancer over time. Symptoms may include fatigue, joint pain, loss of appetite, nausea, vomiting, abdominal pain, dark urine, and jaundice. However, some people with chronic hepatitis D may not have any symptoms until the disease has progressed to a more advanced stage.

Chronic hepatitis D is diagnosed through blood tests that detect HDV antibodies and antigens, as well as liver function tests and imaging studies to assess liver damage. Treatment typically involves antiviral therapy to suppress the replication of both HBV and HDV, as well as supportive care to manage symptoms and prevent complications. In some cases, a liver transplant may be necessary for individuals with advanced liver disease due to chronic hepatitis D.

Hepatocytes are the predominant type of cells in the liver, accounting for about 80% of its cytoplasmic mass. They play a key role in protein synthesis, protein storage, transformation of carbohydrates, synthesis of cholesterol, bile salts and phospholipids, detoxification, modification, and excretion of exogenous and endogenous substances, initiation of formation and secretion of bile, and enzyme production. Hepatocytes are essential for the maintenance of homeostasis in the body.

Drug resistance, viral, refers to the ability of a virus to continue replicating in the presence of antiviral drugs that are designed to inhibit or stop its growth. This occurs when the virus mutates and changes its genetic makeup in such a way that the drug can no longer effectively bind to and inhibit the function of its target protein, allowing the virus to continue infecting host cells and causing disease.

Viral drug resistance can develop due to several factors, including:

1. Mutations in the viral genome that alter the structure or function of the drug's target protein.
2. Changes in the expression levels or location of the drug's target protein within the virus-infected cell.
3. Activation of alternative pathways that allow the virus to replicate despite the presence of the drug.
4. Increased efflux of the drug from the virus-infected cell, reducing its intracellular concentration and effectiveness.

Viral drug resistance is a significant concern in the treatment of viral infections such as HIV, hepatitis B and C, herpes simplex virus, and influenza. It can lead to reduced treatment efficacy, increased risk of treatment failure, and the need for more toxic or expensive drugs. Therefore, it is essential to monitor viral drug resistance during treatment and adjust therapy accordingly to ensure optimal outcomes.

Viral nonstructural proteins (NS) are viral proteins that are not part of the virion structure. They play various roles in the viral life cycle, such as replication of the viral genome, transcription, translation regulation, and modulation of the host cell environment to favor virus replication. These proteins are often produced in large quantities during infection and can manipulate or disrupt various cellular pathways to benefit the virus. They may also be involved in evasion of the host's immune response. The specific functions of viral nonstructural proteins vary depending on the type of virus.

Polyethylene glycols (PEGs) are a family of synthetic, water-soluble polymers with a wide range of molecular weights. They are commonly used in the medical field as excipients in pharmaceutical formulations due to their ability to improve drug solubility, stability, and bioavailability. PEGs can also be used as laxatives to treat constipation or as bowel cleansing agents prior to colonoscopy examinations. Additionally, some PEG-conjugated drugs have been developed for use in targeted cancer therapies.

In a medical context, PEGs are often referred to by their average molecular weight, such as PEG 300, PEG 400, PEG 1500, and so on. Higher molecular weight PEGs tend to be more viscous and have longer-lasting effects in the body.

It's worth noting that while PEGs are generally considered safe for use in medical applications, some people may experience allergic reactions or hypersensitivity to these compounds. Prolonged exposure to high molecular weight PEGs has also been linked to potential adverse effects, such as decreased fertility and developmental toxicity in animal studies. However, more research is needed to fully understand the long-term safety of PEGs in humans.

Hepadnaviridae is a family of small, enveloped viruses that primarily infect the liver cells (hepatocytes) of various species, including humans. The name "Hepadnaviridae" is derived from "hepa" for hepatotrophic (liver-tropic) and "DNA" for the DNA genome of the viruses.

The most well-known member of this family is the human hepatitis B virus (HBV), which causes acute and chronic liver infections, leading to various clinical manifestations such as hepatitis, cirrhosis, and hepatocellular carcinoma.

Hepadnaviruses have a unique replication strategy that involves reverse transcription of an RNA intermediate, making them distinct from other DNA viruses. Their genome is partially double-stranded, with the minus strand being complete and the plus strand incomplete or absent. The genome encodes for four overlapping open reading frames (ORFs) that give rise to several viral proteins, including the surface antigen (HBsAg), core protein (HBcAg), polymerase, and X protein (HBx).

The family Hepadnaviridae includes several other members that infect animals, such as woodchuck hepatitis virus (WHV), ground squirrel hepatitis virus (GSHV), and duck hepatitis B virus (DHBV). These viruses serve as valuable models for understanding the biology and pathogenesis of HBV in humans.

Liver function tests (LFTs) are a group of blood tests that are used to assess the functioning and health of the liver. These tests measure the levels of various enzymes, proteins, and waste products that are produced or metabolized by the liver. Some common LFTs include:

1. Alanine aminotransferase (ALT): An enzyme found primarily in the liver, ALT is released into the bloodstream in response to liver cell damage. Elevated levels of ALT may indicate liver injury or disease.
2. Aspartate aminotransferase (AST): Another enzyme found in various tissues, including the liver, heart, and muscles. Like ALT, AST is released into the bloodstream following tissue damage. High AST levels can be a sign of liver damage or other medical conditions.
3. Alkaline phosphatase (ALP): An enzyme found in several organs, including the liver, bile ducts, and bones. Elevated ALP levels may indicate a blockage in the bile ducts, liver disease, or bone disorders.
4. Gamma-glutamyl transferase (GGT): An enzyme found mainly in the liver, pancreas, and biliary system. Increased GGT levels can suggest liver disease, alcohol consumption, or the use of certain medications.
5. Bilirubin: A yellowish pigment produced when hemoglobin from red blood cells is broken down. Bilirubin is processed by the liver and excreted through bile. High bilirubin levels can indicate liver dysfunction, bile duct obstruction, or certain types of anemia.
6. Albumin: A protein produced by the liver that helps maintain fluid balance in the body and transports various substances in the blood. Low albumin levels may suggest liver damage, malnutrition, or kidney disease.
7. Total protein: A measure of all proteins present in the blood, including albumin and other types of proteins produced by the liver. Decreased total protein levels can indicate liver dysfunction or other medical conditions.

These tests are often ordered together as part of a routine health checkup or when evaluating symptoms related to liver function or disease. The results should be interpreted in conjunction with clinical findings, medical history, and other diagnostic tests.

Reverse Transcriptase Inhibitors (RTIs) are a class of antiretroviral drugs that are primarily used in the treatment and management of HIV (Human Immunodeficiency Virus) infection. They work by inhibiting the reverse transcriptase enzyme, which is essential for the replication of HIV.

HIV is a retrovirus, meaning it has an RNA genome and uses a unique enzyme called reverse transcriptase to convert its RNA into DNA. This process is necessary for the virus to integrate into the host cell's genome and replicate. Reverse Transcriptase Inhibitors interfere with this process by binding to the reverse transcriptase enzyme, preventing it from converting the viral RNA into DNA.

RTIs can be further divided into two categories: nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) and non-nucleoside reverse transcriptase inhibitors (NNRTIs). NRTIs are analogs of the building blocks of DNA, which get incorporated into the growing DNA chain during replication, causing termination of the chain. NNRTIs bind directly to the reverse transcriptase enzyme, causing a conformational change that prevents it from functioning.

By inhibiting the reverse transcriptase enzyme, RTIs can prevent the virus from replicating and reduce the viral load in an infected individual, thereby slowing down the progression of HIV infection and AIDS (Acquired Immunodeficiency Syndrome).

"Pan troglodytes" is the scientific name for a species of great apes known as the Common Chimpanzee. They are native to tropical rainforests in Western and Central Africa. Common Chimpanzees are our closest living relatives, sharing about 98.6% of our DNA. They are highly intelligent and social animals, capable of using tools, exhibiting complex behaviors, and displaying a range of emotions.

Here is a medical definition for 'Pan troglodytes':

The scientific name for the Common Chimpanzee species (genus Pan), a highly intelligent and social great ape native to tropical rainforests in Western and Central Africa. They are our closest living relatives, sharing approximately 98.6% of our DNA. Known for their complex behaviors, tool use, and emotional expression, Common Chimpanzees have been extensively studied in the fields of anthropology, psychology, and primatology to better understand human evolution and behavior.

Liver diseases refer to a wide range of conditions that affect the normal functioning of the liver. The liver is a vital organ responsible for various critical functions such as detoxification, protein synthesis, and production of biochemicals necessary for digestion.

Liver diseases can be categorized into acute and chronic forms. Acute liver disease comes on rapidly and can be caused by factors like viral infections (hepatitis A, B, C, D, E), drug-induced liver injury, or exposure to toxic substances. Chronic liver disease develops slowly over time, often due to long-term exposure to harmful agents or inherent disorders of the liver.

Common examples of liver diseases include hepatitis, cirrhosis (scarring of the liver tissue), fatty liver disease, alcoholic liver disease, autoimmune liver diseases, genetic/hereditary liver disorders (like Wilson's disease and hemochromatosis), and liver cancers. Symptoms may vary widely depending on the type and stage of the disease but could include jaundice, abdominal pain, fatigue, loss of appetite, nausea, and weight loss.

Early diagnosis and treatment are essential to prevent progression and potential complications associated with liver diseases.

An acute disease is a medical condition that has a rapid onset, develops quickly, and tends to be short in duration. Acute diseases can range from minor illnesses such as a common cold or flu, to more severe conditions such as pneumonia, meningitis, or a heart attack. These types of diseases often have clear symptoms that are easy to identify, and they may require immediate medical attention or treatment.

Acute diseases are typically caused by an external agent or factor, such as a bacterial or viral infection, a toxin, or an injury. They can also be the result of a sudden worsening of an existing chronic condition. In general, acute diseases are distinct from chronic diseases, which are long-term medical conditions that develop slowly over time and may require ongoing management and treatment.

Examples of acute diseases include:

* Acute bronchitis: a sudden inflammation of the airways in the lungs, often caused by a viral infection.
* Appendicitis: an inflammation of the appendix that can cause severe pain and requires surgical removal.
* Gastroenteritis: an inflammation of the stomach and intestines, often caused by a viral or bacterial infection.
* Migraine headaches: intense headaches that can last for hours or days, and are often accompanied by nausea, vomiting, and sensitivity to light and sound.
* Myocardial infarction (heart attack): a sudden blockage of blood flow to the heart muscle, often caused by a buildup of plaque in the coronary arteries.
* Pneumonia: an infection of the lungs that can cause coughing, chest pain, and difficulty breathing.
* Sinusitis: an inflammation of the sinuses, often caused by a viral or bacterial infection.

It's important to note that while some acute diseases may resolve on their own with rest and supportive care, others may require medical intervention or treatment to prevent complications and promote recovery. If you are experiencing symptoms of an acute disease, it is always best to seek medical attention to ensure proper diagnosis and treatment.

Polymerase Chain Reaction (PCR) is a laboratory technique used to amplify specific regions of DNA. It enables the production of thousands to millions of copies of a particular DNA sequence in a rapid and efficient manner, making it an essential tool in various fields such as molecular biology, medical diagnostics, forensic science, and research.

The PCR process involves repeated cycles of heating and cooling to separate the DNA strands, allow primers (short sequences of single-stranded DNA) to attach to the target regions, and extend these primers using an enzyme called Taq polymerase, resulting in the exponential amplification of the desired DNA segment.

In a medical context, PCR is often used for detecting and quantifying specific pathogens (viruses, bacteria, fungi, or parasites) in clinical samples, identifying genetic mutations or polymorphisms associated with diseases, monitoring disease progression, and evaluating treatment effectiveness.

Medical Definition:

"Risk factors" are any attribute, characteristic or exposure of an individual that increases the likelihood of developing a disease or injury. They can be divided into modifiable and non-modifiable risk factors. Modifiable risk factors are those that can be changed through lifestyle choices or medical treatment, while non-modifiable risk factors are inherent traits such as age, gender, or genetic predisposition. Examples of modifiable risk factors include smoking, alcohol consumption, physical inactivity, and unhealthy diet, while non-modifiable risk factors include age, sex, and family history. It is important to note that having a risk factor does not guarantee that a person will develop the disease, but rather indicates an increased susceptibility.

Recombinant proteins are artificially created proteins produced through the use of recombinant DNA technology. This process involves combining DNA molecules from different sources to create a new set of genes that encode for a specific protein. The resulting recombinant protein can then be expressed, purified, and used for various applications in research, medicine, and industry.

Recombinant proteins are widely used in biomedical research to study protein function, structure, and interactions. They are also used in the development of diagnostic tests, vaccines, and therapeutic drugs. For example, recombinant insulin is a common treatment for diabetes, while recombinant human growth hormone is used to treat growth disorders.

The production of recombinant proteins typically involves the use of host cells, such as bacteria, yeast, or mammalian cells, which are engineered to express the desired protein. The host cells are transformed with a plasmid vector containing the gene of interest, along with regulatory elements that control its expression. Once the host cells are cultured and the protein is expressed, it can be purified using various chromatography techniques.

Overall, recombinant proteins have revolutionized many areas of biology and medicine, enabling researchers to study and manipulate proteins in ways that were previously impossible.

A mutation is a permanent change in the DNA sequence of an organism's genome. Mutations can occur spontaneously or be caused by environmental factors such as exposure to radiation, chemicals, or viruses. They may have various effects on the organism, ranging from benign to harmful, depending on where they occur and whether they alter the function of essential proteins. In some cases, mutations can increase an individual's susceptibility to certain diseases or disorders, while in others, they may confer a survival advantage. Mutations are the driving force behind evolution, as they introduce new genetic variability into populations, which can then be acted upon by natural selection.

A gene product is the biochemical material, such as a protein or RNA, that is produced by the expression of a gene. "pol" in gene products usually refers to "polymerase," which is an enzyme that synthesizes DNA or RNA molecules by adding nucleotides one by one to a growing chain. Therefore, "gene products, pol" typically refer to the proteins that make up various types of RNA and DNA polymerases, which are involved in the transcription and replication of genetic material. These enzymes play crucial roles in many cellular processes, including gene expression, DNA repair, and cell division.

HIV (Human Immunodeficiency Virus) infection is a viral illness that progressively attacks and weakens the immune system, making individuals more susceptible to other infections and diseases. The virus primarily infects CD4+ T cells, a type of white blood cell essential for fighting off infections. Over time, as the number of these immune cells declines, the body becomes increasingly vulnerable to opportunistic infections and cancers.

HIV infection has three stages:

1. Acute HIV infection: This is the initial stage that occurs within 2-4 weeks after exposure to the virus. During this period, individuals may experience flu-like symptoms such as fever, fatigue, rash, swollen glands, and muscle aches. The virus replicates rapidly, and the viral load in the body is very high.
2. Chronic HIV infection (Clinical latency): This stage follows the acute infection and can last several years if left untreated. Although individuals may not show any symptoms during this phase, the virus continues to replicate at low levels, and the immune system gradually weakens. The viral load remains relatively stable, but the number of CD4+ T cells declines over time.
3. AIDS (Acquired Immunodeficiency Syndrome): This is the most advanced stage of HIV infection, characterized by a severely damaged immune system and numerous opportunistic infections or cancers. At this stage, the CD4+ T cell count drops below 200 cells/mm3 of blood.

It's important to note that with proper antiretroviral therapy (ART), individuals with HIV infection can effectively manage the virus, maintain a healthy immune system, and significantly reduce the risk of transmission to others. Early diagnosis and treatment are crucial for improving long-term health outcomes and reducing the spread of HIV.

An immunization schedule is a series of planned dates when a person, usually a child, should receive specific vaccines in order to be fully protected against certain preventable diseases. The schedule is developed based on scientific research and recommendations from health organizations such as the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC).

The immunization schedule outlines which vaccines are recommended, the number of doses required, the age at which each dose should be given, and the minimum amount of time that must pass between doses. The schedule may vary depending on factors such as the individual's age, health status, and travel plans.

Immunization schedules are important for ensuring that individuals receive timely protection against vaccine-preventable diseases, and for maintaining high levels of immunity in populations, which helps to prevent the spread of disease. It is important to follow the recommended immunization schedule as closely as possible to ensure optimal protection.

Liver failure is a serious condition in which the liver is no longer able to perform its normal functions, such as removing toxins and waste products from the blood, producing bile to help digest food, and regulating blood clotting. This can lead to a buildup of toxins in the body, jaundice (yellowing of the skin and eyes), fluid accumulation in the abdomen, and an increased risk of bleeding. Liver failure can be acute (sudden) or chronic (developing over time). Acute liver failure is often caused by medication toxicity, viral hepatitis, or other sudden illnesses. Chronic liver failure is most commonly caused by long-term damage from conditions such as cirrhosis, hepatitis, alcohol abuse, and non-alcoholic fatty liver disease.

It's important to note that Liver Failure is a life threatening condition and need immediate medical attention.

Coinfection is a term used in medicine to describe a situation where a person is infected with more than one pathogen (infectious agent) at the same time. This can occur when a person is infected with two or more viruses, bacteria, parasites, or fungi. Coinfections can complicate the diagnosis and treatment of infectious diseases, as the symptoms of each infection can overlap and interact with each other.

Coinfections are common in certain populations, such as people who are immunocompromised, have chronic illnesses, or live in areas with high levels of infectious agents. For example, a person with HIV/AIDS may be more susceptible to coinfections with tuberculosis, hepatitis, or pneumocystis pneumonia. Similarly, a person who has recently undergone an organ transplant may be at risk for coinfections with cytomegalovirus, Epstein-Barr virus, or other opportunistic pathogens.

Coinfections can also occur in people who are otherwise healthy but are exposed to multiple infectious agents at once, such as through travel to areas with high levels of infectious diseases or through close contact with animals that carry infectious agents. For example, a person who travels to a tropical area may be at risk for coinfections with malaria and dengue fever, while a person who works on a farm may be at risk for coinfections with influenza and Q fever.

Effective treatment of coinfections requires accurate diagnosis and appropriate antimicrobial therapy for each pathogen involved. In some cases, treating one infection may help to resolve the other, but in other cases, both infections may need to be treated simultaneously to achieve a cure. Preventing coinfections is an important part of infectious disease control, and can be achieved through measures such as vaccination, use of personal protective equipment, and avoidance of high-risk behaviors.

Viral envelope proteins are structural proteins found in the envelope that surrounds many types of viruses. These proteins play a crucial role in the virus's life cycle, including attachment to host cells, fusion with the cell membrane, and entry into the host cell. They are typically made up of glycoproteins and are often responsible for eliciting an immune response in the host organism. The exact structure and function of viral envelope proteins vary between different types of viruses.

Vertical transmission of infectious diseases refers to the spread of an infection from an infected mother to her offspring during pregnancy, childbirth, or breastfeeding. This mode of transmission can occur through several pathways:

1. Transplacental transmission: The infection crosses the placenta and reaches the fetus while it is still in the womb. Examples include HIV, syphilis, and toxoplasmosis.
2. Intrauterine infection: The mother's infection causes direct damage to the developing fetus or its surrounding tissues, leading to complications such as congenital defects. Examples include rubella and cytomegalovirus (CMV).
3. Perinatal transmission: This occurs during childbirth when the infant comes into contact with the mother's infected genital tract or bodily fluids. Examples include group B streptococcus, herpes simplex virus (HSV), and hepatitis B.
4. Postnatal transmission: This occurs after birth, often through breastfeeding, when the infant ingests infected milk or comes into contact with the mother's contaminated bodily fluids. Examples include HIV and HTLV-I (human T-lymphotropic virus type I).

Vertical transmission is a significant concern in public health, as it can lead to severe complications, congenital disabilities, or even death in newborns. Preventive measures, such as prenatal screening, vaccination, and antimicrobial treatment, are crucial for reducing the risk of vertical transmission and ensuring better outcomes for both mothers and their offspring.

Jaundice is a medical condition characterized by the yellowing of the skin, sclera (whites of the eyes), and mucous membranes due to an excess of bilirubin in the bloodstream. Bilirubin is a yellow-orange pigment produced when hemoglobin from red blood cells is broken down. Normally, bilirubin is processed by the liver and excreted through bile into the digestive system. However, if there's an issue with bilirubin metabolism or elimination, it can accumulate in the body, leading to jaundice.

Jaundice can be a symptom of various underlying conditions, such as liver diseases (hepatitis, cirrhosis), gallbladder issues (gallstones, tumors), or blood disorders (hemolysis). It is essential to consult a healthcare professional if jaundice is observed, as it may indicate a severe health problem requiring prompt medical attention.

An amino acid sequence is the specific order of amino acids in a protein or peptide molecule, formed by the linking of the amino group (-NH2) of one amino acid to the carboxyl group (-COOH) of another amino acid through a peptide bond. The sequence is determined by the genetic code and is unique to each type of protein or peptide. It plays a crucial role in determining the three-dimensional structure and function of proteins.

I am not aware of a specific medical definition for the term "China." Generally, it is used to refer to:

1. The People's Republic of China (PRC), which is a country in East Asia. It is the most populous country in the world and the fourth largest by geographical area. Its capital city is Beijing.
2. In a historical context, "China" was used to refer to various dynasties and empires that existed in East Asia over thousands of years. The term "Middle Kingdom" or "Zhongguo" (中国) has been used by the Chinese people to refer to their country for centuries.
3. In a more general sense, "China" can also be used to describe products or goods that originate from or are associated with the People's Republic of China.

If you have a specific context in which you encountered the term "China" related to medicine, please provide it so I can give a more accurate response.

Antibodies, viral are proteins produced by the immune system in response to an infection with a virus. These antibodies are capable of recognizing and binding to specific antigens on the surface of the virus, which helps to neutralize or destroy the virus and prevent its replication. Once produced, these antibodies can provide immunity against future infections with the same virus.

Viral antibodies are typically composed of four polypeptide chains - two heavy chains and two light chains - that are held together by disulfide bonds. The binding site for the antigen is located at the tip of the Y-shaped structure, formed by the variable regions of the heavy and light chains.

There are five classes of antibodies in humans: IgA, IgD, IgE, IgG, and IgM. Each class has a different function and is distributed differently throughout the body. For example, IgG is the most common type of antibody found in the bloodstream and provides long-term immunity against viruses, while IgA is found primarily in mucous membranes and helps to protect against respiratory and gastrointestinal infections.

In addition to their role in the immune response, viral antibodies can also be used as diagnostic tools to detect the presence of a specific virus in a patient's blood or other bodily fluids.

A cell line is a culture of cells that are grown in a laboratory for use in research. These cells are usually taken from a single cell or group of cells, and they are able to divide and grow continuously in the lab. Cell lines can come from many different sources, including animals, plants, and humans. They are often used in scientific research to study cellular processes, disease mechanisms, and to test new drugs or treatments. Some common types of human cell lines include HeLa cells (which come from a cancer patient named Henrietta Lacks), HEK293 cells (which come from embryonic kidney cells), and HUVEC cells (which come from umbilical vein endothelial cells). It is important to note that cell lines are not the same as primary cells, which are cells that are taken directly from a living organism and have not been grown in the lab.

Combination drug therapy is a treatment approach that involves the use of multiple medications with different mechanisms of action to achieve better therapeutic outcomes. This approach is often used in the management of complex medical conditions such as cancer, HIV/AIDS, and cardiovascular diseases. The goal of combination drug therapy is to improve efficacy, reduce the risk of drug resistance, decrease the likelihood of adverse effects, and enhance the overall quality of life for patients.

In combining drugs, healthcare providers aim to target various pathways involved in the disease process, which may help to:

1. Increase the effectiveness of treatment by attacking the disease from multiple angles.
2. Decrease the dosage of individual medications, reducing the risk and severity of side effects.
3. Slow down or prevent the development of drug resistance, a common problem in chronic diseases like HIV/AIDS and cancer.
4. Improve patient compliance by simplifying dosing schedules and reducing pill burden.

Examples of combination drug therapy include:

1. Antiretroviral therapy (ART) for HIV treatment, which typically involves three or more drugs from different classes to suppress viral replication and prevent the development of drug resistance.
2. Chemotherapy regimens for cancer treatment, where multiple cytotoxic agents are used to target various stages of the cell cycle and reduce the likelihood of tumor cells developing resistance.
3. Cardiovascular disease management, which may involve combining medications such as angiotensin-converting enzyme (ACE) inhibitors, beta-blockers, diuretics, and statins to control blood pressure, heart rate, fluid balance, and cholesterol levels.
4. Treatment of tuberculosis, which often involves a combination of several antibiotics to target different aspects of the bacterial life cycle and prevent the development of drug-resistant strains.

When prescribing combination drug therapy, healthcare providers must carefully consider factors such as potential drug interactions, dosing schedules, adverse effects, and contraindications to ensure safe and effective treatment. Regular monitoring of patients is essential to assess treatment response, manage side effects, and adjust the treatment plan as needed.

A chronic disease is a long-term medical condition that often progresses slowly over a period of years and requires ongoing management and care. These diseases are typically not fully curable, but symptoms can be managed to improve quality of life. Common chronic diseases include heart disease, stroke, cancer, diabetes, arthritis, and COPD (chronic obstructive pulmonary disease). They are often associated with advanced age, although they can also affect children and younger adults. Chronic diseases can have significant impacts on individuals' physical, emotional, and social well-being, as well as on healthcare systems and society at large.

Aspartate aminotransferases (ASTs) are a group of enzymes found in various tissues throughout the body, including the heart, liver, and muscles. They play a crucial role in the metabolic process of transferring amino groups between different molecules.

In medical terms, AST is often used as a blood test to measure the level of this enzyme in the serum. Elevated levels of AST can indicate damage or injury to tissues that contain this enzyme, such as the liver or heart. For example, liver disease, including hepatitis and cirrhosis, can cause elevated AST levels due to damage to liver cells. Similarly, heart attacks can also result in increased AST levels due to damage to heart muscle tissue.

It is important to note that an AST test alone cannot diagnose a specific medical condition, but it can provide valuable information when used in conjunction with other diagnostic tests and clinical evaluation.

Substance abuse, intravenous, refers to the harmful or hazardous use of psychoactive substances that are introduced directly into the bloodstream through injection, for non-medical purposes. This behavior can lead to a range of short- and long-term health consequences, including addiction, dependence, and an increased risk of infectious diseases such as HIV and hepatitis C. Intravenous substance abuse often involves drugs such as heroin, cocaine, and amphetamines, and is characterized by the repeated injection of these substances using needles and syringes. The practice can also have serious social consequences, including disrupted family relationships, lost productivity, and criminal behavior.

Treatment outcome is a term used to describe the result or effect of medical treatment on a patient's health status. It can be measured in various ways, such as through symptoms improvement, disease remission, reduced disability, improved quality of life, or survival rates. The treatment outcome helps healthcare providers evaluate the effectiveness of a particular treatment plan and make informed decisions about future care. It is also used in clinical research to compare the efficacy of different treatments and improve patient care.

Infectious pregnancy complications refer to infections that occur during pregnancy and can affect the mother, fetus, or both. These infections can lead to serious consequences such as preterm labor, low birth weight, birth defects, stillbirth, or even death. Some common infectious agents that can cause pregnancy complications include:

1. Bacteria: Examples include group B streptococcus, Escherichia coli, and Listeria monocytogenes, which can cause sepsis, meningitis, or pneumonia in the mother and lead to preterm labor or stillbirth.
2. Viruses: Examples include cytomegalovirus, rubella, varicella-zoster, and HIV, which can cause congenital anomalies, developmental delays, or transmission of the virus to the fetus.
3. Parasites: Examples include Toxoplasma gondii, which can cause severe neurological damage in the fetus if transmitted during pregnancy.
4. Fungi: Examples include Candida albicans, which can cause fungal infections in the mother and lead to preterm labor or stillbirth.

Preventive measures such as vaccination, good hygiene practices, and avoiding high-risk behaviors can help reduce the risk of infectious pregnancy complications. Prompt diagnosis and treatment of infections during pregnancy are also crucial to prevent adverse outcomes.

Immunization programs, also known as vaccination programs, are organized efforts to administer vaccines to populations or communities in order to protect individuals from vaccine-preventable diseases. These programs are typically implemented by public health agencies and involve the planning, coordination, and delivery of immunizations to ensure that a high percentage of people are protected against specific infectious diseases.

Immunization programs may target specific age groups, such as infants and young children, or populations at higher risk of certain diseases, such as travelers, healthcare workers, or individuals with weakened immune systems. The goals of immunization programs include controlling and eliminating vaccine-preventable diseases, reducing the morbidity and mortality associated with these diseases, and protecting vulnerable populations from outbreaks and epidemics.

Immunization programs may be delivered through a variety of settings, including healthcare facilities, schools, community centers, and mobile clinics. They often involve partnerships between government agencies, healthcare providers, non-governmental organizations, and communities to ensure that vaccines are accessible, affordable, and acceptable to the populations they serve. Effective immunization programs require strong leadership, adequate funding, robust data systems, and ongoing monitoring and evaluation to assess their impact and identify areas for improvement.

Trans-activators are proteins that increase the transcriptional activity of a gene or a set of genes. They do this by binding to specific DNA sequences and interacting with the transcription machinery, thereby enhancing the recruitment and assembly of the complexes needed for transcription. In some cases, trans-activators can also modulate the chromatin structure to make the template more accessible to the transcription machinery.

In the context of HIV (Human Immunodeficiency Virus) infection, the term "trans-activator" is often used specifically to refer to the Tat protein. The Tat protein is a viral regulatory protein that plays a critical role in the replication of HIV by activating the transcription of the viral genome. It does this by binding to a specific RNA structure called the Trans-Activation Response Element (TAR) located at the 5' end of all nascent HIV transcripts, and recruiting cellular cofactors that enhance the processivity and efficiency of RNA polymerase II, leading to increased viral gene expression.

Gene expression regulation, viral, refers to the processes that control the production of viral gene products, such as proteins and nucleic acids, during the viral life cycle. This can involve both viral and host cell factors that regulate transcription, RNA processing, translation, and post-translational modifications of viral genes.

Viral gene expression regulation is critical for the virus to replicate and produce progeny virions. Different types of viruses have evolved diverse mechanisms to regulate their gene expression, including the use of promoters, enhancers, transcription factors, RNA silencing, and epigenetic modifications. Understanding these regulatory processes can provide insights into viral pathogenesis and help in the development of antiviral therapies.

Retrospective studies, also known as retrospective research or looking back studies, are a type of observational study that examines data from the past to draw conclusions about possible causal relationships between risk factors and outcomes. In these studies, researchers analyze existing records, medical charts, or previously collected data to test a hypothesis or answer a specific research question.

Retrospective studies can be useful for generating hypotheses and identifying trends, but they have limitations compared to prospective studies, which follow participants forward in time from exposure to outcome. Retrospective studies are subject to biases such as recall bias, selection bias, and information bias, which can affect the validity of the results. Therefore, retrospective studies should be interpreted with caution and used primarily to generate hypotheses for further testing in prospective studies.

Blood-borne pathogens are microorganisms that are present in human blood and can cause disease. They include viruses such as HIV, Hepatitis B and C, and other bacteria and parasites. These pathogens can be transmitted through contact with infected blood or other bodily fluids, primarily through needlesticks or other sharps-related injuries, mucous membrane exposure, or skin exposure with open wounds or cuts. It's important for healthcare workers and others who may come into contact with blood or bodily fluids to be aware of the risks and take appropriate precautions to prevent exposure and transmission.

Guanine is not a medical term per se, but it is a biological molecule that plays a crucial role in the body. Guanine is one of the four nucleobases found in the nucleic acids DNA and RNA, along with adenine, cytosine, and thymine (in DNA) or uracil (in RNA). Specifically, guanine pairs with cytosine via hydrogen bonds to form a base pair.

Guanine is a purine derivative, which means it has a double-ring structure. It is formed through the synthesis of simpler molecules in the body and is an essential component of genetic material. Guanine's chemical formula is C5H5N5O.

While guanine itself is not a medical term, abnormalities or mutations in genes that contain guanine nucleotides can lead to various medical conditions, including genetic disorders and cancer.

Tattooing is defined medically as the process of inserting pigment into the skin's dermis layer to change its color. This procedure creates a permanent design or image. The equipment used for tattooing includes an electrically powered tattoo machine, needles, and ink. Tattooing can carry potential risks such as infection, allergic reactions, and scarring. It is essential to ensure that all tattooing procedures are performed under sterile conditions and by a licensed professional to minimize these risks.

Flaviviridae is a family of viruses that includes many important human pathogens. According to the International Committee on Taxonomy of Viruses (ICTV), Flaviviridae is divided into four genera: Flavivirus, Hepacivirus, Pegivirus, and Pestivirus. These viruses are enveloped and have a single-stranded, positive-sense RNA genome.

1. Flavivirus genus includes several medically important viruses, such as dengue virus, yellow fever virus, Japanese encephalitis virus, West Nile virus, Zika virus, and tick-borne encephalitis virus. These viruses are primarily transmitted by arthropod vectors (mosquitoes or ticks) and can cause a wide range of symptoms, from mild febrile illness to severe hemorrhagic fever and neuroinvasive disease.
2. Hepacivirus genus contains hepatitis C virus (HCV), which is a major causative agent of viral hepatitis and liver diseases, such as cirrhosis and hepatocellular carcinoma. HCV is primarily transmitted through percutaneous exposure to infected blood or blood products, sexual contact, and mother-to-child transmission during childbirth.
3. Pegivirus genus includes pegiviruses (formerly known as GB viruses) that are associated with persistent infection in humans and other animals. While pegiviruses can cause acute illness, they are mostly linked to asymptomatic or mild infections.
4. Pestivirus genus contains several animal pathogens, such as bovine viral diarrhea virus (BVDV), Classical swine fever virus (CSFV), and border disease virus (BDV). These viruses can cause significant economic losses in the livestock industry due to reproductive failure, growth retardation, and immunosuppression.

In summary, Flaviviridae is a family of enveloped, single-stranded, positive-sense RNA viruses that includes several important human and animal pathogens. The family is divided into four genera: Flavivirus, Hepacivirus, Pegivirus, and Pestivirus.

Protein precursors, also known as proproteins or prohormones, are inactive forms of proteins that undergo post-translational modification to become active. These modifications typically include cleavage of the precursor protein by specific enzymes, resulting in the release of the active protein. This process allows for the regulation and control of protein activity within the body. Protein precursors can be found in various biological processes, including the endocrine system where they serve as inactive hormones that can be converted into their active forms when needed.

Viral genes refer to the genetic material present in viruses that contains the information necessary for their replication and the production of viral proteins. In DNA viruses, the genetic material is composed of double-stranded or single-stranded DNA, while in RNA viruses, it is composed of single-stranded or double-stranded RNA.

Viral genes can be classified into three categories: early, late, and structural. Early genes encode proteins involved in the replication of the viral genome, modulation of host cell processes, and regulation of viral gene expression. Late genes encode structural proteins that make up the viral capsid or envelope. Some viruses also have structural genes that are expressed throughout their replication cycle.

Understanding the genetic makeup of viruses is crucial for developing antiviral therapies and vaccines. By targeting specific viral genes, researchers can develop drugs that inhibit viral replication and reduce the severity of viral infections. Additionally, knowledge of viral gene sequences can inform the development of vaccines that stimulate an immune response to specific viral proteins.

Viral activation, also known as viral reactivation or virus reactivation, refers to the process in which a latent or dormant virus becomes active and starts to replicate within a host cell. This can occur when the immune system is weakened or compromised, allowing the virus to evade the body's natural defenses and cause disease.

In some cases, viral activation can be triggered by certain environmental factors, such as stress, exposure to UV light, or infection with another virus. Once activated, the virus can cause symptoms similar to those seen during the initial infection, or it may lead to new symptoms depending on the specific virus and the host's immune response.

Examples of viruses that can remain dormant in the body and be reactivated include herpes simplex virus (HSV), varicella-zoster virus (VZV), cytomegalovirus (CMV), and Epstein-Barr virus (EBV). It is important to note that not all viruses can be reactivated, and some may remain dormant in the body indefinitely without causing any harm.

A nucleoside is a biochemical molecule that consists of a pentose sugar (a type of simple sugar with five carbon atoms) covalently linked to a nitrogenous base. The nitrogenous base can be one of several types, including adenine, guanine, cytosine, thymine, or uracil. Nucleosides are important components of nucleic acids, such as DNA and RNA, which are the genetic materials found in cells. They play a crucial role in various biological processes, including cell division, protein synthesis, and gene expression.

Duck hepatitis virus (DHV) is not typically included in the medical definition of "hepatitis viruses" as it primarily affects birds, particularly ducks and geese, rather than humans. However, for the sake of completeness:

Duck hepatitis virus (DHV) is a species of small, single-stranded RNA viruses that belong to the family Picornaviridae. There are three serotypes of DHV (1, 2, and 3), which can cause an acute, often fatal, disease in young ducklings known as duck viral hepatitis.

DHV-1 and DHV-3 primarily affect ducklings under 4 weeks of age, causing liver damage, hemorrhage, and neurological symptoms. DHV-2, on the other hand, is associated with a milder disease in ducks but can cause a more severe illness in geese.

It's important to note that DHV is not related to human hepatitis viruses (A, B, C, D, and E) and does not pose a risk to human health.

An Enzyme-Linked Immunosorbent Assay (ELISA) is a type of analytical biochemistry assay used to detect and quantify the presence of a substance, typically a protein or peptide, in a liquid sample. It takes its name from the enzyme-linked antibodies used in the assay.

In an ELISA, the sample is added to a well containing a surface that has been treated to capture the target substance. If the target substance is present in the sample, it will bind to the surface. Next, an enzyme-linked antibody specific to the target substance is added. This antibody will bind to the captured target substance if it is present. After washing away any unbound material, a substrate for the enzyme is added. If the enzyme is present due to its linkage to the antibody, it will catalyze a reaction that produces a detectable signal, such as a color change or fluorescence. The intensity of this signal is proportional to the amount of target substance present in the sample, allowing for quantification.

ELISAs are widely used in research and clinical settings to detect and measure various substances, including hormones, viruses, and bacteria. They offer high sensitivity, specificity, and reproducibility, making them a reliable choice for many applications.

In the field of medicine, "time factors" refer to the duration of symptoms or time elapsed since the onset of a medical condition, which can have significant implications for diagnosis and treatment. Understanding time factors is crucial in determining the progression of a disease, evaluating the effectiveness of treatments, and making critical decisions regarding patient care.

For example, in stroke management, "time is brain," meaning that rapid intervention within a specific time frame (usually within 4.5 hours) is essential to administering tissue plasminogen activator (tPA), a clot-busting drug that can minimize brain damage and improve patient outcomes. Similarly, in trauma care, the "golden hour" concept emphasizes the importance of providing definitive care within the first 60 minutes after injury to increase survival rates and reduce morbidity.

Time factors also play a role in monitoring the progression of chronic conditions like diabetes or heart disease, where regular follow-ups and assessments help determine appropriate treatment adjustments and prevent complications. In infectious diseases, time factors are crucial for initiating antibiotic therapy and identifying potential outbreaks to control their spread.

Overall, "time factors" encompass the significance of recognizing and acting promptly in various medical scenarios to optimize patient outcomes and provide effective care.

Recurrence, in a medical context, refers to the return of symptoms or signs of a disease after a period of improvement or remission. It indicates that the condition has not been fully eradicated and may require further treatment. Recurrence is often used to describe situations where a disease such as cancer comes back after initial treatment, but it can also apply to other medical conditions. The likelihood of recurrence varies depending on the type of disease and individual patient factors.

A blood transfusion is a medical procedure in which blood or its components are transferred from one individual (donor) to another (recipient) through a vein. The donated blood can be fresh whole blood, packed red blood cells, platelets, plasma, or cryoprecipitate, depending on the recipient's needs. Blood transfusions are performed to replace lost blood due to severe bleeding, treat anemia, support patients undergoing major surgeries, or manage various medical conditions such as hemophilia, thalassemia, and leukemia. The donated blood must be carefully cross-matched with the recipient's blood type to minimize the risk of transfusion reactions.

Interferons (IFNs) are a group of signaling proteins made and released by host cells in response to the presence of pathogens such as viruses, bacteria, parasites, or tumor cells. They belong to the larger family of cytokines and are crucial for the innate immune system's defense against infections. Interferons exist in multiple forms, classified into three types: type I (alpha and beta), type II (gamma), and type III (lambda). These proteins play a significant role in modulating the immune response, inhibiting viral replication, regulating cell growth, and promoting apoptosis of infected cells. Interferons are used as therapeutic agents for various medical conditions, including certain viral infections, cancers, and autoimmune diseases.

Viremia is a medical term that refers to the presence of viruses in the bloodstream. It occurs when a virus successfully infects a host and replicates within the body's cells, releasing new viral particles into the blood. This condition can lead to various clinical manifestations depending on the specific virus involved and the immune response of the infected individual. Some viral infections result in asymptomatic viremia, while others can cause severe illness or even life-threatening conditions. The detection of viremia is crucial for diagnosing certain viral infections and monitoring disease progression or treatment effectiveness.

Acute liver failure is a sudden and severe loss of liver function that occurs within a few days or weeks. It can be caused by various factors such as drug-induced liver injury, viral hepatitis, or metabolic disorders. In acute liver failure, the liver cannot perform its vital functions, including protein synthesis, detoxification, and metabolism of carbohydrates, fats, and proteins.

The symptoms of acute liver failure include jaundice (yellowing of the skin and eyes), coagulopathy (bleeding disorders), hepatic encephalopathy (neurological symptoms such as confusion, disorientation, and coma), and elevated levels of liver enzymes in the blood. Acute liver failure is a medical emergency that requires immediate hospitalization and treatment, which may include medications, supportive care, and liver transplantation.

Synthetic vaccines are artificially produced, designed to stimulate an immune response and provide protection against specific diseases. Unlike traditional vaccines that are derived from weakened or killed pathogens, synthetic vaccines are created using synthetic components, such as synthesized viral proteins, DNA, or RNA. These components mimic the disease-causing agent and trigger an immune response without causing the actual disease. The use of synthetic vaccines offers advantages in terms of safety, consistency, and scalability in production, making them valuable tools for preventing infectious diseases.

Immunoglobulins (Igs), also known as antibodies, are glycoprotein molecules produced by the immune system's B cells in response to the presence of foreign substances, such as bacteria, viruses, and toxins. These Y-shaped proteins play a crucial role in identifying and neutralizing pathogens and other antigens, thereby protecting the body against infection and disease.

Immunoglobulins are composed of four polypeptide chains: two identical heavy chains and two identical light chains, held together by disulfide bonds. The variable regions of these chains form the antigen-binding sites, which recognize and bind to specific epitopes on antigens. Based on their heavy chain type, immunoglobulins are classified into five main isotypes or classes: IgA, IgD, IgE, IgG, and IgM. Each class has distinct functions in the immune response, such as providing protection in different body fluids and tissues, mediating hypersensitivity reactions, and aiding in the development of immunological memory.

In medical settings, immunoglobulins can be administered therapeutically to provide passive immunity against certain diseases or to treat immune deficiencies, autoimmune disorders, and other conditions that may benefit from immunomodulation.

Serologic tests are laboratory tests that detect the presence or absence of antibodies or antigens in a patient's serum (the clear liquid that separates from clotted blood). These tests are commonly used to diagnose infectious diseases, as well as autoimmune disorders and other medical conditions.

In serologic testing for infectious diseases, a sample of the patient's blood is collected and allowed to clot. The serum is then separated from the clot and tested for the presence of antibodies that the body has produced in response to an infection. The test may be used to identify the specific type of infection or to determine whether the infection is active or has resolved.

Serologic tests can also be used to diagnose autoimmune disorders, such as rheumatoid arthritis and lupus, by detecting the presence of antibodies that are directed against the body's own tissues. These tests can help doctors confirm a diagnosis and monitor the progression of the disease.

It is important to note that serologic tests are not always 100% accurate and may produce false positive or false negative results. Therefore, they should be interpreted in conjunction with other clinical findings and laboratory test results.

A virion is the complete, infectious form of a virus outside its host cell. It consists of the viral genome (DNA or RNA) enclosed within a protein coat called the capsid, which is often surrounded by a lipid membrane called the envelope. The envelope may contain viral proteins and glycoproteins that aid in attachment to and entry into host cells during infection. The term "virion" emphasizes the infectious nature of the virus particle, as opposed to non-infectious components like individual capsid proteins or naked viral genome.

Phylogeny is the evolutionary history and relationship among biological entities, such as species or genes, based on their shared characteristics. In other words, it refers to the branching pattern of evolution that shows how various organisms have descended from a common ancestor over time. Phylogenetic analysis involves constructing a tree-like diagram called a phylogenetic tree, which depicts the inferred evolutionary relationships among organisms or genes based on molecular sequence data or other types of characters. This information is crucial for understanding the diversity and distribution of life on Earth, as well as for studying the emergence and spread of diseases.

A biopsy is a medical procedure in which a small sample of tissue is taken from the body to be examined under a microscope for the presence of disease. This can help doctors diagnose and monitor various medical conditions, such as cancer, infections, or autoimmune disorders. The type of biopsy performed will depend on the location and nature of the suspected condition. Some common types of biopsies include:

1. Incisional biopsy: In this procedure, a surgeon removes a piece of tissue from an abnormal area using a scalpel or other surgical instrument. This type of biopsy is often used when the lesion is too large to be removed entirely during the initial biopsy.

2. Excisional biopsy: An excisional biopsy involves removing the entire abnormal area, along with a margin of healthy tissue surrounding it. This technique is typically employed for smaller lesions or when cancer is suspected.

3. Needle biopsy: A needle biopsy uses a thin, hollow needle to extract cells or fluid from the body. There are two main types of needle biopsies: fine-needle aspiration (FNA) and core needle biopsy. FNA extracts loose cells, while a core needle biopsy removes a small piece of tissue.

4. Punch biopsy: In a punch biopsy, a round, sharp tool is used to remove a small cylindrical sample of skin tissue. This type of biopsy is often used for evaluating rashes or other skin abnormalities.

5. Shave biopsy: During a shave biopsy, a thin slice of tissue is removed from the surface of the skin using a sharp razor-like instrument. This technique is typically used for superficial lesions or growths on the skin.

After the biopsy sample has been collected, it is sent to a laboratory where a pathologist will examine the tissue under a microscope and provide a diagnosis based on their findings. The results of the biopsy can help guide further treatment decisions and determine the best course of action for managing the patient's condition.

Transfection is a term used in molecular biology that refers to the process of deliberately introducing foreign genetic material (DNA, RNA or artificial gene constructs) into cells. This is typically done using chemical or physical methods, such as lipofection or electroporation. Transfection is widely used in research and medical settings for various purposes, including studying gene function, producing proteins, developing gene therapies, and creating genetically modified organisms. It's important to note that transfection is different from transduction, which is the process of introducing genetic material into cells using viruses as vectors.

A nucleocapsid is a protein structure that encloses the genetic material (nucleic acid) of certain viruses. It is composed of proteins encoded by the virus itself, which are synthesized inside the host cell and then assemble around the viral genome to form a stable complex.

The nucleocapsid plays an important role in the viral life cycle. It protects the viral genome from degradation by host enzymes and helps to facilitate the packaging of the genome into new virus particles during assembly. Additionally, the nucleocapsid can also play a role in the regulation of viral gene expression and replication.

In some viruses, such as coronaviruses, the nucleocapsid is encased within an envelope derived from the host cell membrane, while in others, it exists as a naked capsid. The structure and composition of the nucleocapsid can vary significantly between different virus families.

Viral proteins are the proteins that are encoded by the viral genome and are essential for the viral life cycle. These proteins can be structural or non-structural and play various roles in the virus's replication, infection, and assembly process. Structural proteins make up the physical structure of the virus, including the capsid (the protein shell that surrounds the viral genome) and any envelope proteins (that may be present on enveloped viruses). Non-structural proteins are involved in the replication of the viral genome and modulation of the host cell environment to favor viral replication. Overall, a thorough understanding of viral proteins is crucial for developing antiviral therapies and vaccines.

An epitope is a specific region on the surface of an antigen (a molecule that can trigger an immune response) that is recognized by an antibody, B-cell receptor, or T-cell receptor. It is also commonly referred to as an antigenic determinant. Epitopes are typically composed of linear amino acid sequences or conformational structures made up of discontinuous amino acids in the antigen. They play a crucial role in the immune system's ability to differentiate between self and non-self molecules, leading to the targeted destruction of foreign substances like viruses and bacteria. Understanding epitopes is essential for developing vaccines, diagnostic tests, and immunotherapies.

Avihepadnavirus is a genus of viruses in the family Parvoviridae, which infect birds. These viruses are characterized by their small, single-stranded DNA genomes and icosahedral symmetry. They primarily infect the liver of birds and can cause chronic hepatitis and liver cancer. The most well-known member of this genus is the duck hepatitis B virus (DHBV), which has been extensively studied as a model for human hepatitis B virus (HBV) infection. However, it's important to note that avihepadnaviruses are not known to infect humans or other mammals.

Orthohepadnavirus is a genus of viruses in the family Hepadnaviridae, which includes hepatitis B virus (HBV) and related viruses. These viruses are characterized by having a partially double-stranded DNA genome and causing persistent infection in the liver of various animal hosts. The name "Orthohepadnavirus" distinguishes this genus from other genera within the family Hepadnaviridae, such as Avihepadnavirus and Metahepadnavirus, which infect birds and woodchucks, respectively.

The Orthohepadnavirus genus includes several viral species that infect different mammalian hosts, including humans (Hepatitis B virus), gorillas (Gorilla hepatitis B virus), chimpanzees (Chimpanzee hepatitis B virus), woolly monkeys (Woolly monkey hepadnavirus), and other primates. These viruses can cause acute and chronic liver infections, leading to liver inflammation, fibrosis, cirrhosis, and liver cancer.

The Orthohepadnavirus genome is a small, partially double-stranded DNA molecule that encodes for several viral proteins, including the surface antigen (HBsAg), core protein (HBcAg), polymerase, and X protein. The virus replicates via an RNA intermediate using a reverse transcriptase enzyme, which is encoded by the viral genome.

Prevention of Orthohepadnavirus infections relies on vaccination and safe injection practices, as well as screening of blood products and organ donors for viral markers. Treatment options are available for chronic HBV infection, including antiviral therapy with nucleos(t)ide analogs and interferon-alpha.

RNA-directed DNA polymerase is a type of enzyme that can synthesize DNA using an RNA molecule as a template. This process is called reverse transcription, and it is the mechanism by which retroviruses, such as HIV, replicate their genetic material. The enzyme responsible for this reaction in retroviruses is called reverse transcriptase.

Reverse transcriptase is an important target for antiretroviral therapy used to treat HIV infection and AIDS. In addition to its role in viral replication, RNA-directed DNA polymerase also has applications in molecular biology research, such as in the production of complementary DNA (cDNA) copies of RNA molecules for use in downstream applications like cloning and sequencing.

Drug-Induced Liver Injury (DILI) is a medical term that refers to liver damage or injury caused by the use of medications or drugs. This condition can vary in severity, from mild abnormalities in liver function tests to severe liver failure, which may require a liver transplant.

The exact mechanism of DILI can differ depending on the drug involved, but it generally occurs when the liver metabolizes the drug into toxic compounds that damage liver cells. This can happen through various pathways, including direct toxicity to liver cells, immune-mediated reactions, or metabolic idiosyncrasies.

Symptoms of DILI may include jaundice (yellowing of the skin and eyes), fatigue, abdominal pain, nausea, vomiting, loss of appetite, and dark urine. In severe cases, it can lead to complications such as ascites, encephalopathy, and bleeding disorders.

The diagnosis of DILI is often challenging because it requires the exclusion of other potential causes of liver injury. Liver function tests, imaging studies, and sometimes liver biopsies may be necessary to confirm the diagnosis. Treatment typically involves discontinuing the offending drug and providing supportive care until the liver recovers. In some cases, medications that protect the liver or promote its healing may be used.

Hep G2 cells are a type of human liver cancer cell line that were isolated from a well-differentiated hepatocellular carcinoma (HCC) in a patient with hepatitis C virus (HCV) infection. These cells have the ability to grow and divide indefinitely in culture, making them useful for research purposes. Hep G2 cells express many of the same markers and functions as normal human hepatocytes, including the ability to take up and process lipids and produce bile. They are often used in studies related to hepatitis viruses, liver metabolism, drug toxicity, and cancer biology. It is important to note that Hep G2 cells are tumorigenic and should be handled with care in a laboratory setting.

DNA Sequence Analysis is the systematic determination of the order of nucleotides in a DNA molecule. It is a critical component of modern molecular biology, genetics, and genetic engineering. The process involves determining the exact order of the four nucleotide bases - adenine (A), guanine (G), cytosine (C), and thymine (T) - in a DNA molecule or fragment. This information is used in various applications such as identifying gene mutations, studying evolutionary relationships, developing molecular markers for breeding, and diagnosing genetic diseases.

The process of DNA Sequence Analysis typically involves several steps, including DNA extraction, PCR amplification (if necessary), purification, sequencing reaction, and electrophoresis. The resulting data is then analyzed using specialized software to determine the exact sequence of nucleotides.

In recent years, high-throughput DNA sequencing technologies have revolutionized the field of genomics, enabling the rapid and cost-effective sequencing of entire genomes. This has led to an explosion of genomic data and new insights into the genetic basis of many diseases and traits.

'Infectious disease transmission, professional-to-patient' refers to the spread of an infectious agent or disease from a healthcare professional to a patient within a healthcare setting. This can occur through various routes such as:

1. Direct contact transmission: This involves physical contact between the healthcare professional and the patient, which may result in the transfer of microorganisms. Examples include touching, coughing, or sneezing on the patient.

2. Indirect contact transmission: This occurs when a healthcare professional contaminates an object or surface that is then touched by the patient, leading to the spread of infection. Common examples include contaminated medical equipment, bed rails, or doorknobs.

3. Droplet transmission: This type of transmission occurs when an infected individual generates respiratory droplets containing microorganisms, which can then be dispersed through the air and inhaled by a susceptible host. Healthcare professionals can transmit infectious diseases to patients via this route if they have close contact (within 1 meter) with the patient during procedures that generate aerosols or when coughing or sneezing.

4. Airborne transmission: This occurs when microorganisms are suspended in air and transmitted over long distances. Healthcare professionals can become sources of airborne infections through activities such as suctioning, endotracheal intubation, bronchoscopy, or cardiopulmonary resuscitation.

To prevent professional-to-patient transmission of infectious diseases, healthcare professionals should adhere to standard precautions, including hand hygiene, use of personal protective equipment (PPE), safe injection practices, and environmental cleaning and disinfection. Additionally, they should be vaccinated against vaccine-preventable diseases and follow respiratory etiquette, such as wearing masks and covering their mouths and noses when coughing or sneezing.

A biological marker, often referred to as a biomarker, is a measurable indicator that reflects the presence or severity of a disease state, or a response to a therapeutic intervention. Biomarkers can be found in various materials such as blood, tissues, or bodily fluids, and they can take many forms, including molecular, histologic, radiographic, or physiological measurements.

In the context of medical research and clinical practice, biomarkers are used for a variety of purposes, such as:

1. Diagnosis: Biomarkers can help diagnose a disease by indicating the presence or absence of a particular condition. For example, prostate-specific antigen (PSA) is a biomarker used to detect prostate cancer.
2. Monitoring: Biomarkers can be used to monitor the progression or regression of a disease over time. For instance, hemoglobin A1c (HbA1c) levels are monitored in diabetes patients to assess long-term blood glucose control.
3. Predicting: Biomarkers can help predict the likelihood of developing a particular disease or the risk of a negative outcome. For example, the presence of certain genetic mutations can indicate an increased risk for breast cancer.
4. Response to treatment: Biomarkers can be used to evaluate the effectiveness of a specific treatment by measuring changes in the biomarker levels before and after the intervention. This is particularly useful in personalized medicine, where treatments are tailored to individual patients based on their unique biomarker profiles.

It's important to note that for a biomarker to be considered clinically valid and useful, it must undergo rigorous validation through well-designed studies, including demonstrating sensitivity, specificity, reproducibility, and clinical relevance.

Arabinofuranosyluracil (AraU) is a nucleoside analogue, which means it is a synthetic compound similar to the building blocks of DNA and RNA. AraU is formed by combining the sugar arabinose with the nucleobase uracil. Nucleoside analogues like AraU are often used in cancer chemotherapy and antiviral therapy because they can interfere with the replication of DNA and RNA, disrupting the growth or replication of cancer cells or viruses.

In the context of medical research and treatment, AraU has been studied for its potential use as an anticancer and antiviral agent. However, it is not currently approved for use as a medication in humans. Like many nucleoside analogues, AraU can have toxic effects on normal cells as well as cancerous or virus-infected cells, which limits its usefulness as a therapeutic agent.

A case-control study is an observational research design used to identify risk factors or causes of a disease or health outcome. In this type of study, individuals with the disease or condition (cases) are compared with similar individuals who do not have the disease or condition (controls). The exposure history or other characteristics of interest are then compared between the two groups to determine if there is an association between the exposure and the disease.

Case-control studies are often used when it is not feasible or ethical to conduct a randomized controlled trial, as they can provide valuable insights into potential causes of diseases or health outcomes in a relatively short period of time and at a lower cost than other study designs. However, because case-control studies rely on retrospective data collection, they are subject to biases such as recall bias and selection bias, which can affect the validity of the results. Therefore, it is important to carefully design and conduct case-control studies to minimize these potential sources of bias.

I'm sorry for any confusion, but "Taiwan" is not a medical term or concept. It is the name of an island nation located in East Asia. The official name of the country is the Republic of China (ROC). If you have any medical questions or inquiries, I would be happy to help answer those for you!

I apologize, but "Brazil" is not a medical term or condition. It is the largest country in both South America and Latin America by land area and population. If you have any questions related to medical terminology or health concerns, please provide more information and I will do my best to help.

A newborn infant is a baby who is within the first 28 days of life. This period is also referred to as the neonatal period. Newborns require specialized care and attention due to their immature bodily systems and increased vulnerability to various health issues. They are closely monitored for signs of well-being, growth, and development during this critical time.

Radioimmunoassay (RIA) is a highly sensitive analytical technique used in clinical and research laboratories to measure concentrations of various substances, such as hormones, vitamins, drugs, or tumor markers, in biological samples like blood, urine, or tissues. The method relies on the specific interaction between an antibody and its corresponding antigen, combined with the use of radioisotopes to quantify the amount of bound antigen.

In a typical RIA procedure, a known quantity of a radiolabeled antigen (also called tracer) is added to a sample containing an unknown concentration of the same unlabeled antigen. The mixture is then incubated with a specific antibody that binds to the antigen. During the incubation period, the antibody forms complexes with both the radiolabeled and unlabeled antigens.

After the incubation, the unbound (free) radiolabeled antigen is separated from the antibody-antigen complexes, usually through a precipitation or separation step involving centrifugation, filtration, or chromatography. The amount of radioactivity in the pellet (containing the antibody-antigen complexes) is then measured using a gamma counter or other suitable radiation detection device.

The concentration of the unlabeled antigen in the sample can be determined by comparing the ratio of bound to free radiolabeled antigen in the sample to a standard curve generated from known concentrations of unlabeled antigen and their corresponding bound/free ratios. The higher the concentration of unlabeled antigen in the sample, the lower the amount of radiolabeled antigen that will bind to the antibody, resulting in a lower bound/free ratio.

Radioimmunoassays offer high sensitivity, specificity, and accuracy, making them valuable tools for detecting and quantifying low levels of various substances in biological samples. However, due to concerns about radiation safety and waste disposal, alternative non-isotopic immunoassay techniques like enzyme-linked immunosorbent assays (ELISAs) have become more popular in recent years.

I believe there may be a slight misunderstanding in your question. "Prisons" are not a medical term, but rather a term used to describe facilities where individuals who have been convicted of crimes serve their sentences of incarceration. They are run by correctional systems and law enforcement agencies, not healthcare providers or medical organizations.

However, I can certainly provide information about the potential impact of prisons on health and healthcare. Prisons can have significant effects on the physical and mental health of inmates due to factors such as overcrowding, violence, limited access to healthcare services, and the transmission of infectious diseases like HIV and hepatitis C. Additionally, many inmates have underlying health issues that may be exacerbated by incarceration, including substance use disorders, mental illness, and chronic medical conditions.

Therefore, it is important for correctional facilities to provide adequate healthcare services to their inmates, not only to meet basic human rights standards but also to promote public health more broadly by reducing the spread of infectious diseases and improving the health outcomes of individuals who will eventually be released back into the community.

A plasmid is a small, circular, double-stranded DNA molecule that is separate from the chromosomal DNA of a bacterium or other organism. Plasmids are typically not essential for the survival of the organism, but they can confer beneficial traits such as antibiotic resistance or the ability to degrade certain types of pollutants.

Plasmids are capable of replicating independently of the chromosomal DNA and can be transferred between bacteria through a process called conjugation. They often contain genes that provide resistance to antibiotics, heavy metals, and other environmental stressors. Plasmids have also been engineered for use in molecular biology as cloning vectors, allowing scientists to replicate and manipulate specific DNA sequences.

Plasmids are important tools in genetic engineering and biotechnology because they can be easily manipulated and transferred between organisms. They have been used to produce vaccines, diagnostic tests, and genetically modified organisms (GMOs) for various applications, including agriculture, medicine, and industry.

Prospective studies, also known as longitudinal studies, are a type of cohort study in which data is collected forward in time, following a group of individuals who share a common characteristic or exposure over a period of time. The researchers clearly define the study population and exposure of interest at the beginning of the study and follow up with the participants to determine the outcomes that develop over time. This type of study design allows for the investigation of causal relationships between exposures and outcomes, as well as the identification of risk factors and the estimation of disease incidence rates. Prospective studies are particularly useful in epidemiology and medical research when studying diseases with long latency periods or rare outcomes.

Sensitivity and specificity are statistical measures used to describe the performance of a diagnostic test or screening tool in identifying true positive and true negative results.

* Sensitivity refers to the proportion of people who have a particular condition (true positives) who are correctly identified by the test. It is also known as the "true positive rate" or "recall." A highly sensitive test will identify most or all of the people with the condition, but may also produce more false positives.
* Specificity refers to the proportion of people who do not have a particular condition (true negatives) who are correctly identified by the test. It is also known as the "true negative rate." A highly specific test will identify most or all of the people without the condition, but may also produce more false negatives.

In medical testing, both sensitivity and specificity are important considerations when evaluating a diagnostic test. High sensitivity is desirable for screening tests that aim to identify as many cases of a condition as possible, while high specificity is desirable for confirmatory tests that aim to rule out the condition in people who do not have it.

It's worth noting that sensitivity and specificity are often influenced by factors such as the prevalence of the condition in the population being tested, the threshold used to define a positive result, and the reliability and validity of the test itself. Therefore, it's important to consider these factors when interpreting the results of a diagnostic test.

I am not aware of any medical definition for the term "Egypt." Egypt is a country located in the northeastern corner of Africa, known for its rich history and cultural heritage. It is home to various ancient artifacts and monuments, including the Pyramids of Giza and the Sphinx.

If you have any specific medical or health-related questions related to Egypt, such as information about diseases prevalent in the country or healthcare practices there, I would be happy to try to help answer those for you.

Cryoglobulinemia is a medical condition characterized by the presence of abnormal proteins called cryoglobulins in the blood. These proteins become insoluble at lower temperatures and can form immune complexes that can cause inflammation and damage to small blood vessels when they precipitate in cooler parts of the body.

Cryoglobulinemia is often associated with underlying conditions such as autoimmune diseases (such as rheumatoid arthritis or lupus), chronic infections (such as hepatitis C), and certain types of cancer (such as lymphoma). Symptoms can vary widely, but may include purpura (purple spots on the skin), joint pain, peripheral neuropathy (nerve damage causing numbness or weakness), fatigue, and kidney problems.

The diagnosis of cryoglobulinemia is typically made by detecting cryoglobulins in the blood through a special test that requires the blood sample to be kept at cold temperatures. Treatment for cryoglobulinemia depends on the underlying cause, but may include medications such as corticosteroids, immunosuppressants, or chemotherapy drugs.

In epidemiology, the incidence of a disease is defined as the number of new cases of that disease within a specific population over a certain period of time. It is typically expressed as a rate, with the number of new cases in the numerator and the size of the population at risk in the denominator. Incidence provides information about the risk of developing a disease during a given time period and can be used to compare disease rates between different populations or to monitor trends in disease occurrence over time.

"Tupaia" is not a term found in general medical terminology. It is most likely referring to a genus of small mammals known as tree shrews, also called "tupaias." They are native to Southeast Asia and are not closely related to shrews, but rather belong to their own order, Scandentia.

However, if you're referring to a specific medical condition or concept that uses the term "Tupaia," I would need more context to provide an accurate definition.

Secondary immunization, also known as "anamnestic response" or "booster," refers to the enhanced immune response that occurs upon re-exposure to an antigen, having previously been immunized or infected with the same pathogen. This response is characterized by a more rapid and robust production of antibodies and memory cells compared to the primary immune response. The secondary immunization aims to maintain long-term immunity against infectious diseases and improve vaccine effectiveness. It usually involves administering additional doses of a vaccine or booster shots after the initial series of immunizations, which helps reinforce the immune system's ability to recognize and combat specific pathogens.

A cohort study is a type of observational study in which a group of individuals who share a common characteristic or exposure are followed up over time to determine the incidence of a specific outcome or outcomes. The cohort, or group, is defined based on the exposure status (e.g., exposed vs. unexposed) and then monitored prospectively to assess for the development of new health events or conditions.

Cohort studies can be either prospective or retrospective in design. In a prospective cohort study, participants are enrolled and followed forward in time from the beginning of the study. In contrast, in a retrospective cohort study, researchers identify a cohort that has already been assembled through medical records, insurance claims, or other sources and then look back in time to assess exposure status and health outcomes.

Cohort studies are useful for establishing causality between an exposure and an outcome because they allow researchers to observe the temporal relationship between the two. They can also provide information on the incidence of a disease or condition in different populations, which can be used to inform public health policy and interventions. However, cohort studies can be expensive and time-consuming to conduct, and they may be subject to bias if participants are not representative of the population or if there is loss to follow-up.

Immunoglobulin M (IgM) is a type of antibody that is primarily found in the blood and lymph fluid. It is the first antibody to be produced in response to an initial exposure to an antigen, making it an important part of the body's primary immune response. IgM antibodies are large molecules that are composed of five basic units, giving them a pentameric structure. They are primarily found on the surface of B cells as membrane-bound immunoglobulins (mlgM), where they function as receptors for antigens. Once an mlgM receptor binds to an antigen, it triggers the activation and differentiation of the B cell into a plasma cell that produces and secretes large amounts of soluble IgM antibodies.

IgM antibodies are particularly effective at agglutination (clumping) and complement activation, which makes them important in the early stages of an immune response to help clear pathogens from the bloodstream. However, they are not as stable or long-lived as other types of antibodies, such as IgG, and their levels tend to decline after the initial immune response has occurred.

In summary, Immunoglobulin M (IgM) is a type of antibody that plays a crucial role in the primary immune response to antigens by agglutination and complement activation. It is primarily found in the blood and lymph fluid, and it is produced by B cells after they are activated by an antigen.

An antigen is any substance that can stimulate an immune response, particularly the production of antibodies. Viral antigens are antigens that are found on or produced by viruses. They can be proteins, glycoproteins, or carbohydrates present on the surface or inside the viral particle.

Viral antigens play a crucial role in the immune system's recognition and response to viral infections. When a virus infects a host cell, it may display its antigens on the surface of the infected cell. This allows the immune system to recognize and target the infected cells for destruction, thereby limiting the spread of the virus.

Viral antigens are also important targets for vaccines. Vaccines typically work by introducing a harmless form of a viral antigen to the body, which then stimulates the production of antibodies and memory T-cells that can recognize and respond quickly and effectively to future infections with the actual virus.

It's worth noting that different types of viruses have different antigens, and these antigens can vary between strains of the same virus. This is why there are often different vaccines available for different viral diseases, and why flu vaccines need to be updated every year to account for changes in the circulating influenza virus strains.

I'm sorry for any confusion, but "replicon" is not a term that has a widely accepted or specific medical definition. It is a term that is used in the field of molecular biology, where it refers to a segment of DNA that contains an origin of replication. The origin of replication is the site on the DNA molecule where the process of DNA replication is initiated. This concept is important in the fields of genetics and virology, but it is not a term that is commonly used in clinical medicine.

If you have any questions related to the medical field, I would be happy to try to help answer them for you!

I apologize for any confusion, but "Sciuridae" is not a medical term. It is a scientific name in the field of biology, specifically for the family of animals that include squirrels, chipmunks, marmots, and prairie dogs, among others. These are rodents known for their agility in climbing trees and their ability to store food.

Follow-up studies are a type of longitudinal research that involve repeated observations or measurements of the same variables over a period of time, in order to understand their long-term effects or outcomes. In medical context, follow-up studies are often used to evaluate the safety and efficacy of medical treatments, interventions, or procedures.

In a typical follow-up study, a group of individuals (called a cohort) who have received a particular treatment or intervention are identified and then followed over time through periodic assessments or data collection. The data collected may include information on clinical outcomes, adverse events, changes in symptoms or functional status, and other relevant measures.

The results of follow-up studies can provide important insights into the long-term benefits and risks of medical interventions, as well as help to identify factors that may influence treatment effectiveness or patient outcomes. However, it is important to note that follow-up studies can be subject to various biases and limitations, such as loss to follow-up, recall bias, and changes in clinical practice over time, which must be carefully considered when interpreting the results.

Infectious disease transmission refers to the spread of an infectious agent or pathogen from an infected person, animal, or contaminated object to another susceptible host. This can occur through various routes, including:

1. Contact transmission: Direct contact with an infected person or animal, such as through touching, kissing, or sexual contact.
2. Droplet transmission: Inhalation of respiratory droplets containing the pathogen, which are generated when an infected person coughs, sneezes, talks, or breathes heavily.
3. Airborne transmission: Inhalation of smaller particles called aerosols that can remain suspended in the air for longer periods and travel farther distances than droplets.
4. Fecal-oral transmission: Consuming food or water contaminated with fecal matter containing the pathogen, often through poor hygiene practices.
5. Vector-borne transmission: Transmission via an intermediate vector, such as a mosquito or tick, that becomes infected after feeding on an infected host and then transmits the pathogen to another host during a subsequent blood meal.
6. Vehicle-borne transmission: Consuming food or water contaminated with the pathogen through vehicles like soil, water, or fomites (inanimate objects).

Preventing infectious disease transmission is crucial in controlling outbreaks and epidemics. Measures include good personal hygiene, vaccination, use of personal protective equipment (PPE), safe food handling practices, and environmental disinfection.

Transaminases, also known as aminotransferases, are a group of enzymes found in various tissues of the body, particularly in the liver, heart, muscle, and kidneys. They play a crucial role in the metabolism of amino acids, the building blocks of proteins.

There are two major types of transaminases: aspartate aminotransferase (AST) and alanine aminotransferase (ALT). Both enzymes are normally present in low concentrations in the bloodstream. However, when tissues that contain these enzymes are damaged or injured, such as during liver disease or muscle damage, the levels of AST and ALT in the blood may significantly increase.

Measurement of serum transaminase levels is a common laboratory test used to assess liver function and detect liver injury or damage. Increased levels of these enzymes in the blood can indicate conditions such as hepatitis, liver cirrhosis, drug-induced liver injury, heart attack, and muscle disorders. It's important to note that while elevated transaminase levels may suggest liver disease, they do not specify the type or cause of the condition, and further diagnostic tests are often required for accurate diagnosis and treatment.

I'm sorry for any confusion, but "Pakistan" is a country in South Asia and not a medical term or condition. If you have any medical questions or terms you would like defined, I would be happy to help!

A cross-sectional study is a type of observational research design that examines the relationship between variables at one point in time. It provides a snapshot or a "cross-section" of the population at a particular moment, allowing researchers to estimate the prevalence of a disease or condition and identify potential risk factors or associations.

In a cross-sectional study, data is collected from a sample of participants at a single time point, and the variables of interest are measured simultaneously. This design can be used to investigate the association between exposure and outcome, but it cannot establish causality because it does not follow changes over time.

Cross-sectional studies can be conducted using various data collection methods, such as surveys, interviews, or medical examinations. They are often used in epidemiology to estimate the prevalence of a disease or condition in a population and to identify potential risk factors that may contribute to its development. However, because cross-sectional studies only provide a snapshot of the population at one point in time, they cannot account for changes over time or determine whether exposure preceded the outcome.

Therefore, while cross-sectional studies can be useful for generating hypotheses and identifying potential associations between variables, further research using other study designs, such as cohort or case-control studies, is necessary to establish causality and confirm any findings.

DNA primers are short single-stranded DNA molecules that serve as a starting point for DNA synthesis. They are typically used in laboratory techniques such as the polymerase chain reaction (PCR) and DNA sequencing. The primer binds to a complementary sequence on the DNA template through base pairing, providing a free 3'-hydroxyl group for the DNA polymerase enzyme to add nucleotides and synthesize a new strand of DNA. This allows for specific and targeted amplification or analysis of a particular region of interest within a larger DNA molecule.

Virus assembly, also known as virion assembly, is the final stage in the virus life cycle where individual viral components come together to form a complete viral particle or virion. This process typically involves the self-assembly of viral capsid proteins around the viral genome (DNA or RNA) and, in enveloped viruses, the acquisition of a lipid bilayer membrane containing viral glycoproteins. The specific mechanisms and regulation of virus assembly vary among different viral families, but it is often directed by interactions between viral structural proteins and genomic nucleic acid.

Aflatoxin B1 is a toxic metabolite produced by certain strains of the fungus Aspergillus flavus and Aspergillus parasiticus. It is a potent carcinogen and is classified as a Group 1 carcinogen by the International Agency for Research on Cancer (IARC). Aflatoxin B1 contamination can occur in a variety of agricultural products, including grains, nuts, spices, and dried fruits, and is a particular concern in regions with hot and humid climates. Exposure to aflatoxin B1 can occur through the consumption of contaminated food and has been linked to various health effects, including liver cancer, immune suppression, and stunted growth in children.

Immunoenzyme techniques are a group of laboratory methods used in immunology and clinical chemistry that combine the specificity of antibody-antigen reactions with the sensitivity and amplification capabilities of enzyme reactions. These techniques are primarily used for the detection, quantitation, or identification of various analytes (such as proteins, hormones, drugs, viruses, or bacteria) in biological samples.

In immunoenzyme techniques, an enzyme is linked to an antibody or antigen, creating a conjugate. This conjugate then interacts with the target analyte in the sample, forming an immune complex. The presence and amount of this immune complex can be visualized or measured by detecting the enzymatic activity associated with it.

There are several types of immunoenzyme techniques, including:

1. Enzyme-linked Immunosorbent Assay (ELISA): A widely used method for detecting and quantifying various analytes in a sample. In ELISA, an enzyme is attached to either the capture antibody or the detection antibody. After the immune complex formation, a substrate is added that reacts with the enzyme, producing a colored product that can be measured spectrophotometrically.
2. Immunoblotting (Western blot): A method used for detecting specific proteins in a complex mixture, such as a protein extract from cells or tissues. In this technique, proteins are separated by gel electrophoresis and transferred to a membrane, where they are probed with an enzyme-conjugated antibody directed against the target protein.
3. Immunohistochemistry (IHC): A method used for detecting specific antigens in tissue sections or cells. In IHC, an enzyme-conjugated primary or secondary antibody is applied to the sample, and the presence of the antigen is visualized using a chromogenic substrate that produces a colored product at the site of the antigen-antibody interaction.
4. Immunofluorescence (IF): A method used for detecting specific antigens in cells or tissues by employing fluorophore-conjugated antibodies. The presence of the antigen is visualized using a fluorescence microscope.
5. Enzyme-linked immunosorbent assay (ELISA): A method used for detecting and quantifying specific antigens or antibodies in liquid samples, such as serum or culture supernatants. In ELISA, an enzyme-conjugated detection antibody is added after the immune complex formation, and a substrate is added that reacts with the enzyme to produce a colored product that can be measured spectrophotometrically.

These techniques are widely used in research and diagnostic laboratories for various applications, including protein characterization, disease diagnosis, and monitoring treatment responses.

Immunoglobulin G (IgG) is a type of antibody, which is a protective protein produced by the immune system in response to foreign substances like bacteria or viruses. IgG is the most abundant type of antibody in human blood, making up about 75-80% of all antibodies. It is found in all body fluids and plays a crucial role in fighting infections caused by bacteria, viruses, and toxins.

IgG has several important functions:

1. Neutralization: IgG can bind to the surface of bacteria or viruses, preventing them from attaching to and infecting human cells.
2. Opsonization: IgG coats the surface of pathogens, making them more recognizable and easier for immune cells like neutrophils and macrophages to phagocytose (engulf and destroy) them.
3. Complement activation: IgG can activate the complement system, a group of proteins that work together to help eliminate pathogens from the body. Activation of the complement system leads to the formation of the membrane attack complex, which creates holes in the cell membranes of bacteria, leading to their lysis (destruction).
4. Antibody-dependent cellular cytotoxicity (ADCC): IgG can bind to immune cells like natural killer (NK) cells and trigger them to release substances that cause target cells (such as virus-infected or cancerous cells) to undergo apoptosis (programmed cell death).
5. Immune complex formation: IgG can form immune complexes with antigens, which can then be removed from the body through various mechanisms, such as phagocytosis by immune cells or excretion in urine.

IgG is a critical component of adaptive immunity and provides long-lasting protection against reinfection with many pathogens. It has four subclasses (IgG1, IgG2, IgG3, and IgG4) that differ in their structure, function, and distribution in the body.

A capsid is the protein shell that encloses and protects the genetic material of a virus. It is composed of multiple copies of one or more proteins that are arranged in a specific structure, which can vary in shape and symmetry depending on the type of virus. The capsid plays a crucial role in the viral life cycle, including protecting the viral genome from host cell defenses, mediating attachment to and entry into host cells, and assisting with the assembly of new virus particles during replication.

I apologize for any confusion, but "prisoners" is not a medical term. It generally refers to individuals who are deprived of their personal freedom and are being held in a prison or jail as a result of being convicted of a crime or while awaiting trial. If you have any questions related to medical terminology, I would be happy to help!

Promoter regions in genetics refer to specific DNA sequences located near the transcription start site of a gene. They serve as binding sites for RNA polymerase and various transcription factors that regulate the initiation of gene transcription. These regulatory elements help control the rate of transcription and, therefore, the level of gene expression. Promoter regions can be composed of different types of sequences, such as the TATA box and CAAT box, and their organization and composition can vary between different genes and species.

I apologize for the confusion, but "Moldova" is not a medical term. It is a country in Eastern Europe, bordered by Romania to the west and Ukraine to the north, east, and south. If you have any questions related to medical terminology or health science, please don't hesitate to ask!

Genetic variation refers to the differences in DNA sequences among individuals and populations. These variations can result from mutations, genetic recombination, or gene flow between populations. Genetic variation is essential for evolution by providing the raw material upon which natural selection acts. It can occur within a single gene, between different genes, or at larger scales, such as differences in the number of chromosomes or entire sets of chromosomes. The study of genetic variation is crucial in understanding the genetic basis of diseases and traits, as well as the evolutionary history and relationships among species.

Needlestick injuries are sharp object injuries typically involving hollow-bore needles, which can result in exposure to bloodborne pathogens. They often occur during the use or disposal of contaminated needles in healthcare settings. These injuries pose a significant risk for transmission of infectious diseases such as HIV, Hepatitis B, and Hepatitis C. It is essential to follow strict protocols for handling and disposing of needles and other sharp objects to minimize the risk of needlestick injuries.

Disease progression is the worsening or advancement of a medical condition over time. It refers to the natural course of a disease, including its development, the severity of symptoms and complications, and the impact on the patient's overall health and quality of life. Understanding disease progression is important for developing appropriate treatment plans, monitoring response to therapy, and predicting outcomes.

The rate of disease progression can vary widely depending on the type of medical condition, individual patient factors, and the effectiveness of treatment. Some diseases may progress rapidly over a short period of time, while others may progress more slowly over many years. In some cases, disease progression may be slowed or even halted with appropriate medical interventions, while in other cases, the progression may be inevitable and irreversible.

In clinical practice, healthcare providers closely monitor disease progression through regular assessments, imaging studies, and laboratory tests. This information is used to guide treatment decisions and adjust care plans as needed to optimize patient outcomes and improve quality of life.

Bilirubin is a yellowish pigment that is produced by the liver when it breaks down old red blood cells. It is a normal byproduct of hemoglobin metabolism and is usually conjugated (made water-soluble) in the liver before being excreted through the bile into the digestive system. Elevated levels of bilirubin can cause jaundice, a yellowing of the skin and eyes. Increased bilirubin levels may indicate liver disease or other medical conditions such as gallstones or hemolysis. It is also measured to assess liver function and to help diagnose various liver disorders.

Alpha-fetoprotein (AFP) is a protein produced by the yolk sac and the liver during fetal development. In adults, AFP is normally present in very low levels in the blood. However, abnormal production of AFP can occur in certain medical conditions, such as:

* Liver cancer or hepatocellular carcinoma (HCC)
* Germ cell tumors, including non-seminomatous testicular cancer and ovarian cancer
* Hepatitis or liver inflammation
* Certain types of benign liver disease, such as cirrhosis or hepatic adenomas

Elevated levels of AFP in the blood can be detected through a simple blood test. This test is often used as a tumor marker to help diagnose and monitor certain types of cancer, particularly HCC. However, it's important to note that an elevated AFP level alone is not enough to diagnose cancer, and further testing is usually needed to confirm the diagnosis. Additionally, some non-cancerous conditions can also cause elevated AFP levels, so it's important to interpret the test results in the context of the individual's medical history and other diagnostic tests.

Medical mass screening, also known as population screening, is a public health service that aims to identify and detect asymptomatic individuals in a given population who have or are at risk of a specific disease. The goal is to provide early treatment, reduce morbidity and mortality, and prevent the spread of diseases within the community.

A mass screening program typically involves offering a simple, quick, and non-invasive test to a large number of people in a defined population, regardless of their risk factors or symptoms. Those who test positive are then referred for further diagnostic tests and appropriate medical interventions. Examples of mass screening programs include mammography for breast cancer detection, PSA (prostate-specific antigen) testing for prostate cancer, and fecal occult blood testing for colorectal cancer.

It is important to note that mass screening programs should be evidence-based, cost-effective, and ethically sound, with clear benefits outweighing potential harms. They should also consider factors such as the prevalence of the disease in the population, the accuracy and reliability of the screening test, and the availability and effectiveness of treatment options.

Sexually Transmitted Diseases (STDs) are infections that can be passed from one person to another through sexual contact. When focusing on viral STDs, these are infections caused by viruses that can be spread through sexual contact including vaginal, anal, and oral sex. Some common examples of viral STDs include HIV/AIDS, genital herpes, human papillomavirus (HPV), hepatitis B, and genital warts. These viral infections can lead to serious health complications if not diagnosed and treated promptly. It's important to note that some viral STDs may not have noticeable symptoms, but can still be passed on to sexual partners and cause long-term health problems.

Medical definitions are often avoided in favor of more objective language when discussing personal characteristics or identities, such as sexual orientation. This is because sexual orientation is not considered a medical condition or disorder, but rather a natural part of human diversity. The American Psychological Association defines sexual orientation as "an enduring emotional, romantic, sexual, or affectional attraction to another person." It can be distinguished into different categories, including heterosexuality (attraction to individuals of the other gender), bisexuality (attraction to individuals of either gender), and homosexuality (attraction to individuals of the same gender).

It's important to note that a person's sexual orientation is not considered a choice or something that can be changed through willpower or therapy. It is a deeply ingrained aspect of a person's identity, and it is protected under laws and regulations in many countries as a fundamental human right.

Circular DNA is a type of DNA molecule that forms a closed loop, rather than the linear double helix structure commonly associated with DNA. This type of DNA is found in some viruses, plasmids (small extrachromosomal DNA molecules found in bacteria), and mitochondria and chloroplasts (organelles found in plant and animal cells).

Circular DNA is characterized by the absence of telomeres, which are the protective caps found on linear chromosomes. Instead, circular DNA has a specific sequence where the two ends join together, known as the origin of replication and the replication terminus. This structure allows for the DNA to be replicated efficiently and compactly within the cell.

Because of its circular nature, circular DNA is more resistant to degradation by enzymes that cut linear DNA, making it more stable in certain environments. Additionally, the ability to easily manipulate and clone circular DNA has made it a valuable tool in molecular biology and genetic engineering.

Immunization is defined medically as the process where an individual is made immune or resistant to an infectious disease, typically through the administration of a vaccine. The vaccine stimulates the body's own immune system to recognize and fight off the specific disease-causing organism, thereby preventing or reducing the severity of future infections with that organism.

Immunization can be achieved actively, where the person is given a vaccine to trigger an immune response, or passively, where antibodies are transferred to the person through immunoglobulin therapy. Immunizations are an important part of preventive healthcare and have been successful in controlling and eliminating many infectious diseases worldwide.

DNA-directed DNA polymerase is a type of enzyme that synthesizes new strands of DNA by adding nucleotides to an existing DNA template in a 5' to 3' direction. These enzymes are essential for DNA replication, repair, and recombination. They require a single-stranded DNA template, a primer with a free 3' hydroxyl group, and the four deoxyribonucleoside triphosphates (dNTPs) as substrates to carry out the polymerization reaction.

DNA polymerases also have proofreading activity, which allows them to correct errors that occur during DNA replication by removing mismatched nucleotides and replacing them with the correct ones. This helps ensure the fidelity of the genetic information passed from one generation to the next.

There are several different types of DNA polymerases, each with specific functions and characteristics. For example, DNA polymerase I is involved in both DNA replication and repair, while DNA polymerase III is the primary enzyme responsible for DNA replication in bacteria. In eukaryotic cells, DNA polymerase alpha, beta, gamma, delta, and epsilon have distinct roles in DNA replication, repair, and maintenance.

Pregnancy is a physiological state or condition where a fertilized egg (zygote) successfully implants and grows in the uterus of a woman, leading to the development of an embryo and finally a fetus. This process typically spans approximately 40 weeks, divided into three trimesters, and culminates in childbirth. Throughout this period, numerous hormonal and physical changes occur to support the growing offspring, including uterine enlargement, breast development, and various maternal adaptations to ensure the fetus's optimal growth and well-being.

CD81 is a type of protein that is found on the surface of certain cells in the human body. It is a member of the tetraspanin family of proteins, which are involved in various cellular processes including cell adhesion, motility, and activation. CD81 has been shown to be important in the function of the immune system, particularly in the regulation of T cells.

CD81 is also known as a potential antigen, which means that it can stimulate an immune response when introduced into the body. Specifically, CD81 can bind to another protein called CD19, and this interaction has been shown to be important for the activation and survival of B cells, which are a type of white blood cell involved in the production of antibodies.

In some cases, CD81 may be targeted by the immune system in certain autoimmune diseases or during rejection of transplanted organs. Additionally, CD81 has been identified as a potential target for cancer immunotherapy, as it is overexpressed on some types of cancer cells and can help to inhibit the anti-tumor immune response.

GB virus C (GBV-C), also known as hepatitis G virus (HGV) or human pegivirus (HPgV), is a single-stranded, positive-sense RNA virus that belongs to the Flaviviridae family. It was initially identified in 1995 and is closely related to hepatitis C virus (HCV). However, unlike HCV, GBV-C is not associated with any significant liver disease and does not cause hepatitis.

GBV-C infection is usually asymptomatic and often resolves on its own without treatment. It is primarily transmitted through blood and bodily fluids, such as through sharing needles or during sexual contact. Vertical transmission from mother to child can also occur, although it is less common than with HCV.

While GBV-C infection is generally benign, there is some evidence to suggest that it may have immunomodulatory effects and could potentially impact the course of other viral infections, such as HIV. However, more research is needed to fully understand the clinical significance of GBV-C infection.

Reagent kits, diagnostic are prepackaged sets of chemical reagents and other components designed for performing specific diagnostic tests or assays. These kits are often used in clinical laboratories to detect and measure the presence or absence of various biomarkers, such as proteins, antibodies, antigens, nucleic acids, or small molecules, in biological samples like blood, urine, or tissues.

Diagnostic reagent kits typically contain detailed instructions for their use, along with the necessary reagents, controls, and sometimes specialized equipment or supplies. They are designed to simplify the testing process, reduce human error, and increase standardization, ensuring accurate and reliable results. Examples of diagnostic reagent kits include those used for pregnancy tests, infectious disease screening, drug testing, genetic testing, and cancer biomarker detection.

Blood safety is a term used to describe the measures taken to ensure that blood and blood products are free from infectious agents and are safe for transfusion. This includes rigorous screening processes for donors, testing of donated blood for various infectious diseases such as HIV, hepatitis B and C, syphilis, and West Nile virus, and proper handling, storage, and distribution of blood products. Additionally, strict quality control measures are in place to ensure the accuracy and reliability of test results. The goal of blood safety is to protect recipients from transfusion-transmitted infections while ensuring an adequate supply of safe blood for those in need.

Virology is the study of viruses, their classification, and their effects on living organisms. It involves the examination of viral genetic material, viral replication, how viruses cause disease, and the development of antiviral drugs and vaccines to treat or prevent virus infections. Virologists study various types of viruses that can infect animals, plants, and microorganisms, as well as understand their evolution and transmission patterns.

I'm sorry for any confusion, but "India" is not a medical term or concept. It is a country in South Asia, the second-most populous country in the world, known for its rich history, diverse culture, and numerous contributions to various fields including medicine. If you have any questions related to medical topics, I would be happy to help answer them!

Hepatoblastoma is a rare type of liver cancer that primarily affects children, particularly those under the age of 3. It originates from the hepatoblasts, which are immature cells in the liver that eventually develop into mature liver cells (hepatocytes).

The tumor typically grows as a single mass in one lobe of the liver, although multiple tumors can also occur. Hepatoblastoma may cause symptoms such as abdominal pain or swelling, loss of appetite, weight loss, and early satiety. In some cases, it might lead to hormonal imbalances due to the production of certain proteins by the tumor.

The exact cause of hepatoblastoma remains unknown, but genetic factors and certain medical conditions like Beckwith-Wiedemann syndrome and familial adenomatous polyposis (FAP) have been associated with an increased risk of developing this type of cancer. Treatment usually involves surgical resection of the tumor, chemotherapy, and sometimes liver transplantation in advanced cases. Regular follow-up care is essential to monitor for potential recurrence.

Flaviviridae infections refer to a group of diseases caused by viruses that belong to the Flaviviridae family. This family includes several important human pathogens, such as dengue virus, yellow fever virus, West Nile virus, Japanese encephalitis virus, and Zika virus.

These viruses are primarily transmitted to humans through the bites of infected mosquitoes or ticks. The symptoms of Flaviviridae infections can vary depending on the specific virus, but they often include fever, headache, muscle and joint pain, rash, and fatigue. In severe cases, these infections can lead to serious complications such as hemorrhagic fever, encephalitis, or neuropathy.

Prevention measures for Flaviviridae infections include avoiding mosquito and tick bites, using insect repellent, wearing protective clothing, and getting vaccinated if vaccines are available for the specific virus. Treatment is generally supportive and may include fluid replacement, pain relief, and management of complications. There are no specific antiviral treatments available for most Flaviviridae infections.

'Tumor cells, cultured' refers to the process of removing cancerous cells from a tumor and growing them in controlled laboratory conditions. This is typically done by isolating the tumor cells from a patient's tissue sample, then placing them in a nutrient-rich environment that promotes their growth and multiplication.

The resulting cultured tumor cells can be used for various research purposes, including the study of cancer biology, drug development, and toxicity testing. They provide a valuable tool for researchers to better understand the behavior and characteristics of cancer cells outside of the human body, which can lead to the development of more effective cancer treatments.

It is important to note that cultured tumor cells may not always behave exactly the same way as they do in the human body, so findings from cell culture studies must be validated through further research, such as animal models or clinical trials.

I'm sorry for any confusion, but "United States" is a geopolitical entity, specifically the name of the country consisting of 50 states, and it is not a medical term or concept. Therefore, I can't provide a medical definition for it. If you have any questions related to health, medicine, or biology, I would be happy to try to help answer those!

I cannot provide a medical definition for "equipment reuse" as it is not a term that is commonly used in the medical field. However, I can give you some general information about equipment reuse in healthcare settings.

Equipment reuse refers to the practice of using previously owned or disposable medical equipment and supplies multiple times after they have been sterilized or disinfected according to established protocols. This practice is often adopted by healthcare facilities as a way to reduce costs, conserve resources, and minimize waste.

Examples of medical equipment that may be reused include anesthesia breathing circuits, blood pressure cuffs, stethoscopes, and electronic thermometers. It's important to note that any reprocessed or reused medical equipment must undergo strict cleaning, disinfection, and sterilization procedures to ensure the safety of patients and healthcare workers.

Reusing medical equipment can have benefits such as reducing costs and waste, but it also carries risks if not done properly. Proper training and adherence to established protocols are crucial to ensuring that reused equipment is safe for use.

Genetic transcription is the process by which the information in a strand of DNA is used to create a complementary RNA molecule. This process is the first step in gene expression, where the genetic code in DNA is converted into a form that can be used to produce proteins or functional RNAs.

During transcription, an enzyme called RNA polymerase binds to the DNA template strand and reads the sequence of nucleotide bases. As it moves along the template, it adds complementary RNA nucleotides to the growing RNA chain, creating a single-stranded RNA molecule that is complementary to the DNA template strand. Once transcription is complete, the RNA molecule may undergo further processing before it can be translated into protein or perform its functional role in the cell.

Transcription can be either "constitutive" or "regulated." Constitutive transcription occurs at a relatively constant rate and produces essential proteins that are required for basic cellular functions. Regulated transcription, on the other hand, is subject to control by various intracellular and extracellular signals, allowing cells to respond to changing environmental conditions or developmental cues.

"Intramuscular injections" refer to a medical procedure where a medication or vaccine is administered directly into the muscle tissue. This is typically done using a hypodermic needle and syringe, and the injection is usually given into one of the large muscles in the body, such as the deltoid (shoulder), vastus lateralis (thigh), or ventrogluteal (buttock) muscles.

Intramuscular injections are used for a variety of reasons, including to deliver medications that need to be absorbed slowly over time, to bypass stomach acid and improve absorption, or to ensure that the medication reaches the bloodstream quickly and directly. Common examples of medications delivered via intramuscular injection include certain vaccines, antibiotics, and pain relievers.

It is important to follow proper technique when administering intramuscular injections to minimize pain and reduce the risk of complications such as infection or injury to surrounding tissues. Proper site selection, needle length and gauge, and injection technique are all critical factors in ensuring a safe and effective intramuscular injection.

Patient-to-professional transmission of infectious diseases refers to the spread of an infectious agent or disease from a patient to a healthcare professional. This can occur through various routes, including:

1. Contact transmission: This includes direct contact, such as touching or shaking hands with an infected patient, or indirect contact, such as touching a contaminated surface or object.
2. Droplet transmission: This occurs when an infected person coughs, sneezes, talks, or breathes out droplets containing the infectious agent, which can then be inhaled by a nearby healthcare professional.
3. Airborne transmission: This involves the spread of infectious agents through the air over long distances, usually requiring specialized medical procedures or equipment.

Healthcare professionals are at risk of patient-to-professional transmission of infectious diseases due to their close contact with patients and the potential for exposure to various pathogens. It is essential for healthcare professionals to follow standard precautions, including hand hygiene, personal protective equipment (PPE), and respiratory protection, to minimize the risk of transmission. Additionally, proper vaccination and education on infection prevention and control measures can further reduce the risk of patient-to-professional transmission of infectious diseases.

Renal dialysis is a medical procedure that is used to artificially remove waste products, toxins, and excess fluids from the blood when the kidneys are no longer able to perform these functions effectively. This process is also known as hemodialysis.

During renal dialysis, the patient's blood is circulated through a special machine called a dialyzer or an artificial kidney, which contains a semi-permeable membrane that filters out waste products and excess fluids from the blood. The cleaned blood is then returned to the patient's body.

Renal dialysis is typically recommended for patients with advanced kidney disease or kidney failure, such as those with end-stage renal disease (ESRD). It is a life-sustaining treatment that helps to maintain the balance of fluids and electrolytes in the body, prevent the buildup of waste products and toxins, and control blood pressure.

There are two main types of renal dialysis: hemodialysis and peritoneal dialysis. Hemodialysis is the most common type and involves using a dialyzer to filter the blood outside the body. Peritoneal dialysis, on the other hand, involves placing a catheter in the abdomen and using the lining of the abdomen (peritoneum) as a natural filter to remove waste products and excess fluids from the body.

Overall, renal dialysis is an essential treatment option for patients with kidney failure, helping them to maintain their quality of life and prolong their survival.

A cell line that is derived from tumor cells and has been adapted to grow in culture. These cell lines are often used in research to study the characteristics of cancer cells, including their growth patterns, genetic changes, and responses to various treatments. They can be established from many different types of tumors, such as carcinomas, sarcomas, and leukemias. Once established, these cell lines can be grown and maintained indefinitely in the laboratory, allowing researchers to conduct experiments and studies that would not be feasible using primary tumor cells. It is important to note that tumor cell lines may not always accurately represent the behavior of the original tumor, as they can undergo genetic changes during their time in culture.

Syphilis is a sexually transmitted infection (STI) caused by the bacterium Treponema pallidum. It progresses in several stages if left untreated, with symptoms varying in each stage. The primary stage involves the appearance of a single, painless sore or multiple sores at the site where the bacteria entered the body, often on the genitals or around the mouth. During the secondary stage, individuals may experience rashes, fever, swollen lymph nodes, and other flu-like symptoms. In later stages, syphilis can lead to severe complications affecting the heart, brain, and other organs, known as tertiary syphilis. Neurosyphilis is a form of tertiary syphilis that affects the nervous system, causing various neurological problems. Congenital syphilis occurs when a pregnant woman with syphilis transmits the infection to her unborn child, which can result in serious birth defects and health issues for the infant. Early detection and appropriate antibiotic treatment can cure syphilis and prevent further complications.

Pyrimidinones are a class of heterocyclic organic compounds that contain a pyrimidine ring fused with a ketone group. The basic structure of a pyrimidinone consists of two nitrogen atoms and four carbon atoms in a six-membered ring, with a carbonyl (C=O) group attached to one of the carbon atoms.

In a medical context, pyrimidinones are important because many naturally occurring and synthetic compounds that contain this structure have been found to have biological activity. For example, some pyrimidinones have antiviral, antibacterial, or anticancer properties, making them useful in the development of new drugs for various medical conditions.

One well-known drug that contains a pyrimidinone ring is the antiviral medication Ribavirin, which is used to treat hepatitis C and certain viral hemorrhagic fevers. Other pyrimidinones are being studied for their potential therapeutic benefits in areas such as cancer therapy, neuroprotection, and inflammation.

Serum, in the context of clinical and medical laboratory science, refers to the fluid that is obtained after blood coagulation. It is the yellowish, straw-colored liquid fraction of whole blood that remains after the clotting factors have been removed. Serum contains various proteins, electrolytes, hormones, antibodies, antigens, and other substances, which can be analyzed to help diagnose and monitor a wide range of medical conditions. It is commonly used for various clinical tests such as chemistry panels, immunological assays, drug screening, and infectious disease testing.

Combined vaccines are defined in medical terms as vaccines that contain two or more antigens from different diseases, which are given to provide protection against multiple diseases at the same time. This approach reduces the number of injections required and simplifies the immunization schedule, especially during early childhood. Examples of combined vaccines include:

1. DTaP-Hib-IPV (e.g., Pentacel): A vaccine that combines diphtheria, tetanus, pertussis (whooping cough), Haemophilus influenzae type b (Hib) disease, and poliovirus components in one injection to protect against these five diseases.
2. MMRV (e.g., ProQuad): A vaccine that combines measles, mumps, rubella, and varicella (chickenpox) antigens in a single injection to provide immunity against all four diseases.
3. HepA-HepB (e.g., Twinrix): A vaccine that combines hepatitis A and hepatitis B antigens in one injection, providing protection against both types of hepatitis.
4. MenACWY-TT (e.g., MenQuadfi): A vaccine that combines four serogroups of meningococcal bacteria (A, C, W, Y) with tetanus toxoid as a carrier protein in one injection for the prevention of invasive meningococcal disease caused by these serogroups.
5. PCV13-PPSV23 (e.g., Vaxneuvance): A vaccine that combines 13 pneumococcal serotypes with PPSV23, providing protection against a broader range of pneumococcal diseases in adults aged 18 years and older.

Combined vaccines have been thoroughly tested for safety and efficacy to ensure they provide a strong immune response and an acceptable safety profile. They are essential tools in preventing various infectious diseases and improving overall public health.

"Age factors" refer to the effects, changes, or differences that age can have on various aspects of health, disease, and medical care. These factors can encompass a wide range of issues, including:

1. Physiological changes: As people age, their bodies undergo numerous physical changes that can affect how they respond to medications, illnesses, and medical procedures. For example, older adults may be more sensitive to certain drugs or have weaker immune systems, making them more susceptible to infections.
2. Chronic conditions: Age is a significant risk factor for many chronic diseases, such as heart disease, diabetes, cancer, and arthritis. As a result, age-related medical issues are common and can impact treatment decisions and outcomes.
3. Cognitive decline: Aging can also lead to cognitive changes, including memory loss and decreased decision-making abilities. These changes can affect a person's ability to understand and comply with medical instructions, leading to potential complications in their care.
4. Functional limitations: Older adults may experience physical limitations that impact their mobility, strength, and balance, increasing the risk of falls and other injuries. These limitations can also make it more challenging for them to perform daily activities, such as bathing, dressing, or cooking.
5. Social determinants: Age-related factors, such as social isolation, poverty, and lack of access to transportation, can impact a person's ability to obtain necessary medical care and affect their overall health outcomes.

Understanding age factors is critical for healthcare providers to deliver high-quality, patient-centered care that addresses the unique needs and challenges of older adults. By taking these factors into account, healthcare providers can develop personalized treatment plans that consider a person's age, physical condition, cognitive abilities, and social circumstances.

A disease outbreak is defined as the occurrence of cases of a disease in excess of what would normally be expected in a given time and place. It may affect a small and localized group or a large number of people spread over a wide area, even internationally. An outbreak may be caused by a new agent, a change in the agent's virulence or host susceptibility, or an increase in the size or density of the host population.

Outbreaks can have significant public health and economic impacts, and require prompt investigation and control measures to prevent further spread of the disease. The investigation typically involves identifying the source of the outbreak, determining the mode of transmission, and implementing measures to interrupt the chain of infection. This may include vaccination, isolation or quarantine, and education of the public about the risks and prevention strategies.

Examples of disease outbreaks include foodborne illnesses linked to contaminated food or water, respiratory infections spread through coughing and sneezing, and mosquito-borne diseases such as Zika virus and West Nile virus. Outbreaks can also occur in healthcare settings, such as hospitals and nursing homes, where vulnerable populations may be at increased risk of infection.

Alcoholic Liver Cirrhosis is a medical condition characterized by irreversible scarring (fibrosis) and damage to the liver caused by excessive consumption of alcohol over an extended period. The liver's normal structure and function are progressively impaired as healthy liver tissue is replaced by scarred tissue, leading to the formation of nodules (regenerative noduli).

The condition typically develops after years of heavy drinking, with a higher risk for those who consume more than 60 grams of pure alcohol daily. The damage caused by alcoholic liver cirrhosis can be life-threatening and may result in complications such as:

1. Ascites (accumulation of fluid in the abdomen)
2. Encephalopathy (neurological dysfunction due to liver failure)
3. Esophageal varices (dilated veins in the esophagus that can rupture and bleed)
4. Hepatorenal syndrome (kidney failure caused by liver disease)
5. Increased susceptibility to infections
6. Liver cancer (hepatocellular carcinoma)
7. Portal hypertension (increased blood pressure in the portal vein that supplies blood to the liver)

Abstaining from alcohol and managing underlying medical conditions are crucial for slowing down or halting disease progression. Treatment may involve medications, dietary changes, and supportive care to address complications. In severe cases, a liver transplant might be necessary.

I'm sorry for any confusion, but "Turkey" is not a medical term. It is a common name for the country located in Eastern Europe and Western Asia, as well as a type of large bird native to North America that is often eaten as a holiday meal. If you have any questions about medical terminology or health-related topics, I'd be happy to try and help answer them!

Molecular cloning is a laboratory technique used to create multiple copies of a specific DNA sequence. This process involves several steps:

1. Isolation: The first step in molecular cloning is to isolate the DNA sequence of interest from the rest of the genomic DNA. This can be done using various methods such as PCR (polymerase chain reaction), restriction enzymes, or hybridization.
2. Vector construction: Once the DNA sequence of interest has been isolated, it must be inserted into a vector, which is a small circular DNA molecule that can replicate independently in a host cell. Common vectors used in molecular cloning include plasmids and phages.
3. Transformation: The constructed vector is then introduced into a host cell, usually a bacterial or yeast cell, through a process called transformation. This can be done using various methods such as electroporation or chemical transformation.
4. Selection: After transformation, the host cells are grown in selective media that allow only those cells containing the vector to grow. This ensures that the DNA sequence of interest has been successfully cloned into the vector.
5. Amplification: Once the host cells have been selected, they can be grown in large quantities to amplify the number of copies of the cloned DNA sequence.

Molecular cloning is a powerful tool in molecular biology and has numerous applications, including the production of recombinant proteins, gene therapy, functional analysis of genes, and genetic engineering.

Hepatic encephalopathy (HE) is a neuropsychiatric syndrome associated with liver dysfunction and/or portosystemic shunting. It results from the accumulation of toxic substances, such as ammonia and inflammatory mediators, which are normally metabolized by the liver. HE can present with a wide range of symptoms, including changes in sleep-wake cycle, altered mental status, confusion, disorientation, asterixis (flapping tremor), and in severe cases, coma. The diagnosis is based on clinical evaluation, neuropsychological testing, and exclusion of other causes of cognitive impairment. Treatment typically involves addressing the underlying liver dysfunction, reducing ammonia production through dietary modifications and medications, and preventing further episodes with lactulose or rifaximin therapy.

Transgenic mice are genetically modified rodents that have incorporated foreign DNA (exogenous DNA) into their own genome. This is typically done through the use of recombinant DNA technology, where a specific gene or genetic sequence of interest is isolated and then introduced into the mouse embryo. The resulting transgenic mice can then express the protein encoded by the foreign gene, allowing researchers to study its function in a living organism.

The process of creating transgenic mice usually involves microinjecting the exogenous DNA into the pronucleus of a fertilized egg, which is then implanted into a surrogate mother. The offspring that result from this procedure are screened for the presence of the foreign DNA, and those that carry the desired genetic modification are used to establish a transgenic mouse line.

Transgenic mice have been widely used in biomedical research to model human diseases, study gene function, and test new therapies. They provide a valuable tool for understanding complex biological processes and developing new treatments for a variety of medical conditions.

I'm sorry for any confusion, but the term "Albania" does not have a medical definition. Albania is a country located in southeastern Europe, known officially as the Republic of Albania. It is bordered by Montenegro to the northwest, Kosovo to the northeast, North Macedonia to the east, and Greece to the south and southeast. Its capital and largest city is Tirana. If you have any questions about medical topics or definitions, I'd be happy to try to help answer them for you!

HLA-DP alpha-chains are part of the human leukocyte antigen (HLA) system, which is located on chromosome 6 and plays a critical role in the immune system. The HLA system encodes cell surface proteins responsible for presenting peptide antigens to T-cells, thereby initiating an immune response.

HLA-DP alpha-chains are one of the three types of HLA class II alpha chains (the others being HLA-DR and HLA-DQ). They combine with HLA-DP beta-chains to form heterodimeric complexes, which further assemble into HLA-DP dimers. These dimers present peptide antigens to CD4+ T-cells, stimulating a helper T-cell response.

The HLA-DP alpha-chain is encoded by the HLA-DPA gene and has a molecular weight of approximately 33 kDa. Like other HLA genes, HLA-DPA exhibits extensive polymorphism, with multiple alleles contributing to the diversity of peptide presentation and immune response among different individuals.

DNA virus infections refer to diseases or conditions caused by the invasion and replication of DNA viruses in a host organism. DNA viruses are a type of virus that uses DNA as their genetic material. They can cause a variety of diseases, ranging from relatively mild illnesses to severe or life-threatening conditions.

Some examples of DNA viruses include herpes simplex virus (HSV), varicella-zoster virus (VZV), human papillomavirus (HPV), hepatitis B virus (HBV), and adenoviruses. These viruses can cause a range of diseases, including cold sores, genital herpes, chickenpox, shingles, cervical cancer, liver cancer, and respiratory infections.

DNA virus infections typically occur when the virus enters the body through a break in the skin or mucous membranes, such as those found in the eyes, nose, mouth, or genitals. Once inside the body, the virus infects cells and uses their machinery to replicate itself, often causing damage to the host cells in the process.

The symptoms of DNA virus infections can vary widely depending on the specific virus and the severity of the infection. Treatment may include antiviral medications, which can help to reduce the severity and duration of symptoms, as well as prevent the spread of the virus to others. In some cases, vaccines may be available to prevent DNA virus infections.

BALB/c is an inbred strain of laboratory mouse that is widely used in biomedical research. The strain was developed at the Institute of Cancer Research in London by Henry Baldwin and his colleagues in the 1920s, and it has since become one of the most commonly used inbred strains in the world.

BALB/c mice are characterized by their black coat color, which is determined by a recessive allele at the tyrosinase locus. They are also known for their docile and friendly temperament, making them easy to handle and work with in the laboratory.

One of the key features of BALB/c mice that makes them useful for research is their susceptibility to certain types of tumors and immune responses. For example, they are highly susceptible to developing mammary tumors, which can be induced by chemical carcinogens or viral infection. They also have a strong Th2-biased immune response, which makes them useful models for studying allergic diseases and asthma.

BALB/c mice are also commonly used in studies of genetics, neuroscience, behavior, and infectious diseases. Because they are an inbred strain, they have a uniform genetic background, which makes it easier to control for genetic factors in experiments. Additionally, because they have been bred in the laboratory for many generations, they are highly standardized and reproducible, making them ideal subjects for scientific research.

An immunoassay is a biochemical test that measures the presence or concentration of a specific protein, antibody, or antigen in a sample using the principles of antibody-antigen reactions. It is commonly used in clinical laboratories to diagnose and monitor various medical conditions such as infections, hormonal disorders, allergies, and cancer.

Immunoassays typically involve the use of labeled reagents, such as enzymes, radioisotopes, or fluorescent dyes, that bind specifically to the target molecule. The amount of label detected is proportional to the concentration of the target molecule in the sample, allowing for quantitative analysis.

There are several types of immunoassays, including enzyme-linked immunosorbent assay (ELISA), radioimmunoassay (RIA), fluorescence immunoassay (FIA), and chemiluminescent immunoassay (CLIA). Each type has its own advantages and limitations, depending on the sensitivity, specificity, and throughput required for a particular application.

I'm sorry for any confusion, but "Gambia" is not a medical term. It is the name of a country located in West Africa, officially known as the Republic of The Gambia. If you have any questions about medical terminology or health-related topics, I would be happy to try and help answer those for you.

I'm sorry for any confusion, but "Iran" is not a medical term or concept. It is the name of a country located in southwest Asia. If you have any questions about medical terminology or health-related topics, I would be happy to try and help answer them!

I could not find a specific medical definition for "Vaccines, DNA." However, I can provide you with some information about DNA vaccines.

DNA vaccines are a type of vaccine that uses genetically engineered DNA to stimulate an immune response in the body. They work by introducing a small piece of DNA into the body that contains the genetic code for a specific antigen (a substance that triggers an immune response). The cells of the body then use this DNA to produce the antigen, which prompts the immune system to recognize and attack it.

DNA vaccines have several advantages over traditional vaccines. They are relatively easy to produce, can be stored at room temperature, and can be designed to protect against a wide range of diseases. Additionally, because they use DNA to stimulate an immune response, DNA vaccines do not require the growth and culture of viruses or bacteria, which can make them safer than traditional vaccines.

DNA vaccines are still in the experimental stages, and more research is needed to determine their safety and effectiveness. However, they have shown promise in animal studies and are being investigated as a potential tool for preventing a variety of infectious diseases, including influenza, HIV, and cancer.

I'm sorry for any confusion, but "Vietnam" is not a medical term. It is the name of a country located in Southeast Asia. If you have any questions about medical conditions or terminology, I would be happy to help clarify those for you.

Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) is a laboratory technique used in molecular biology to amplify and detect specific DNA sequences. This technique is particularly useful for the detection and quantification of RNA viruses, as well as for the analysis of gene expression.

The process involves two main steps: reverse transcription and polymerase chain reaction (PCR). In the first step, reverse transcriptase enzyme is used to convert RNA into complementary DNA (cDNA) by reading the template provided by the RNA molecule. This cDNA then serves as a template for the PCR amplification step.

In the second step, the PCR reaction uses two primers that flank the target DNA sequence and a thermostable polymerase enzyme to repeatedly copy the targeted cDNA sequence. The reaction mixture is heated and cooled in cycles, allowing the primers to anneal to the template, and the polymerase to extend the new strand. This results in exponential amplification of the target DNA sequence, making it possible to detect even small amounts of RNA or cDNA.

RT-PCR is a sensitive and specific technique that has many applications in medical research and diagnostics, including the detection of viruses such as HIV, hepatitis C virus, and SARS-CoV-2 (the virus that causes COVID-19). It can also be used to study gene expression, identify genetic mutations, and diagnose genetic disorders.

A genetic vector is a vehicle, often a plasmid or a virus, that is used to introduce foreign DNA into a host cell as part of genetic engineering or gene therapy techniques. The vector contains the desired gene or genes, along with regulatory elements such as promoters and enhancers, which are needed for the expression of the gene in the target cells.

The choice of vector depends on several factors, including the size of the DNA to be inserted, the type of cell to be targeted, and the efficiency of uptake and expression required. Commonly used vectors include plasmids, adenoviruses, retroviruses, and lentiviruses.

Plasmids are small circular DNA molecules that can replicate independently in bacteria. They are often used as cloning vectors to amplify and manipulate DNA fragments. Adenoviruses are double-stranded DNA viruses that infect a wide range of host cells, including human cells. They are commonly used as gene therapy vectors because they can efficiently transfer genes into both dividing and non-dividing cells.

Retroviruses and lentiviruses are RNA viruses that integrate their genetic material into the host cell's genome. This allows for stable expression of the transgene over time. Lentiviruses, a subclass of retroviruses, have the advantage of being able to infect non-dividing cells, making them useful for gene therapy applications in post-mitotic tissues such as neurons and muscle cells.

Overall, genetic vectors play a crucial role in modern molecular biology and medicine, enabling researchers to study gene function, develop new therapies, and modify organisms for various purposes.

Aflatoxins are toxic compounds produced by certain types of mold (Aspergillus flavus and Aspergillus parasiticus) that grow on crops such as grains, nuts, and spices. These toxins can contaminate food and animal feed, posing a serious health risk to both humans and animals. Aflatoxin exposure has been linked to various health problems, including liver damage, cancer, immune system suppression, and growth impairment in children. Regular monitoring and control measures are necessary to prevent aflatoxin contamination in food and feed supplies.

Interferon-gamma (IFN-γ) is a soluble cytokine that is primarily produced by the activation of natural killer (NK) cells and T lymphocytes, especially CD4+ Th1 cells and CD8+ cytotoxic T cells. It plays a crucial role in the regulation of the immune response against viral and intracellular bacterial infections, as well as tumor cells. IFN-γ has several functions, including activating macrophages to enhance their microbicidal activity, increasing the presentation of major histocompatibility complex (MHC) class I and II molecules on antigen-presenting cells, stimulating the proliferation and differentiation of T cells and NK cells, and inducing the production of other cytokines and chemokines. Additionally, IFN-γ has direct antiproliferative effects on certain types of tumor cells and can enhance the cytotoxic activity of immune cells against infected or malignant cells.

The term "Asian Continental Ancestry Group" is a medical/ethnic classification used to describe a person's genetic background and ancestry. According to this categorization, individuals with origins in the Asian continent are grouped together. This includes populations from regions such as East Asia (e.g., China, Japan, Korea), South Asia (e.g., India, Pakistan, Bangladesh), Southeast Asia (e.g., Philippines, Indonesia, Thailand), and Central Asia (e.g., Kazakhstan, Uzbekistan, Tajikistan). It is important to note that this broad categorization may not fully capture the genetic diversity within these regions or accurately reflect an individual's specific ancestral origins.

"Cells, cultured" is a medical term that refers to cells that have been removed from an organism and grown in controlled laboratory conditions outside of the body. This process is called cell culture and it allows scientists to study cells in a more controlled and accessible environment than they would have inside the body. Cultured cells can be derived from a variety of sources, including tissues, organs, or fluids from humans, animals, or cell lines that have been previously established in the laboratory.

Cell culture involves several steps, including isolation of the cells from the tissue, purification and characterization of the cells, and maintenance of the cells in appropriate growth conditions. The cells are typically grown in specialized media that contain nutrients, growth factors, and other components necessary for their survival and proliferation. Cultured cells can be used for a variety of purposes, including basic research, drug development and testing, and production of biological products such as vaccines and gene therapies.

It is important to note that cultured cells may behave differently than they do in the body, and results obtained from cell culture studies may not always translate directly to human physiology or disease. Therefore, it is essential to validate findings from cell culture experiments using additional models and ultimately in clinical trials involving human subjects.

A Severity of Illness Index is a measurement tool used in healthcare to assess the severity of a patient's condition and the risk of mortality or other adverse outcomes. These indices typically take into account various physiological and clinical variables, such as vital signs, laboratory values, and co-morbidities, to generate a score that reflects the patient's overall illness severity.

Examples of Severity of Illness Indices include the Acute Physiology and Chronic Health Evaluation (APACHE) system, the Simplified Acute Physiology Score (SAPS), and the Mortality Probability Model (MPM). These indices are often used in critical care settings to guide clinical decision-making, inform prognosis, and compare outcomes across different patient populations.

It is important to note that while these indices can provide valuable information about a patient's condition, they should not be used as the sole basis for clinical decision-making. Rather, they should be considered in conjunction with other factors, such as the patient's overall clinical presentation, treatment preferences, and goals of care.

Passive immunization is a type of temporary immunity that is transferred to an individual through the injection of antibodies produced outside of the body, rather than through the active production of antibodies in the body in response to vaccination or infection. This can be done through the administration of preformed antibodies, such as immune globulins, which contain a mixture of antibodies that provide immediate protection against specific diseases.

Passive immunization is often used in situations where individuals have been exposed to a disease and do not have time to develop their own active immune response, or in cases where individuals are unable to produce an adequate immune response due to certain medical conditions. It can also be used as a short-term measure to provide protection until an individual can receive a vaccination that will confer long-term immunity.

Passive immunization provides immediate protection against disease, but the protection is typically short-lived, lasting only a few weeks or months. This is because the transferred antibodies are gradually broken down and eliminated by the body over time. In contrast, active immunization confers long-term immunity through the production of memory cells that can mount a rapid and effective immune response upon re-exposure to the same pathogen in the future.

I'm sorry for any confusion, but "Thailand" is not a medical term. It is a country located in Southeast Asia. If you have any questions about medical terms or concepts, I would be happy to help answer those for you!

I apologize for any confusion, but "Asia" is not a medical term. It is the largest continent in the world, comprising about 30% of the Earth's total land area and containing around 60% of the world's current human population. It is divided into several regions, including Northern Asia (Siberia), Eastern Asia (China, Japan, Korea, Mongolia, Taiwan), Southern Asia (India, Pakistan, Bangladesh, Sri Lanka, Maldives), Southeastern Asia (Vietnam, Thailand, Indonesia, Philippines, Malaysia, Singapore, Myanmar, Cambodia, Laos, Brunei), and Western Asia (Middle East).

If you have any questions related to medical terminology or health-related topics, I'd be happy to help.

Hemophilia A is a genetic bleeding disorder caused by a deficiency in clotting factor VIII. This results in impaired blood clotting and prolonged bleeding, particularly after injuries or surgeries. Symptoms can range from mild to severe, with the most severe form resulting in spontaneous bleeding into joints and muscles, leading to pain, swelling, and potential joint damage over time. Hemophilia A primarily affects males, as it is an X-linked recessive disorder, and is usually inherited from a carrier mother. However, about one third of cases result from a spontaneous mutation in the gene for factor VIII. Treatment typically involves replacement therapy with infusions of factor VIII concentrates to prevent or control bleeding episodes.

According to the US Department of Health and Human Services, Asian Americans are defined as "a person having origins in any of the original peoples of the Far East, Southeast Asia, or the Indian subcontinent including, for example, Cambodia, China, India, Japan, Korea, Malaysia, Pakistan, the Philippine Islands, Thailand, and Vietnam."

It's important to note that this definition is used primarily in a US context and may not be applicable or relevant in other parts of the world. Additionally, it's worth noting that the term "Asian American" encompasses a vast array of diverse cultures, languages, histories, and experiences, and should not be essentialized or oversimplified.

I'm sorry for any confusion, but "Korea" is not a medical term. It refers to a region in East Asia that is divided into two distinct sovereign states: North Korea (officially the Democratic People's Republic of Korea) and South Korea (officially the Republic of Korea).

If you're looking for medical terms, I'd be happy to help. Could you please provide more context?

The Diphtheria-Tetanus-Pertussis (DTaP) vaccine is a combination immunization that protects against three bacterial diseases: diphtheria, tetanus (lockjaw), and pertussis (whooping cough).

Diphtheria is an upper respiratory infection that can lead to breathing difficulties, heart failure, paralysis, or even death. Tetanus is a bacterial infection that affects the nervous system and causes muscle stiffness and spasms, leading to "lockjaw." Pertussis is a highly contagious respiratory infection characterized by severe coughing fits, which can make it difficult to breathe and may lead to pneumonia, seizures, or brain damage.

The DTaP vaccine contains inactivated toxins (toxoids) from the bacteria that cause these diseases. It is typically given as a series of five shots, with doses administered at 2 months, 4 months, 6 months, 15-18 months, and 4-6 years of age. The vaccine helps the immune system develop protection against the diseases without causing the actual illness.

It is important to note that there are other combination vaccines available that protect against these same diseases, such as DT (diphtheria and tetanus toxoids) and Tdap (tetanus, diphtheria, and acellular pertussis), which contain higher doses of the diphtheria and pertussis components. These vaccines are recommended for different age groups and may be used as booster shots to maintain immunity throughout adulthood.

2-Aminopurine is a fluorescent purine analog, which means it is a compound that is similar in structure to the naturally occurring molecule called purines, which are building blocks of DNA and RNA. 2-Aminopurine is used in research to study the structure and function of nucleic acids (DNA and RNA) due to its fluorescent properties. It can be incorporated into oligonucleotides (short stretches of nucleic acids) to allow for the monitoring of interactions between nucleic acids, such as during DNA replication or transcription. The fluorescence of 2-Aminopurine changes upon excitation with light and can be used to detect structural changes in nucleic acids or to measure the distance between two fluorophores.

End-stage liver disease (ESLD) is a term used to describe advanced and irreversible liver damage, usually caused by chronic liver conditions such as cirrhosis, hepatitis, or alcoholic liver disease. At this stage, the liver can no longer function properly, leading to a range of serious complications.

The symptoms of ESLD may include:

* Jaundice (yellowing of the skin and eyes)
* Ascites (accumulation of fluid in the abdomen)
* Encephalopathy (confusion, drowsiness, or coma caused by the buildup of toxins in the brain)
* Bleeding from the gastrointestinal tract
* Infections
* Kidney failure

Treatment for ESLD typically focuses on managing symptoms and preventing complications. In some cases, a liver transplant may be necessary to improve survival. However, due to the shortage of available donor livers, many people with ESLD are not eligible for transplantation. The prognosis for individuals with ESLD is generally poor, with a median survival time of less than one year.

Virus internalization, also known as viral entry, is the process by which a virus enters a host cell to infect it and replicate its genetic material. This process typically involves several steps:

1. Attachment: The viral envelope proteins bind to specific receptors on the surface of the host cell.
2. Entry: The virus then enters the host cell through endocytosis or membrane fusion, depending on the type of virus.
3. Uncoating: Once inside the host cell, the viral capsid is removed, releasing the viral genome into the cytoplasm.
4. Replication: The viral genome then uses the host cell's machinery to replicate itself and produce new viral particles.

It's important to note that the specific mechanisms of virus internalization can vary widely between different types of viruses, and are an active area of research in virology and infectious disease.

T-lymphocytes, also known as T-cells, are a type of white blood cell that plays a key role in the adaptive immune system's response to infection. They are produced in the bone marrow and mature in the thymus gland. There are several different types of T-cells, including CD4+ helper T-cells, CD8+ cytotoxic T-cells, and regulatory T-cells (Tregs).

CD4+ helper T-cells assist in activating other immune cells, such as B-lymphocytes and macrophages. They also produce cytokines, which are signaling molecules that help coordinate the immune response. CD8+ cytotoxic T-cells directly kill infected cells by releasing toxic substances. Regulatory T-cells help maintain immune tolerance and prevent autoimmune diseases by suppressing the activity of other immune cells.

T-lymphocytes are important in the immune response to viral infections, cancer, and other diseases. Dysfunction or depletion of T-cells can lead to immunodeficiency and increased susceptibility to infections. On the other hand, an overactive T-cell response can contribute to autoimmune diseases and chronic inflammation.

Population surveillance in a public health and medical context refers to the ongoing, systematic collection, analysis, interpretation, and dissemination of health-related data for a defined population over time. It aims to monitor the health status, identify emerging health threats or trends, and evaluate the impact of interventions within that population. This information is used to inform public health policy, prioritize healthcare resources, and guide disease prevention and control efforts. Population surveillance can involve various data sources, such as vital records, disease registries, surveys, and electronic health records.

Antibody formation, also known as humoral immune response, is the process by which the immune system produces proteins called antibodies in response to the presence of a foreign substance (antigen) in the body. This process involves several steps:

1. Recognition: The antigen is recognized and bound by a type of white blood cell called a B lymphocyte or B cell, which then becomes activated.
2. Differentiation: The activated B cell undergoes differentiation to become a plasma cell, which is a type of cell that produces and secretes large amounts of antibodies.
3. Antibody production: The plasma cells produce and release antibodies, which are proteins made up of four polypeptide chains (two heavy chains and two light chains) arranged in a Y-shape. Each antibody has two binding sites that can recognize and bind to specific regions on the antigen called epitopes.
4. Neutralization or elimination: The antibodies bind to the antigens, neutralizing them or marking them for destruction by other immune cells. This helps to prevent the spread of infection and protect the body from harmful substances.

Antibody formation is an important part of the adaptive immune response, which allows the body to specifically recognize and respond to a wide variety of pathogens and foreign substances.

Viral structural proteins are the protein components that make up the viral particle or capsid, providing structure and stability to the virus. These proteins are encoded by the viral genome and are involved in the assembly of new virus particles during the replication cycle. They can be classified into different types based on their location and function, such as capsid proteins, matrix proteins, and envelope proteins. Capsid proteins form the protein shell that encapsulates the viral genome, while matrix proteins are located between the capsid and the envelope, and envelope proteins are embedded in the lipid bilayer membrane that surrounds some viruses.

'Hospital Personnel' is a general term that refers to all individuals who are employed by or provide services on behalf of a hospital. This can include, but is not limited to:

1. Healthcare professionals such as doctors, nurses, pharmacists, therapists, and technicians.
2. Administrative staff who manage the hospital's operations, including human resources, finance, and management.
3. Support services personnel such as maintenance workers, food service workers, housekeeping staff, and volunteers.
4. Medical students, interns, and trainees who are gaining clinical experience in the hospital setting.

All of these individuals play a critical role in ensuring that the hospital runs smoothly and provides high-quality care to its patients.

Poliovirus Vaccine, Inactivated (IPV) is a vaccine used to prevent poliomyelitis (polio), a highly infectious disease caused by the poliovirus. IPV contains inactivated (killed) polioviruses of all three poliovirus types. It works by stimulating an immune response in the body, but because the viruses are inactivated, they cannot cause polio. After vaccination, the immune system recognizes and responds to the inactivated viruses, producing antibodies that protect against future infection with wild, or naturally occurring, polioviruses. IPV is typically given as an injection in the leg or arm, and a series of doses are required for full protection. It is a safe and effective way to prevent polio and its complications.

I'm sorry for any confusion, but "Italy" is not a medical term or concept. It is a country located in Southern Europe. If you have any questions related to medical terminology or health-related topics, I would be happy to try and help answer those for you.

Recombinant fusion proteins are artificially created biomolecules that combine the functional domains or properties of two or more different proteins into a single protein entity. They are generated through recombinant DNA technology, where the genes encoding the desired protein domains are linked together and expressed as a single, chimeric gene in a host organism, such as bacteria, yeast, or mammalian cells.

The resulting fusion protein retains the functional properties of its individual constituent proteins, allowing for novel applications in research, diagnostics, and therapeutics. For instance, recombinant fusion proteins can be designed to enhance protein stability, solubility, or immunogenicity, making them valuable tools for studying protein-protein interactions, developing targeted therapies, or generating vaccines against infectious diseases or cancer.

Examples of recombinant fusion proteins include:

1. Etaglunatide (ABT-523): A soluble Fc fusion protein that combines the heavy chain fragment crystallizable region (Fc) of an immunoglobulin with the extracellular domain of the human interleukin-6 receptor (IL-6R). This fusion protein functions as a decoy receptor, neutralizing IL-6 and its downstream signaling pathways in rheumatoid arthritis.
2. Etanercept (Enbrel): A soluble TNF receptor p75 Fc fusion protein that binds to tumor necrosis factor-alpha (TNF-α) and inhibits its proinflammatory activity, making it a valuable therapeutic option for treating autoimmune diseases like rheumatoid arthritis, ankylosing spondylitis, and psoriasis.
3. Abatacept (Orencia): A fusion protein consisting of the extracellular domain of cytotoxic T-lymphocyte antigen 4 (CTLA-4) linked to the Fc region of an immunoglobulin, which downregulates T-cell activation and proliferation in autoimmune diseases like rheumatoid arthritis.
4. Belimumab (Benlysta): A monoclonal antibody that targets B-lymphocyte stimulator (BLyS) protein, preventing its interaction with the B-cell surface receptor and inhibiting B-cell activation in systemic lupus erythematosus (SLE).
5. Romiplostim (Nplate): A fusion protein consisting of a thrombopoietin receptor agonist peptide linked to an immunoglobulin Fc region, which stimulates platelet production in patients with chronic immune thrombocytopenia (ITP).
6. Darbepoetin alfa (Aranesp): A hyperglycosylated erythropoiesis-stimulating protein that functions as a longer-acting form of recombinant human erythropoietin, used to treat anemia in patients with chronic kidney disease or cancer.
7. Palivizumab (Synagis): A monoclonal antibody directed against the F protein of respiratory syncytial virus (RSV), which prevents RSV infection and is administered prophylactically to high-risk infants during the RSV season.
8. Ranibizumab (Lucentis): A recombinant humanized monoclonal antibody fragment that binds and inhibits vascular endothelial growth factor A (VEGF-A), used in the treatment of age-related macular degeneration, diabetic retinopathy, and other ocular disorders.
9. Cetuximab (Erbitux): A chimeric monoclonal antibody that binds to epidermal growth factor receptor (EGFR), used in the treatment of colorectal cancer and head and neck squamous cell carcinoma.
10. Adalimumab (Humira): A fully humanized monoclonal antibody that targets tumor necrosis factor-alpha (TNF-α), used in the treatment of various inflammatory diseases, including rheumatoid arthritis, psoriasis, and Crohn's disease.
11. Bevacizumab (Avastin): A recombinant humanized monoclonal antibody that binds to VEGF-A, used in the treatment of various cancers, including colorectal, lung, breast, and kidney cancer.
12. Trastuzumab (Herceptin): A humanized monoclonal antibody that targets HER2/neu receptor, used in the treatment of breast cancer.
13. Rituximab (Rituxan): A chimeric monoclonal antibody that binds to CD20 antigen on B cells, used in the treatment of non-Hodgkin's lymphoma and rheumatoid arthritis.
14. Palivizumab (Synagis): A humanized monoclonal antibody that binds to the F protein of respiratory syncytial virus, used in the prevention of respiratory syncytial virus infection in high-risk infants.
15. Infliximab (Remicade): A chimeric monoclonal antibody that targets TNF-α, used in the treatment of various inflammatory diseases, including Crohn's disease, ulcerative colitis, rheumatoid arthritis, and ankylosing spondylitis.
16. Natalizumab (Tysabri): A humanized monoclonal antibody that binds to α4β1 integrin, used in the treatment of multiple sclerosis and Crohn's disease.
17. Adalimumab (Humira): A fully human monoclonal antibody that targets TNF-α, used in the treatment of various inflammatory diseases, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, and ulcerative colitis.
18. Golimumab (Simponi): A fully human monoclonal antibody that targets TNF-α, used in the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.
19. Certolizumab pegol (Cimzia): A PEGylated Fab' fragment of a humanized monoclonal antibody that targets TNF-α, used in the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and Crohn's disease.
20. Ustekinumab (Stelara): A fully human monoclonal antibody that targets IL-12 and IL-23, used in the treatment of psoriasis, psoriatic arthritis, and Crohn's disease.
21. Secukinumab (Cosentyx): A fully human monoclonal antibody that targets IL-17A, used in the treatment of psoriasis, psoriatic arthritis, and ankylosing spondylitis.
22. Ixekizumab (Taltz): A fully human monoclonal antibody that targets IL-17A, used in the treatment of psoriasis and psoriatic arthritis.
23. Brodalumab (Siliq): A fully human monoclonal antibody that targets IL-17 receptor A, used in the treatment of psoriasis.
24. Sarilumab (Kevzara): A fully human monoclonal antibody that targets the IL-6 receptor, used in the treatment of rheumatoid arthritis.
25. Tocilizumab (Actemra): A humanized monoclonal antibody that targets the IL-6 receptor, used in the treatment of rheumatoid arthritis, systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, giant cell arteritis, and chimeric antigen receptor T-cell-induced cytokine release syndrome.
26. Siltuximab (Sylvant): A chimeric monoclonal antibody that targets IL-6, used in the treatment of multicentric Castleman disease.
27. Satralizumab (Enspryng): A humanized monoclonal antibody that targets IL-6 receptor alpha, used in the treatment of neuromyelitis optica spectrum disorder.
28. Sirukumab (Plivensia): A human monoclonal antibody that targets IL-6, used in the treatment

A tissue donor is an individual who has agreed to allow organs and tissues to be removed from their body after death for the purpose of transplantation to restore the health or save the life of another person. The tissues that can be donated include corneas, heart valves, skin, bone, tendons, ligaments, veins, and cartilage. These tissues can enhance the quality of life for many recipients and are often used in reconstructive surgeries. It is important to note that tissue donation does not interfere with an open casket funeral or other cultural or religious practices related to death and grieving.

Needle sharing is the reuse of needles or syringes by more than one person, often in the context of injecting drugs. This behavior is considered high-risk as it can lead to the transmission of bloodborne pathogens such as HIV, Hepatitis B, and Hepatitis C. It's a significant public health concern due to its association with intravenous drug use.

Messenger RNA (mRNA) is a type of RNA (ribonucleic acid) that carries genetic information copied from DNA in the form of a series of three-base code "words," each of which specifies a particular amino acid. This information is used by the cell's machinery to construct proteins, a process known as translation. After being transcribed from DNA, mRNA travels out of the nucleus to the ribosomes in the cytoplasm where protein synthesis occurs. Once the protein has been synthesized, the mRNA may be degraded and recycled. Post-transcriptional modifications can also occur to mRNA, such as alternative splicing and addition of a 5' cap and a poly(A) tail, which can affect its stability, localization, and translation efficiency.

A Laboratory Infection, also known as a laboratory-acquired infection (LAI), is an infection that occurs in individuals who are exposed to pathogens or other harmful microorganisms while working in a laboratory setting. These infections can occur through various routes of exposure, including inhalation, skin contact, or ingestion of contaminated materials.

Laboratory infections pose significant risks to laboratory workers, researchers, and even visitors who may come into contact with infectious agents during their work or visit. To minimize these risks, laboratories follow strict biosafety protocols, including the use of personal protective equipment (PPE), proper handling and disposal of contaminated materials, and adherence to established safety guidelines.

Examples of laboratory infections include tuberculosis, salmonella, hepatitis B and C, and various other bacterial, viral, fungal, and parasitic infections. Prompt diagnosis, treatment, and implementation of appropriate infection control measures are crucial to prevent the spread of these infections within the laboratory setting and beyond.

"Health personnel" is a broad term that refers to individuals who are involved in maintaining, promoting, and restoring the health of populations or individuals. This can include a wide range of professionals such as:

1. Healthcare providers: These are medical doctors, nurses, midwives, dentists, pharmacists, allied health professionals (like physical therapists, occupational therapists, speech therapists, dietitians, etc.), and other healthcare workers who provide direct patient care.

2. Public health professionals: These are individuals who work in public health agencies, non-governmental organizations, or academia to promote health, prevent diseases, and protect populations from health hazards. They include epidemiologists, biostatisticians, health educators, environmental health specialists, and health services researchers.

3. Health managers and administrators: These are professionals who oversee the operations, finances, and strategic planning of healthcare organizations, such as hospitals, clinics, or public health departments. They may include hospital CEOs, medical directors, practice managers, and healthcare consultants.

4. Health support staff: This group includes various personnel who provide essential services to healthcare organizations, such as medical records technicians, billing specialists, receptionists, and maintenance workers.

5. Health researchers and academics: These are professionals involved in conducting research, teaching, and disseminating knowledge related to health sciences, medicine, public health, or healthcare management in universities, research institutions, or think tanks.

The World Health Organization (WHO) defines "health worker" as "a person who contributes to the promotion, protection, or improvement of health through prevention, treatment, rehabilitation, palliation, health promotion, and health education." This definition encompasses a wide range of professionals working in various capacities to improve health outcomes.

Host-pathogen interactions refer to the complex and dynamic relationship between a living organism (the host) and a disease-causing agent (the pathogen). This interaction can involve various molecular, cellular, and physiological processes that occur between the two entities. The outcome of this interaction can determine whether the host will develop an infection or not, as well as the severity and duration of the illness.

During host-pathogen interactions, the pathogen may release virulence factors that allow it to evade the host's immune system, colonize tissues, and obtain nutrients for its survival and replication. The host, in turn, may mount an immune response to recognize and eliminate the pathogen, which can involve various mechanisms such as inflammation, phagocytosis, and the production of antimicrobial agents.

Understanding the intricacies of host-pathogen interactions is crucial for developing effective strategies to prevent and treat infectious diseases. This knowledge can help identify new targets for therapeutic interventions, inform vaccine design, and guide public health policies to control the spread of infectious agents.

HIV (Human Immunodeficiency Virus) is a species of lentivirus (a subgroup of retrovirus) that causes HIV infection and over time, HIV infection can lead to AIDS (Acquired Immunodeficiency Syndrome). This virus attacks the immune system, specifically the CD4 cells, also known as T cells, which are a type of white blood cell that helps coordinate the body's immune response. As HIV destroys these cells, the body becomes more vulnerable to other infections and diseases. It is primarily spread through bodily fluids like blood, semen, vaginal fluids, and breast milk.

It's important to note that while there is no cure for HIV, with proper medical care, HIV can be controlled. Treatment for HIV is called antiretroviral therapy (ART). If taken as prescribed, this medicine reduces the amount of HIV in the body to a very low level, which keeps the immune system working and prevents illness. This treatment also greatly reduces the risk of transmission.

Monoclonal antibodies are a type of antibody that are identical because they are produced by a single clone of cells. They are laboratory-produced molecules that act like human antibodies in the immune system. They can be designed to attach to specific proteins found on the surface of cancer cells, making them useful for targeting and treating cancer. Monoclonal antibodies can also be used as a therapy for other diseases, such as autoimmune disorders and inflammatory conditions.

Monoclonal antibodies are produced by fusing a single type of immune cell, called a B cell, with a tumor cell to create a hybrid cell, or hybridoma. This hybrid cell is then able to replicate indefinitely, producing a large number of identical copies of the original antibody. These antibodies can be further modified and engineered to enhance their ability to bind to specific targets, increase their stability, and improve their effectiveness as therapeutic agents.

Monoclonal antibodies have several mechanisms of action in cancer therapy. They can directly kill cancer cells by binding to them and triggering an immune response. They can also block the signals that promote cancer growth and survival. Additionally, monoclonal antibodies can be used to deliver drugs or radiation directly to cancer cells, increasing the effectiveness of these treatments while minimizing their side effects on healthy tissues.

Monoclonal antibodies have become an important tool in modern medicine, with several approved for use in cancer therapy and other diseases. They are continuing to be studied and developed as a promising approach to treating a wide range of medical conditions.

"Age distribution" is a term used to describe the number of individuals within a population or sample that fall into different age categories. It is often presented in the form of a graph, table, or chart, and can provide important information about the demographic structure of a population.

The age distribution of a population can be influenced by a variety of factors, including birth rates, mortality rates, migration patterns, and aging. Public health officials and researchers use age distribution data to inform policies and programs related to healthcare, social services, and other areas that affect the well-being of populations.

For example, an age distribution graph might show a larger number of individuals in the younger age categories, indicating a population with a high birth rate. Alternatively, it might show a larger number of individuals in the older age categories, indicating a population with a high life expectancy or an aging population. Understanding the age distribution of a population can help policymakers plan for future needs and allocate resources more effectively.

Untranslated regions (UTRs) are sections of an mRNA molecule that do not contain information for protein synthesis. There are two types of UTRs: 5' UTR, which is located at the 5' end of the mRNA molecule, and 3' UTR, which is located at the 3' end.

The 5' UTR typically contains regulatory elements that control the translation of the mRNA into protein. These elements can affect the efficiency and timing of translation, as well as the stability of the mRNA molecule. The 5' UTR may also contain upstream open reading frames (uORFs), which are short sequences that can be translated into small peptides and potentially regulate the translation of the main coding sequence.

The length and sequence composition of the 5' UTR can have significant impacts on gene expression, and variations in these regions have been associated with various diseases, including cancer and neurological disorders. Therefore, understanding the structure and function of 5' UTRs is an important area of research in molecular biology and genetics.

Infectious canine hepatitis is a viral disease in dogs caused by canine adenovirus type 1 (CAV-1). The disease primarily affects the liver, but other organs such as the kidneys, eyes, and respiratory system may also be involved.

The virus is transmitted through direct contact with infected dogs or their urine, feces, saliva, or ocular/nasal discharge. It can also be spread through contaminated objects, water, or food. After infection, the virus incubates for 4-7 days before signs of illness appear.

Clinical signs of infectious canine hepatitis can vary widely in severity, from mild to severe. They may include fever, lethargy, loss of appetite, vomiting, diarrhea, abdominal pain, increased thirst and urination, jaundice (yellowing of the skin, mucous membranes, and whites of the eyes), and cloudiness or bluish discoloration of the cornea. In severe cases, neurological signs such as seizures or coma may occur.

Treatment for infectious canine hepatitis is primarily supportive, as there is no specific antiviral therapy available. Treatment may include fluid therapy to maintain hydration and electrolyte balance, nutritional support, medications to control vomiting and diarrhea, and management of any secondary bacterial infections that may develop.

Prevention of infectious canine hepatitis is achieved through vaccination with a modified-live or inactivated vaccine containing CAV-1. Puppies should receive their first vaccination at 6-8 weeks of age, followed by a booster at 10-12 weeks and another booster at 14-16 weeks. Annual revaccination is recommended to maintain immunity.

Superinfection is a medical term that refers to a secondary infection which occurs during or following the treatment of an initial infection. This second infection is often caused by a different microorganism that is resistant to the medication used to treat the first infection. Superinfections can occur in various parts of the body, such as the skin, respiratory system, gastrointestinal tract, or urinary tract, and are more common in individuals with weakened immune systems, chronic illnesses, or those who have been on antibiotics for an extended period.

Superinfections can lead to more severe complications, prolonged hospital stays, increased healthcare costs, and higher mortality rates if not promptly diagnosed and treated appropriately. Healthcare providers must be vigilant in monitoring patients' responses to treatment and recognizing signs of superinfection, such as worsening symptoms or the development of new ones, to ensure timely intervention and optimal patient outcomes.

A viral vaccine is a biological preparation that introduces your body to a specific virus in a way that helps your immune system build up protection against the virus without causing the illness. Viral vaccines can be made from weakened or inactivated forms of the virus, or parts of the virus such as proteins or sugars. Once introduced to the body, the immune system recognizes the virus as foreign and produces an immune response, including the production of antibodies. These antibodies remain in the body and provide immunity against future infection with that specific virus.

Viral vaccines are important tools for preventing infectious diseases caused by viruses, such as influenza, measles, mumps, rubella, polio, hepatitis A and B, rabies, rotavirus, chickenpox, shingles, and some types of cancer. Vaccination programs have led to the control or elimination of many infectious diseases that were once common.

It's important to note that viral vaccines are not effective against bacterial infections, and separate vaccines must be developed for each type of virus. Additionally, because viruses can mutate over time, it is necessary to update some viral vaccines periodically to ensure continued protection.

Cytotoxic T-lymphocytes, also known as CD8+ T cells, are a type of white blood cell that plays a central role in the cell-mediated immune system. They are responsible for identifying and destroying virus-infected cells and cancer cells. When a cytotoxic T-lymphocyte recognizes a specific antigen presented on the surface of an infected or malignant cell, it becomes activated and releases toxic substances such as perforins and granzymes, which can create pores in the target cell's membrane and induce apoptosis (programmed cell death). This process helps to eliminate the infected or malignant cells and prevent the spread of infection or cancer.

An endemic disease is a type of disease that is regularly found among particular people or in a certain population, and is spread easily from person to person. The rate of infection is consistently high in these populations, but it is relatively stable and does not change dramatically over time. Endemic diseases are contrasted with epidemic diseases, which suddenly increase in incidence and spread rapidly through a large population.

Endemic diseases are often associated with poverty, poor sanitation, and limited access to healthcare. They can also be influenced by environmental factors such as climate, water quality, and exposure to vectors like mosquitoes or ticks. Examples of endemic diseases include malaria in some tropical countries, tuberculosis (TB) in many parts of the world, and HIV/AIDS in certain populations.

Effective prevention and control measures for endemic diseases typically involve improving access to healthcare, promoting good hygiene and sanitation practices, providing vaccinations when available, and implementing vector control strategies. By addressing the underlying social and environmental factors that contribute to the spread of these diseases, it is possible to reduce their impact on affected populations and improve overall health outcomes.

The Chi-square distribution is a continuous probability distribution that is often used in statistical hypothesis testing. It is the distribution of a sum of squares of k independent standard normal random variables. The resulting quantity follows a chi-square distribution with k degrees of freedom, denoted as χ²(k).

The probability density function (pdf) of the Chi-square distribution with k degrees of freedom is given by:

f(x; k) = (1/ (2^(k/2) * Γ(k/2))) \* x^((k/2)-1) \* e^(-x/2), for x > 0 and 0, otherwise.

Where Γ(k/2) is the gamma function evaluated at k/2. The mean and variance of a Chi-square distribution with k degrees of freedom are k and 2k, respectively.

The Chi-square distribution has various applications in statistical inference, including testing goodness-of-fit, homogeneity of variances, and independence in contingency tables.

Fatty liver, also known as hepatic steatosis, is a medical condition characterized by the abnormal accumulation of fat in the liver. The liver's primary function is to process nutrients, filter blood, and fight infections, among other tasks. When excess fat builds up in the liver cells, it can impair liver function and lead to inflammation, scarring, and even liver failure if left untreated.

Fatty liver can be caused by various factors, including alcohol consumption, obesity, nonalcoholic fatty liver disease (NAFLD), viral hepatitis, and certain medications or medical conditions. NAFLD is the most common cause of fatty liver in the United States and other developed countries, affecting up to 25% of the population.

Symptoms of fatty liver may include fatigue, weakness, weight loss, loss of appetite, nausea, abdominal pain or discomfort, and jaundice (yellowing of the skin and eyes). However, many people with fatty liver do not experience any symptoms, making it essential to diagnose and manage the condition through regular check-ups and blood tests.

Treatment for fatty liver depends on the underlying cause. Lifestyle changes such as weight loss, exercise, and dietary modifications are often recommended for people with NAFLD or alcohol-related fatty liver disease. Medications may also be prescribed to manage related conditions such as diabetes, high cholesterol, or metabolic syndrome. In severe cases of liver damage, a liver transplant may be necessary.

An amino acid substitution is a type of mutation in which one amino acid in a protein is replaced by another. This occurs when there is a change in the DNA sequence that codes for a particular amino acid in a protein. The genetic code is redundant, meaning that most amino acids are encoded by more than one codon (a sequence of three nucleotides). As a result, a single base pair change in the DNA sequence may not necessarily lead to an amino acid substitution. However, if a change does occur, it can have a variety of effects on the protein's structure and function, depending on the nature of the substituted amino acids. Some substitutions may be harmless, while others may alter the protein's activity or stability, leading to disease.

Logistic models, specifically logistic regression models, are a type of statistical analysis used in medical and epidemiological research to identify the relationship between the risk of a certain health outcome or disease (dependent variable) and one or more independent variables, such as demographic factors, exposure variables, or other clinical measurements.

In contrast to linear regression models, logistic regression models are used when the dependent variable is binary or dichotomous in nature, meaning it can only take on two values, such as "disease present" or "disease absent." The model uses a logistic function to estimate the probability of the outcome based on the independent variables.

Logistic regression models are useful for identifying risk factors and estimating the strength of associations between exposures and health outcomes, adjusting for potential confounders, and predicting the probability of an outcome given certain values of the independent variables. They can also be used to develop clinical prediction rules or scores that can aid in decision-making and patient care.

In the context of medical and biological sciences, a "binding site" refers to a specific location on a protein, molecule, or cell where another molecule can attach or bind. This binding interaction can lead to various functional changes in the original protein or molecule. The other molecule that binds to the binding site is often referred to as a ligand, which can be a small molecule, ion, or even another protein.

The binding between a ligand and its target binding site can be specific and selective, meaning that only certain ligands can bind to particular binding sites with high affinity. This specificity plays a crucial role in various biological processes, such as signal transduction, enzyme catalysis, or drug action.

In the case of drug development, understanding the location and properties of binding sites on target proteins is essential for designing drugs that can selectively bind to these sites and modulate protein function. This knowledge can help create more effective and safer therapeutic options for various diseases.

Cost-benefit analysis (CBA) is a systematic process used to compare the costs and benefits of different options to determine which one provides the greatest net benefit. In a medical context, CBA can be used to evaluate the value of medical interventions, treatments, or policies by estimating and monetizing all the relevant costs and benefits associated with each option.

The costs included in a CBA may include direct costs such as the cost of the intervention or treatment itself, as well as indirect costs such as lost productivity or time away from work. Benefits may include improved health outcomes, reduced morbidity or mortality, and increased quality of life.

Once all the relevant costs and benefits have been identified and quantified, they are typically expressed in monetary terms to allow for a direct comparison. The option with the highest net benefit (i.e., the difference between total benefits and total costs) is considered the most cost-effective.

It's important to note that CBA has some limitations and can be subject to various biases and assumptions, so it should be used in conjunction with other evaluation methods to ensure a comprehensive understanding of the value of medical interventions or policies.

Counterimmunoelectrophoresis (CIEP) is a laboratory technique used in the field of immunology and serology for the identification and detection of antigens or antibodies in a sample. It is a type of electrophoretic technique that involves the migration of antigens and antibodies in an electric field towards each other, resulting in the formation of a precipitin line at the point where they meet and react.

In CIEP, the antigen is placed in the gel matrix in a trough or well, while the antibody is placed in a separate trough located perpendicularly to the antigen trough. An electric current is then applied, causing both the antigens and antibodies to migrate towards each other through the gel matrix. When they meet, they form a precipitin line, which can be visualized as a white band or line in the gel.

CIEP is a rapid and sensitive technique that can be used to detect and identify specific antigens or antibodies in a sample. It is often used in the diagnosis of infectious diseases, autoimmune disorders, and other medical conditions where the presence of specific antigens or antibodies needs to be detected.

It's important to note that CIEP has been largely replaced by more modern techniques such as ELISA and Western blotting, which offer greater sensitivity and specificity. However, it is still used in some research and diagnostic settings due to its simplicity and cost-effectiveness.

Torque teno virus (TTV) is a single-stranded DNA virus that belongs to the family Anelloviridae. It was first identified in 1997 and has since been found to be present in the majority of human populations worldwide. The virus is classified into several genotypes and subtypes, with TTV being the prototype member of the genus Alphainellovirus.

TTV is a small virus, measuring only about 30-40 nanometers in diameter. It has a circular genome that ranges in size from 2.8 to 3.9 kilobases and encodes for several non-structural proteins involved in viral replication. The virus does not appear to cause any specific disease symptoms, but it has been associated with various clinical conditions such as liver disease, respiratory tract infections, and cancer.

TTV is primarily transmitted through the fecal-oral route, although other modes of transmission have also been suggested, including saliva, blood, and vertical transmission from mother to child during pregnancy or delivery. The virus has been detected in various body fluids, tissues, and organs, including blood, stool, respiratory secretions, and the liver.

The clinical significance of TTV infection remains unclear, as it is frequently found in both healthy individuals and those with various diseases. However, some studies have suggested that TTV viral load or genotype may be associated with certain clinical conditions, such as liver disease, transplant rejection, and cancer. Further research is needed to better understand the role of TTV in human health and disease.

Protein binding, in the context of medical and biological sciences, refers to the interaction between a protein and another molecule (known as the ligand) that results in a stable complex. This process is often reversible and can be influenced by various factors such as pH, temperature, and concentration of the involved molecules.

In clinical chemistry, protein binding is particularly important when it comes to drugs, as many of them bind to proteins (especially albumin) in the bloodstream. The degree of protein binding can affect a drug's distribution, metabolism, and excretion, which in turn influence its therapeutic effectiveness and potential side effects.

Protein-bound drugs may be less available for interaction with their target tissues, as only the unbound or "free" fraction of the drug is active. Therefore, understanding protein binding can help optimize dosing regimens and minimize adverse reactions.

I'm sorry for any confusion, but "Greece" is not a medical term or concept. Greece is a country located in southeastern Europe, known for its rich history, culture, and contributions to various fields including philosophy, politics, arts, and sciences. If you have any questions related to medical topics or definitions, I'd be happy to help.

Biliary cirrhosis is a specific type of liver cirrhosis that results from chronic inflammation and scarring of the bile ducts, leading to impaired bile flow, liver damage, and fibrosis. It can be further classified into primary biliary cholangitis (PBC) and secondary biliary cirrhosis. PBC is an autoimmune disease, while secondary biliary cirrhosis is often associated with chronic gallstones, biliary tract obstruction, or recurrent pyogenic cholangitis. Symptoms may include fatigue, itching, jaundice, and abdominal discomfort. Diagnosis typically involves blood tests, imaging studies, and sometimes liver biopsy. Treatment focuses on managing symptoms, slowing disease progression, and preventing complications.

Immunosuppressive agents are medications that decrease the activity of the immune system. They are often used to prevent the rejection of transplanted organs and to treat autoimmune diseases, where the immune system mistakenly attacks the body's own tissues. These drugs work by interfering with the immune system's normal responses, which helps to reduce inflammation and damage to tissues. However, because they suppress the immune system, people who take immunosuppressive agents are at increased risk for infections and other complications. Examples of immunosuppressive agents include corticosteroids, azathioprine, cyclophosphamide, mycophenolate mofetil, tacrolimus, and sirolimus.

An antigen-antibody complex is a type of immune complex that forms when an antibody binds to a specific antigen. An antigen is any substance that triggers an immune response, while an antibody is a protein produced by the immune system to neutralize or destroy foreign substances like antigens.

When an antibody binds to an antigen, it forms a complex that can be either soluble or insoluble. Soluble complexes are formed when the antigen is small and can move freely through the bloodstream. Insoluble complexes, on the other hand, are formed when the antigen is too large to move freely, such as when it is part of a bacterium or virus.

The formation of antigen-antibody complexes plays an important role in the immune response. Once formed, these complexes can be recognized and cleared by other components of the immune system, such as phagocytes, which help to prevent further damage to the body. However, in some cases, the formation of large numbers of antigen-antibody complexes can lead to inflammation and tissue damage, contributing to the development of certain autoimmune diseases.

Nucleic acid hybridization is a process in molecular biology where two single-stranded nucleic acids (DNA, RNA) with complementary sequences pair together to form a double-stranded molecule through hydrogen bonding. The strands can be from the same type of nucleic acid or different types (i.e., DNA-RNA or DNA-cDNA). This process is commonly used in various laboratory techniques, such as Southern blotting, Northern blotting, polymerase chain reaction (PCR), and microarray analysis, to detect, isolate, and analyze specific nucleic acid sequences. The hybridization temperature and conditions are critical to ensure the specificity of the interaction between the two strands.

Viral hepatitis is caused by five different viruses (hepatitis A, B, C, D, and E). Hepatitis A and hepatitis E behave similarly ... In the Mediterranean, hepatitis D is predominant among hepatitis B virus co-infected people. Similar to Hepatitis A, hepatitis ... and are self-limiting illnesses that do not lead to chronic hepatitis. Hepatitis B, hepatitis C, and hepatitis D are ... Hepatitis D is a defective virus that requires hepatitis B to replicate and is only found with hepatitis B co-infection. In ...
... is hepatitis (inflammation of the liver) due to excessive intake of alcohol. Patients typically have a ... Alcoholic hepatitis is distinct from cirrhosis caused by long-term alcohol consumption. Alcoholic hepatitis can occur in ... A liver biopsy is not required for the diagnosis, however it can help confirm alcoholic hepatitis as the cause of the hepatitis ... Alcoholic hepatitis occurs in approximately 1/3 of chronic alcohol drinkers. 10-20% of patients with alcoholic hepatitis ...
... is a type of viral hepatitis caused by the hepatitis delta virus (HDV). HDV is one of five known hepatitis viruses ... Vaccination against hepatitis B protects against hepatitis D viral infection as hepatitis D requires hepatitis B viral ... In combination with hepatitis B virus, hepatitis D has the highest fatality rate of all the hepatitis infections, at 20%. A ... November 2009). "Hepatitis B virus and hepatitis delta virus genotypes in outbreaks of fulminant hepatitis (Labrea black fever ...
"Source details: Hepatitis Monthly". Scopus Preview. Elsevier. Retrieved 2019-12-05. "Hepatitis Monthly". 2018 Journal Citation ... Hepatitis Monthly is a monthly peer-reviewed open access medical journal published by Brieflands Publishing, formerly known as ... "Hepatitis Monthly". MIAR: Information Matrix for the Analysis of Journals. University of Barcelona. Retrieved 2019-12-05. " ...
... it is also imperative to be able to exclude the possibility of acute viral hepatitis. Ischemic hepatitis is related to another ... can also cause ischemic hepatitis.[medical citation needed] People who develop ischemic hepatitis may have weakness, fatigue, ... Ischemic hepatitis, also known as shock liver, is a condition defined as an acute liver injury caused by insufficient blood ... Ischemic hepatitis can be caused by a number of reasons (that lead to low blood pressure) including: Abnormal heart rhythm ...
Non-A-E hepatitis, also known as hepatitis X, is an infectious disease of the liver referring to a case of viral hepatitis that ... The specific cause of non-A-E hepatitis is unknown. It is considered a rare disorder. "Non-A-E hepatitis". Genetic and Rare ... "Acute Non-A-E Hepatitis in the United States and the Role of Hepatitis G Virus Infection". N Engl J Med. 336 (11): 741-746. doi ... "TTV infection in patients with acute hepatitis of defined aetiology and in acute non-A-E hepatitis". Journal of Hepatology. 32 ...
The causes of neonatal hepatitis are many. Viruses that have been identified include cytomegalovirus, rubella virus, hepatitis ... Neonatal hepatitis refers to many forms of liver dysfunction that affects fetuses and neonates. It is most often caused by ... The infant with neonatal hepatitis usually has jaundice that appears at one to two months of age, is not gaining weight and ... Jaundice that is caused by neonatal hepatitis is not the same as physiologic neonatal jaundice. In contrast with physiologic ...
World Hepatitis Day, observed 28 July, aims to raise global awareness of hepatitis B and hepatitis C and encourage prevention, ... Hepatitis B was originally known as "serum hepatitis". Acute infection with hepatitis B virus is associated with acute viral ... when combined with hepatitis B immunoglobulin and the hepatitis B vaccine, especially for pregnant women with high hepatitis B ... hepatitis B immunoglobulin alone, or the combination of vaccine plus hepatitis B immunoglobulin, all prevent hepatitis B ...
... is inflammation of the liver caused by infection with the hepatitis E virus (HEV); it is a type of viral hepatitis ... Hepatitis E has mainly a fecal-oral transmission route that is similar to hepatitis A, although the viruses are unrelated. In ... Like hepatitis A, hepatitis E usually follows an acute and self-limiting course of illness (the condition is temporary and the ... In 2017, hepatitis E was estimated to affect more than 19 million people. Those most commonly at risk of HEV are men aged 15 to ...
... ". Discogs. Retrieved 2018-01-23. "NOFX - Hepatitis Bathtub - Discography - FatWreckWiki". www.fatwreckwiki. ... Hepatitis Bathtub is an EP by NOFX released on December 23, 2016 through Fat Wreck Chords. The EP was released as a four-song 7 ... The Hepatitis Bathtub and Other Stories was eventually released in April 2016. "Too Mixed Up" "Nothing But a Nightmare" ( ... It was also available as a deluxe package in limited edition color vinyl with a hardcover copy of NOFX's book The Hepatitis ...
World Hepatitis Day occurs each year on July 28 to bring awareness to viral hepatitis. Early symptoms of Hepatitis A infection ... Hepatitis A is an infectious disease of the liver caused by Hepatovirus A (HAV); it is a type of viral hepatitis. Many cases ... It is one of five known hepatitis viruses: A, B, C, D, and E. The hepatitis A vaccine is effective for prevention.[needs update ... 2019 United States hepatitis A outbreak Matheny, SC; Kingery, JE (1 December 2012). "Hepatitis A." Am Fam Physician. 86 (11): ...
Hepatitis D is caused by the hepatitis D virus (HDV), or hepatitis delta virus; it belongs to the genus Deltavirus. HDV is ... Patients with hepatitis C are susceptible to severe hepatitis if they contract either hepatitis A or B, so all persons with ... Hepatitis E is caused by the Hepatitis E virus (HEV), from the family Hepeviridae. It produces symptoms similar to hepatitis A ... Hepatitis A and hepatitis B can be prevented by vaccination. Effective treatments for hepatitis C are available but costly. In ...
... is an infectious disease caused by the hepatitis C virus (HCV) that primarily affects the liver; it is a type of ... It is one of five known hepatitis viruses: A, B, C, D, and E. Diagnosis is by blood testing to look for either antibodies to ... There is no vaccine against hepatitis C. Prevention includes harm reduction efforts among people who inject drugs, testing ... viral hepatitis. During the initial infection period, people often have mild or no symptoms. Early symptoms can include fever, ...
Other causes of hepatitis: Viral hepatitis - it is necessary to distinguish autoimmune hepatitis from acute hepatitis caused by ... Autoimmune hepatitis, formerly known as lupoid hepatitis, plasma cell hepatitis, or autoimmune chronic active hepatitis, is a ... doi:10.1002/hep.23584. PMID 20513004. S2CID 30356212. Than NN, Jeffery HC, Oo YH (2016). "Autoimmune Hepatitis: Progress from ... Autoimmune hepatitis was previously called "lupoid" hepatitis due to people having an associated autoimmune disease like system ...
Co-infection of hepatitis B and various other viruses can also occur. hepatitis C, hepatitis D (a satellite virus of hepatitis ... Hepatitis B virus causes the disease hepatitis B. Hepatitis is considered to be the leading cause of liver cancer worldwide ( ... "Hepatitis B Foundation: Hepatitis C and Hepatitis B Coinfection". www.hepb.org. Retrieved 2 December 2022. Thio, Chloe L. (May ... Rates of hepatitis B infection are equal across male and females. Hepatitis B virus is more prominently found in US citizens of ...
"Turkey Viral Hepatitis - WikiVet English". Retrieved 10 July 2011. v t e (Articles lacking in-text citations from October 2011 ... The aetiological agent of turkey viral hepatitis is a virus from the Picornaviridae family. The disease is restricted to ...
... is May 19 in the United States. "Hepatitis Awareness Month and Hepatitis Testing Day - Division of Viral ... v t e (Health awareness days, Hepatitis, May observances, Observances in the United States, All stub articles, Health stubs). ... Hepatitis - CDC". www.cdc.gov. Retrieved 24 May 2017. ...
The hepatitis C virus is the cause of hepatitis C and some cancers such as liver cancer (hepatocellular carcinoma, abbreviated ... doi:10.1002/hep.20819. PMID 16149085. S2CID 21393716. Yu ML, Chuang WL (2009). "Treatment of chronic hepatitis C in Asia: when ... Wikimedia Commons has media related to Hepatitis C virus. Wikispecies has information related to Hepatitis C virus. Academic ... Unlike hepatitis A and B, there is currently no vaccine to prevent hepatitis C infection. The study of HCV has been hampered by ...
The Hepatitis B Foundation (HBF) is an American nonprofit organization dedicated to finding a cure for hepatitis B and ... To meet the unmet needs of those living with chronic hepatitis B, they created the Hepatitis B Foundation with the help of the ... The Hepatitis B Foundation is a nonprofit organization that provides resources and information about hepatitis B, engages in ... "Hepatitis B group launches campaign". The Intelligencer. February 14, 2011. The Hepatitis B Foundation which is headquartered ...
... (WHV) is a species of the genus Orthohepadnavirus. It was first discovered in 1977 in a captive ... Tennant, W. C. (1999). "The Woodchuck Model of Hepatitis B Virus Infection". Handbook of animal models of infection: ... Tyler, Gail V.; Summers, Jesse W.; Synder, Robert L. (1981). "Woodchuck Hepatitis Virus in Natural Woodchuck Populations". ... this has led to the use of WHV in woodchucks as a model for human Hepatitis B virus infections. ...
... is a rare medical condition characterised by granulomas in the liver, recurrent fever, ... The condition is not a true hepatitis, and some experts believe it is a variant of sarcoidosis. Herrine, Steven K. (November ...
Hepatitis B vaccination, hepatitis B immunoglobulin, and the combination of hepatitis B vaccine plus hepatitis B immunoglobulin ... is a vaccine against hepatitis A and hepatitis B. Pediarix is a vaccine against diphtheria, tetanus, pertussis, hepatitis B, ... Hepatitis B vaccine is a vaccine that prevents hepatitis B. The first dose is recommended within 24 hours of birth with either ... "FAQs about Hepatitis B Vaccine (Hep B) and Multiple Sclerosis". U.S. Centers for Disease Control and Prevention (CDC). 9 ...
... (ICH) is an acute liver infection in dogs caused by Canine mastadenovirus A, formerly called Canine ... Diagnosis is made by recognizing the combination of symptoms and abnormal blood tests that occur in infectious canine hepatitis ... ISBN 978-0-7216-6795-9. "Infectious Canine Hepatitis: Introduction". The Merck Veterinary Manual. 2006. Retrieved 2007-01-28. ... infectious canine hepatitis virus, and distemper virus experimental challenges". Vet Ther. 5 (3): 173-86. PMID 15578450. Canine ...
"World Hepatitis Day 2016" (PDF). World Hepatitis Alliance. 2016. "World Hepatitis Summit". World Hepatitis Summit. 2017. "World ... all of whom must be chronic viral hepatitis patients: someone who has or has had chronic hepatitis B or chronic hepatitis C ... the first World Hepatitis Summit was convened by the WHO and World Hepatitis Alliance with the aim of uniting World Hepatitis ... NOhep was created by the World Hepatitis Alliance with the aim of becoming a global movement to eliminate viral hepatitis. WHA ...
Duck hepatitis is an acute and fatal disease in ducklings caused by the Avihepatovirus DHV-1 and DHV-3. It causes opisthotonus ... and hepatitis. DHV-1 is found worldwide. It causes disease in young ducklings, usually ...
Hepatitis A and B vaccine is a vaccine against hepatitis A and hepatitis B. Hepatitis A and typhoid vaccine is a vaccine ... Hepatitis A vaccine is a vaccine that prevents hepatitis A. It is effective in around 95% of cases and lasts for at least ... It is a freeze-dried live attenuated hepatitis A vaccine. Hepatitis A virus H2 strain is produced in human diploid cells. A ... A few formulations combine hepatitis A with either hepatitis B or typhoid vaccine. Soreness or redness where the shot is given ...
... is a disease of large animals, especially sheep, caused by Clostridium novyi infection. The ... Stampfi, Henry (March 2014). "Infectious Necrotic Hepatitis". The Merck Veterinary Manual. Merck Sharp & Dohme Corp. Retrieved ... Wikimedia Commons has media related to infectious necrotic hepatitis. (Articles with short description, Short description ...
IFN-free Regimens HCV Comorbidities Clinical Challenges in Hepatitis C Hepatitis B Hepatitis D and E Hepatocellular carcinoma ... Frankfurt, Germany.: Journal of Viral Hepatitis: Vol 19, No s3". Journal of Viral Hepatitis. 19. 2012. doi:10.1111/jvh.2012.19. ... "Abstracts for the Viral Hepatitis Congress 2013, 26-28 September 2013, Frankfurt, Germany: Journal of Viral Hepatitis: Vol 20, ... No s3". Journal of Viral Hepatitis. 20. 2013. doi:10.1111/jvh.2013.20.issue-s3. v t e (Academic conferences, Viral hepatitis, ...
A hepatitis C vaccine, a vaccine capable of protecting against the hepatitis C virus (HCV), is not yet available. Although ... "The hepatitis C virus". WHO. Archived from the original on 4 October 2013. Retrieved 1 October 2013. Torresi J (7 November 2017 ... "Hepatitis C Questions and Answers for the Public". Centers for Disease Control and Prevention. 10 September 2019. Retrieved 20 ... Strickland GT, El-Kamary SS, Klenerman P, Nicosia A (June 2008). "Hepatitis C vaccine: supply and demand". The Lancet. ...
Hepatitis. 2019: Invest in eliminating hepatitis. 2020: Hepatitis Free Future 2021: Hepatitis can't wait 2022: Bringing ... World Health Organization World Hepatitis Day, World Hepatitis Alliance World Hepatitis Day, Hepatitis Types, Causes and ... World Hepatitis Alliance, World Hepatitis Day Wrap-Up Report 2012. "World Hepatitis Day 2015 to focus on prevention". World ... 2014: Hepatitis: Think Again 2015: Prevention of viral Hepatitis. Act now. 2016: Know Hepatitis-Act now. 2017: Eliminate ...
2020 Viral Hepatitis Surveillance Report , CDC. *Trends and Characteristics in Maternal Hepatitis C Virus Infection Rates ... QuickStats: Prevalence of Past or Present Infection with Hepatitis B Virus Among Adults Aged ≥18 Years, by Race and Hispanic ... Centers for Disease Control and Prevention: Viral Hepatitis. *National Institute for Allergy and Infectious Diseases: Viral ... QuickStats: Percentage of Adults Aged ≥18 Years with Current Hepatitis C Virus Infection, by Health Insurance Coverage - ...
... hepatitis means inflammation of the liver. There are five main hepatitis viruses (A, B, C, D or E). Learn about the different ... Hepatitis B, hepatitis C, and hepatitis D spread through contact with the blood of someone who has the disease. Hepatitis B and ... How is viral hepatitis spread?. Hepatitis A and hepatitis E usually spread through contact with food or water that was ... What causes hepatitis?. There are different types of hepatitis, with different causes:. *Viral hepatitis is the most common ...
... hepatitis C symptoms and hepatitis C treatment. Read about hepatitis C transmission, hepatitis C tests, hepatitis C vaccine, ... Hepatitis C : Review clinical reference information, guidelines, and medical news on hepatitis C-- ... No Need to Restrict Hep C DAA Therapy Based on Alcohol Use ... Pediatric Hepatitis C * Perioperative Management of the Patient ...
The hepatitis C virus (HCV) is a major cause of both acute and chronic hepatitis. ... High doses of alpha-interferon are required in chronic hepatitis due to coinfection with hepatitis B virus and hepatitis C ... Transmission of hepatitis C in an isolated area in Japan: community-acquired infection. The South Kiso Hepatitis Study Group. ... Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. ...
Hepatitis E is caused by hepatitis E virus (HEV), a spherical, nonenveloped, single-stranded, single-serotype, RNA virus ... Due to the lack of systematic surveillance for hepatitis E, the incidence and characteristics of hepatitis E cases in the ... Acute hepatitis E is diagnosed by detecting HEV IgM in serum. Detecting HEV RNA in serum or stool specimens further confirms ... Treatment for acute hepatitis E is supportive care. Oral ribavirin has been shown to be effective in the treatment of chronic ...
... Prevention. How great is the risk for hepatitis B?. You may be at risk for hepatitis B if you:. How is hepatitis B ... If you had hepatitis A, it is still possible to get hepatitis B. If you had hepatitis C, another form of hepatitis that can be ... Can hepatitis B be spread by food?. Unlike hepatitis A, another form of hepatitis, hepatitis B is not spread through food or ... Can hepatitis B be spread by food?. What is the hepatitis B carrier state?. What are the symptoms of hepatitis B?. How serious ...
LBXHA - Hepatitis A antibody. Variable Name: LBXHA SAS Label: Hepatitis A antibody. English Text: Hepatitis A antibody. Target ... New immunization strategies have been developed to eliminate the spread of the hepatitis B virus (HBV) and the hepatitis A ... Reported results for all assays meet the Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and ... Hepatitis A (HEPA_H) Data File: HEPA_H.xpt First Published: October 2015. Last Revised: NA ...
World Health Statistics data visualizations ...
Enable Javascript support in the browser ...
Enable Javascript support in the browser ...
Hepatitis A and E. Viral hepatitis is a group of viruses (hepatitis A, B, C, the rarer type D, and E) that can cause both acute ... In rare cases, acute hepatitis E can lead to acute liver failure (fulminant hepatitis) and death. Pregnant women with hepatitis ... Hepatitis A. Hepatitis A causes mild to severe illness in an estimated 1.4 million people per year, with a further 113 million ... The Hepatitis E virus has at least four different genotypes, of which two have been found only in humans. While hepatitis E ...
Acute hepatitis E - Nigeria - http://www.who.int/csr/don/12-july-2017-hepatitis-e-nigeria/en/ ...
Viral hepatitis is caused by five different viruses (hepatitis A, B, C, D, and E). Hepatitis A and hepatitis E behave similarly ... In the Mediterranean, hepatitis D is predominant among hepatitis B virus co-infected people. Similar to Hepatitis A, hepatitis ... and are self-limiting illnesses that do not lead to chronic hepatitis. Hepatitis B, hepatitis C, and hepatitis D are ... Hepatitis D is a defective virus that requires hepatitis B to replicate and is only found with hepatitis B co-infection. In ...
CDC works with partners to respond to viral hepatitis outbreaks, conducting serologic and molecular testing on clinical samples ... Hepatitis A Outbreaksplus icon *Outbreaks of hepatitis A across the United Statesplus icon *Frequently Asked Questions: ... Hawaii outbreak of hepatitis A - 2016. *Multistate outbreak of hepatitis A virus infections - 2013plus icon *Recall and Advice ... Interim outbreak-specific guidance on hepatitis A vaccine administration. *Outbreaks of hepatitis A are occurring across the ...
Viral Hepatitis, STD, and TB Prevention Epidemiologic and Economic Modeling Agreement (NEEMA) ... Cost Analysis of Single-Dose Hepatitis B Revaccination Among Infants Born to Hepatitis B Surface Antigen-Positive Mothers and ... Hepatitis C Virus Antibody Testing Among 13-to 21-Year-Olds in a Large Sample of US Federally Qualified Health Centers. Jama. ... Perinatal transmission of hepatitis C virus: defining the cascade of care The Journal of pediatrics. 2018 Dec 1;203:34-40. ...
Hepatitis B virus (HBV) infection in a pregnant person poses a serious risk to their infant at birth. ... Perinatal hepatitis B Hepatitis B virus (HBV) infection in a pregnant person poses a serious risk to their infant at birth. ... Pregnant persons should be tested for evidence of hepatitis B virus (HBV) infection, specifically hepatitis B surface antigen ( ... Perinatal hepatitis B * …. This page is located more than 3 levels deep within a topic. Some page levels are currently hidden. ...
... and treatment of autoimmune hepatitis, a disease in which your immune system attacks the liver, causing inflammation and damage ... Autoimmune Hepatitis. View or Print All Sections Definition & Facts Autoimmune hepatitis is a chronic disease in which your ... Many people with autoimmune hepatitis have no symptoms. Experts arent sure what causes autoimmune hepatitis. ... Doctors diagnose autoimmune hepatitis based on a combination of information from your medical history, a physical exam, blood ...
The hepatitis C virus (HCV) spreads through blood or other body fluids, and can lead to cirrhosis or liver cancer. The most ... Hepatitis C. What Is Hepatitis C?. Hepatitis C is an infection of the liver caused by the hepatitis C virus (HCV). It can lead ... How Do Acute Hepatitis C and Chronic Hepatitis C Differ?. Doctors refer to hepatitis C infections as either acute or chronic:. ... What Problems Can Hepatitis C Cause?. Hepatitis C is the most serious type of hepatitis. Its now one of the most common ...
... diagnosis and treatment for patients with all phases of hepatitis B infection. ... The Hepatitis B Clinic at Massachusetts General Hospital offers comprehensive evaluation, ... Hepatitis B infection can exist in a variety of states, and some of them dont need treatment. However, anyone with hepatitis B ... Hepatitis B Clinic. The Hepatitis B Clinic at Massachusetts General Hospital offers comprehensive evaluation, diagnosis and ...
Posts about Hepatitis written by What Doctors Dont Tell You ... QUESTIONS FROM READERS:HIV AND HEPATITIS VACCINE. What Doctors ... A recent issue of GP (22 May) exhorted all doctors to go get their hep B shots. In a perfect example of the old adage that ... VACCINE LINKED TO MS:New study confirms worst suspicions over the hepatitis B jab. What Doctors Dont Tell You ... Besides the possibility of contracting AIDS or hepatitis, blood transfusion carries a host of other risks, perhaps even aiding ...
Find out about the different types of hepatitis. ... Hepatitis, an infectious liver disease, is more contagious than ... The three most common hepatitis viruses are hepatitis A, hepatitis B, and hepatitis C. (Hepatitis viruses D and E are rare in ... Hepatitis. What Is Hepatitis?. Hepatitis (pronounced: hep-uh-TIE-tiss) is an inflammation of the liver. The liver, in the right ... Read more about hepatitis B.. What Is Hepatitis C?. The hepatitis C virus spreads from person to person through blood or other ...
Mystery Hepatitis in Children Still Spreading Across the World, No Cause Identified. ... Spike in Adult Hepatitis Cases Linked to Surge in Homelessness, Opioid Crisis. ... Is SARS-CoV-2 Spike Protein Related to the Hepatitis in Children Outbreak? Heres What We Know. ... Hundreds More Cases of Severe Hepatitis of Unknown Origin Reported in Children. ...
Infectious agents that cause hepatitis include viruses and parasites. Noninfectious causes include certain drugs and toxic ... In some instances hepatitis results from an autoimmune reaction. ... Hepatitis, inflammation of the liver that results from a ... hepatitis C hepatitis B granulomatous hepatitis hepatocellular hepatitis canalicular hepatitis ...(Show more) ... Hepatitis A. Hepatitis A, caused by the hepatitis A virus (HAV), is the most common worldwide. The onset of hepatitis A usually ...
Learn more about the costs of hepatitis C treatment here. ... Hepatitis C is a viral infection with different treatment ... What is hepatitis C viral load?. Hepatitis C viral load refers to how much hepatitis C virus is present in a persons ... Several medications to treat hepatitis C have met FDA approval since then. Costs for hepatitis C treatment remain high, however ... Organizations that offer help to people with hepatitis C, including the American Liver Foundation, Hepatitis Foundation ...
Symptoms of hep E infection are pain in the right side if the abdomen, stool changes, jaundice, and brown or dark urine. Hep E ... The hepatitis E virus is transmitted via the fecal-oral route from eating contaminated foods or drinks. There is no vaccine or ... Hepatitis E is a viral infection caused by the hep E virus. ... cure for hep E infection in the U.S. ... Chronic hepatitis E is more common in most people with hepatitis C. However, hep E occurs less often than hep B, and very ...
... FAQs * WHAT IS HEPATITIS A?. Hepatitis A is a liver disease caused by the hepatitis A virus. It can last a few ... Home » Health » Diseases & Conditions » Information On: » Hepatitis A Hepatitis A. Hepatitis A is a highly contagious liver ... Hepatitis A 2017 Outbreak. LA County Health Alert: Increase in Hep A among Men Who Have Sex with Men (MSM) (November 2, 2017). ... HOW IS HEPATITIS A TREATED?. Hepatitis A goes away on its own in most cases. You can help yourself get better faster by ...
Learn more about the link between hepatitis C and cirrhosis here. ... The liver is a powerful organ that the hepatitis C virus can ... Hepatitis C is a virus that people contract when they come into contact with the blood of someone who has hepatitis C. ... People with hepatitis C may have an increased risk for severe COVID-19 symptoms and liver damage. Learn more about hepatitis C ... Hepatitis C can cause cirrhosis, but cirrhosis cannot cause hepatitis C. This is because a person must have exposure to the ...
  • Hepatitis can be an acute (short-term) infection or a chronic (long-term) infection. (medlineplus.gov)
  • The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. (medscape.com)
  • Hepatitis C virus infection. (medscape.com)
  • Current and future therapies for hepatitis C virus infection. (medscape.com)
  • Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014. (medscape.com)
  • Among immunosuppressed people, particularly solid organ allograft recipients infected with HEV-3, hepatitis E can progress to chronic infection. (cdc.gov)
  • Hepatitis B virus infection can lead to severe illness, liver damage, and in some cases, death. (cdc.gov)
  • Live in the same house with someone who has lifelong hepatitis B virus infection. (cdc.gov)
  • Hepatitis B virus is found in the blood and body fluids of persons with hepatitis B. Contact with even small amounts of infected blood can cause infection. (cdc.gov)
  • Because these serious problems may not develop until many years after a person becomes infected with hepatitis B virus, those who have a lifelong infection should be evaluated periodically by a medical care provider. (cdc.gov)
  • Recommendations have also been developed for the prevention and control of the hepatitis C virus (HCV) infection. (cdc.gov)
  • NHANES testing for markers of infection with hepatitis viruses will be used to determine secular trends in infection rates across most age and racial/ethnic groups, and will provide a national picture of the epidemiologic determinants of these infections. (cdc.gov)
  • Viral hepatitis is a group of viruses (hepatitis A, B, C, the rarer type D, and E) that can cause both acute and chronic infection and inflammation of the liver. (who.int)
  • A vaccine to prevent hepatitis E virus infection has been developed and is licensed in China, but is not yet available elsewhere. (who.int)
  • The acute form of hepatitis, generally caused by viral infection, is characterized by constitutional symptoms that are typically self-limiting. (wikipedia.org)
  • The complication more frequently occurs in instances of hepatitis B and D co-infection at a rate of 2-20% and in pregnant women with hepatitis E at rate of 15-20% of cases. (wikipedia.org)
  • Toy M, Hutton D, Harris AM, Nelson N, Salomon JA, So S. Cost-Effectiveness of 1-Time Universal Screening for Chronic Hepatitis B Infection in Adults in the United States .Clin Infect Dis. (cdc.gov)
  • Hepatitis B virus (HBV) infection in a pregnant person poses a serious risk to their infant at birth. (mass.gov)
  • Pregnant persons should be tested for evidence of hepatitis B virus (HBV) infection, specifically hepatitis B surface antigen (HBsAg), during every pregnancy. (mass.gov)
  • All HBsAg positive pregnant persons should be further tested for HBV DNA levels to guide the use of maternal antiviral therapy, and referred for care appropriately using the CDC's Screening and Referral Algorithm for Hepatitis B Virus (HBV) Infection among Pregnant Women (PDF) . (mass.gov)
  • For the latest recommendations for treatment of chronic HBV infection in pregnant persons, see pages 276-277 in the American Association for the Study of Liver Diseases Guidelines for Treatment of Chronic Hepatitis . (mass.gov)
  • PVST consists of both HBsAg and anti-HBs, and it is imperative that both tests be run to be able to determine if the baby is protected against hepatitis B infection. (mass.gov)
  • Hepatitis C is an infection of the liver caused by the hepatitis C virus (HCV). (kidshealth.org)
  • Children who have hepatitis (heh-puh-TYE-tus) C most often got the infection as newborns from their mothers. (kidshealth.org)
  • Hepatitis C can be a "silent but deadly" infection. (kidshealth.org)
  • What Happens After a Hepatitis C Infection? (kidshealth.org)
  • Individuals with chronic hepatitis B infection are at risk for cirrhosis and liver cancer, even in the absence of cirrhosis. (massgeneral.org)
  • At the Massachusetts General Hospital Hepatitis B Clinic, we offers comprehensive evaluation, diagnosis and treatment plans for patients with all phases of hepatitis B infection . (massgeneral.org)
  • A liver biopsy, which may be recommended for people with long-term hepatitis B infection, particularly if the virus is very active. (massgeneral.org)
  • Hepatitis B infection can exist in a variety of states, and some of them don't need treatment. (massgeneral.org)
  • However, anyone with hepatitis B infection should be monitored regularly for the development of active hepatitis, which should be treated. (massgeneral.org)
  • Treatment of active hepatitis B infection can include either an oral antiviral pill or an injected medication called interferon. (massgeneral.org)
  • The Mass General Liver Center is participating in a nationwide study to help identify how the immune system affects the phases of hepatitis B infection, with the hopes of identifying how the disease progresses, identifying individuals who need treatment and developing better therapy to treat hepatitis B. (massgeneral.org)
  • If your patient has evidence of hepatitis B infection, our Hepatitis B Clinic can help risk stratify your patient and establish a plan for ongoing disease monitoring or treatment with the most up-to-date antiviral therapy. (massgeneral.org)
  • We are also eager to assist in the care of patients with hepatitis B infection or exposure who are pregnant or due to undergo immunosuppressive therapy or chemotherapy, to help determine the need for antiviral treatment or prophylaxis. (massgeneral.org)
  • To refer a patient with suspected or established hepatitis B infection or exposure, please contact the Hepatitis B Clinic at 617-726-3524. (massgeneral.org)
  • The hepatitis A vaccine has made the infection less common in the United States and other developed countries. (kidshealth.org)
  • Hepatitis B is a more serious infection. (kidshealth.org)
  • The hepatitis B vaccine is approved for people of all ages to prevent HBV infection. (kidshealth.org)
  • Hepatitis C is a condition that affects approximately 3.5 million Americans , with as many as half potentially unaware that they have the infection, according to the United States Centers for Disease Control and Prevention (CDC). (medicalnewstoday.com)
  • What should I know about hepatitis E (hep E) viral infection? (medicinenet.com)
  • Hepatitis E is a viral infection , which is caused by the hepatitis E virus that usually comes from dirty water. (medicinenet.com)
  • Hepatitis E viral infection causes symptoms and signs, for example, soreness and swelling of the liver (hepatitis) and yellow eyes ( jaundice ). (medicinenet.com)
  • Hepatitis E viral infection symptoms and signs include yellow eyes and skin, nausea and vomiting , pain in the right side of the abdomen, dark or brown urine, and light-colored stool . (medicinenet.com)
  • What is hepatitis E (hep E) viral infection? (medicinenet.com)
  • About 3.3% of people with hep E infection die. (medicinenet.com)
  • Chronic hepatitis does not go away and is a long-lasting infection of the liver. (medicinenet.com)
  • Hepatitis A is a highly contagious liver infection caused by the hepatitis A virus. (longbeach.gov)
  • Patients who were exposed to Hepatitis C as part of these violations and never became acutely ill may be infected, unaware of it and spread the infection to others or be at risk for long term serious infection side effects, researchers say. (eurekalert.org)
  • Hepatitis B infection is transmitted through sexual contact, contact with contaminated blood (for example, through shared needles used for illicit, intravenous drugs), and from mother to child. (medicinenet.com)
  • Hepatitis B is a liver infection caused by the Hepatitis B virus ( HBV ). (medicinenet.com)
  • however, about 5% of people are not able to eliminate the hepatitis B virus and develop chronic infection. (medicinenet.com)
  • Hello, I was diagnosed with Hepatitis B infection (HbsAg positive), but after 3 months HBsAg turned Non-reactive and the viral DNA i. (medhelp.org)
  • Hepatitis E is an enterically transmitted infection that is typically self-limited. (medscape.com)
  • Hepatitis E results from HEV infection and is spread by fecally contaminated water within endemic areas. (medscape.com)
  • Hepatitis A is a viral infection that specifically targets the liver. (healthline.com)
  • Unlike hepatitis B and hepatitis C , HAV infection does not lead to chronic liver disease and often resolves on its own without causing long-term damage. (healthline.com)
  • In a minority of cases, HEV causes acute and chronic hepatitis, but infection is commonly asymptomatic or unrecognized. (nature.com)
  • Extra-hepatic manifestations of autochthonous hepatitis E infection. (nature.com)
  • Acute hepatitis E infection acquired in California. (nature.com)
  • Specifically, the study analyzed serum samples from 275 Iberian lynxes, and liver and feces samples from 176 others, to test the prevalence and seroprevalence of the Hepatitis E Virus, i.e. the presence of active virus and of antibodies once the infection has passed. (eurekalert.org)
  • The document added three groups at a higher risk for HBV infection: those incarcerated or formerly incarcerated, people with current or past hepatitis C virus infection, and people with current or past sexually transmitted infections and multiple sex partners. (medscape.com)
  • Along with vaccination strategies, universal screening of adults and appropriate testing of persons at increased risk for HBV infection will improve health outcomes, reduce the prevalence of HBV infection in the United States, and advance viral hepatitis elimination goals," the authors write. (medscape.com)
  • Explaining the study, lead author Professor Mala Maini (UCL Division of Infection & Immunity), said: "Chronic hepatitis B virus infection is a major global health problem and the most common cause of liver cancer in the world. (sciencedaily.com)
  • Commenting on the findings, first author Dr Nathalie Schmidt (UCL Division of Infection & Immunity), said: "We have found a highly effective novel target for the treatment of chronic hepatitis B virus infection and liver cancer. (sciencedaily.com)
  • A hepatitis panel is a blood test used to find markers of hepatitis infection. (healthlinkbc.ca)
  • A positive result may mean that you have hepatitis antibodies from a recent infection. (healthlinkbc.ca)
  • For many, especially children, hepatitis B infection is asympomatic. (health.mil)
  • For some people, including most infected in infancy, hepatitis B can become a long-term, chronic infection. (health.mil)
  • In Western countries when we hear the word "hepatitis" we tend to think in terms of Hepatitis A, B, or C. However, there are several different strains of the disease, one of them being Hepatitis E. As with all other types of hepatitis, Hepatitis E is caused by infection with a specific virus, in this case Hepatitis E Virus (HEV). (womens-health.co.uk)
  • Hepatitis C is a viral infection of the liver. (healthline.com)
  • There is a very high rates of morbidity and mortality in Egypt due to hepatitis C chronic infection or its complications either cirrhosis or liver cancer. (bartleby.com)
  • Hepatitis A is a contagious liver disease that results from infection with the Hepatitis A virus. (cabrillo.edu)
  • Understanding your hepatitis B blood test results can be confusing, so you want to be sure about your diagnosis - are you infected with hepatitis B, have you recovered from a hepatitis B infection, or do you have a chronic hepatitis B infection? (hepb.org)
  • A "positive" or "reactive" HBsAg test result means that the person is infected with the hepatitis B virus, which can be an "acute" or a "chronic" infection. (hepb.org)
  • A "positive" or "reactive" HBsAb (or anti-HBs) test result indicates that a person has either successfully responded to the hepatitis B vaccine or has recovered from an acute hepatitis B infection. (hepb.org)
  • This result (along with a negative HbsAg result) means that you are immune to (protected from) a future hepatitis B infection. (hepb.org)
  • What you described are not symptoms of a hep c infection. (medhelp.org)
  • Having previously been infected with hepatitis C provides no immunity from future infection. (medhelp.org)
  • More frozen berry products have been recalled due to possible Hepatitis A contamination, with at least five people contracting the infection in the food scare. (theage.com.au)
  • The most common serious liver infection in the world is hepatitis B, with about three-hundred and fifty million people who are chronic carriers of the infection. (disabled-world.com)
  • When evaluating a patient with suspected hepatitis B virus (HBV) infection, also consider the other viral hepatitides and etiologies that can lead to cirrhosis and liver failure, such as drug hepatotoxicity. (medscape.com)
  • Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. (medscape.com)
  • What are the symptoms of hepatitis? (medlineplus.gov)
  • The recovery phase is characterized by resolution of the clinical symptoms of hepatitis with persistent elevations in liver lab values and potentially a persistently enlarged liver. (wikipedia.org)
  • Your doctor may order a hepatitis panel if you have symptoms of hepatitis. (healthlinkbc.ca)
  • It is important to be aware of the symptoms of hepatitis, so that you get help immediately. (vetinfo.com)
  • Autoimmune hepatitis is a chronic type in which your body's immune system attacks your liver. (medlineplus.gov)
  • There are vaccines to prevent hepatitis A and B. Autoimmune hepatitis cannot be prevented. (medlineplus.gov)
  • Autoimmune hepatitis may be treated with medications to suppress the immune system. (wikipedia.org)
  • Both drug-induced hepatitis and autoimmune hepatitis can present very similarly to acute viral hepatitis, with slight variations in symptoms depending on the cause. (wikipedia.org)
  • Fulminant hepatitis, or massive hepatic cell death, is a rare and life-threatening complication of acute hepatitis that can occur in cases of hepatitis B, D, and E, in addition to drug-induced and autoimmune hepatitis. (wikipedia.org)
  • Without treatment, autoimmune hepatitis may get worse and lead to complications, such as cirrhosis. (nih.gov)
  • Many people with autoimmune hepatitis have no symptoms. (nih.gov)
  • Experts aren't sure what causes autoimmune hepatitis. (nih.gov)
  • Doctors diagnose autoimmune hepatitis based on a combination of information from your medical history, a physical exam, blood tests, imaging tests, and liver biopsy. (nih.gov)
  • No single test can diagnose autoimmune hepatitis. (nih.gov)
  • Doctors treat autoimmune hepatitis with medicines that suppress your immune system, most often corticosteroids and immunosuppressants. (nih.gov)
  • If autoimmune hepatitis leads to liver failure or liver cancer, you may need a liver transplant. (nih.gov)
  • Doctors may recommend that people who take corticosteroids to treat autoimmune hepatitis also take dietary supplements of calcium and vitamin D to help prevent osteoporosis. (nih.gov)
  • If you have autoimmune hepatitis, you should eat a healthy, well-balanced diet. (nih.gov)
  • Signs and symptoms of acute hepatitis E include abdominal pain, anorexia, fever, jaundice, and lethargy, and are indistinguishable from other causes of viral hepatitis. (cdc.gov)
  • Some people or animals with hepatitis have no symptoms, whereas others develop yellow discoloration of the skin and whites of the eyes (jaundice), poor appetite, vomiting, tiredness, abdominal pain, and diarrhea. (wikipedia.org)
  • Some types of hepatitis cause only acute infections. (medlineplus.gov)
  • In the United States today, an estimated one million persons have life long hepatitis B virus infections. (cdc.gov)
  • Hepatitis viruses constitute a major public health problem because of the morbidity and mortality associated with the acute and chronic consequences of these infections. (cdc.gov)
  • Acute viral hepatitis follows three distinct phases: The initial prodromal phase (preceding symptoms) involves non-specific and flu-like symptoms common to many acute viral infections. (wikipedia.org)
  • Cost-Effectiveness of Hepatitis B Testing and Vaccination of Adults Seeking Care for Sexually Transmitted Infections .Sex Transm Dis. (cdc.gov)
  • Hutton DW, Toy M, Salomon JA, Conners EE, Nelson NP, Harris AM, So S. Cost-Effectiveness of Hepatitis B Testing and Vaccination of Adults Seeking Care for Sexually Transmitted Infections. (cdc.gov)
  • The medical definition of hepatitis E is a kind of inflammation and swelling of the liver that is caused by the hepatitis E virus (hep E). There are about 20 million cases of hep E infections per year in the world. (medicinenet.com)
  • Most hep E infections happen in parts of the world that have poor sanitation or unsafe water supplies. (medicinenet.com)
  • Hepatitis is a condition characterized by liver inflammation, often resulting from viral infections, excessive alcohol consumption, or other factors. (healthline.com)
  • To reduce new hepatitis C infections, he said, states need to provide clean syringes for injection drug users who otherwise have no other contact with the health care system than emergency departments and jails. (startribune.com)
  • New research from Boston Medical Center shows that routine Hepatitis C (HCV) testing at federally qualified health centers improves diagnosis rates and health outcomes for people with HCV infections in the United States, and is cost-effective. (news-medical.net)
  • Contaminated water supplies are often the cause of Hepatitis E infections. (womens-health.co.uk)
  • Adenovirus infections might cause the acute hepatitis in children observed. (bmj.com)
  • Adenovirus infections do not normally cause hepatitis in healthy children suggesting that a completely new type of adenovirus might have been introduced into the human population. (bmj.com)
  • Approximately fifteen to twenty-five percent of persons with chronic hepatitis B infections die from liver disease. (disabled-world.com)
  • Universal Adult Hepatitis B Screening and Vaccination as the Path to Elimination. (cdc.gov)
  • Estimating vaccination threshold and impact in the 2017-2019 hepatitis A virus outbreak among persons experiencing homelessness or who use drugs in Louisville, Kentucky, United States. (cdc.gov)
  • Evaluating the Cost-Effectiveness of Hepatitis B Vaccination Strategies in High-impact Settings for Adults. (cdc.gov)
  • Pediatricians should ensure that babies born to HBV positive persons are followed closely and complete their hepatitis B vaccination series by 6 months of age on a 0-, 1-2-, and 6-month schedule. (mass.gov)
  • Once their vaccination series has been completed, babies should then have Post-Vaccination Serological Testing (PVST) done between 9-12 months of age, or 1-2 months after the last dose of hepatitis b vaccine, if the series was delayed. (mass.gov)
  • There are no specific drugs or treatments to treat and cure hepatitis E, moreover, the only country that has a hep E vaccination is China at this time. (medicinenet.com)
  • While the implementation of vaccination programs and improvements in sanitation have led to a global decrease in hepatitis A cases, it remains a highly contagious virus capable of surviving on surfaces for months . (healthline.com)
  • The New Jersey Department of Health (NJDOH) Hepatitis Services Locator is an interactive directory for finding free or low cost publicly-funded hepatitis services, including vaccination, testing, and treatment. (nj.gov)
  • Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. (medscape.com)
  • The vaccine scheduler table summarizes the current vaccination schedule for young children, adolescents, and adults for Hepatitis B. The data is updated regularly with the most recent official country reporting collected through the WHO/UNICEF joint reporting process. (who.int)
  • The spectrum of illness ranges from asymptomatic to severe disease resulting in fulminant hepatitis and death. (cdc.gov)
  • Although the disease is rarely fatal and patients that recover have a lifelong immunity, it can cause debilitating symptoms and in rarer cases deadly acute liver failure (fulminant hepatitis). (who.int)
  • In rare cases, acute hepatitis E can lead to acute liver failure (fulminant hepatitis) and death. (who.int)
  • Complications of acute viral hepatitis include fulminant hepatitis, which is a very severe, rapidly developing form of the disease that results in severe liver failure, impaired kidney function, difficulty in the clotting of blood, and marked changes in neurological function. (britannica.com)
  • Rare complications of hepatitis E include severe ("fulminant") hepatitis, liver failure, and death. (medicinenet.com)
  • These images are a random sampling from a Bing search on the term "Fulminant Hepatitis. (fpnotebook.com)
  • There is a severe and life-threatening form of acute hepatitis referred to as, 'Fulminant,' hepatitis that a very small number of people develop. (disabled-world.com)
  • The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. (medscape.com)
  • Kim A. Hepatitis C virus. (medscape.com)
  • Toich L. Will hepatitis C virus medication costs drop in the years ahead? (medscape.com)
  • Available at https://www.pharmacytimes.com/resource-centers/hepatitisc/will-hepatitis-c-virus-medicaton-costs-drop-in-the-years-ahead . (medscape.com)
  • Sterling RK, Bralow S. Extrahepatic manifestations of hepatitis C virus. (medscape.com)
  • Mahmoudvand S, Shokri S, Taherkhani R, Farshadpour F. Hepatitis C virus core protein modulates several signaling pathways involved in hepatocellular carcinoma. (medscape.com)
  • Sexual transmission of hepatitis C virus among monogamous heterosexual couples: the HCV partners study. (medscape.com)
  • Vertical transmission of hepatitis C virus: systematic review and meta-analysis. (medscape.com)
  • Hepatitis E is caused by hepatitis E virus (HEV), a spherical, nonenveloped, single-stranded, single-serotype, RNA virus belonging to the Hepeviridae family. (cdc.gov)
  • Have sex with a person infected with hepatitis B virus. (cdc.gov)
  • How is hepatitis B virus spread? (cdc.gov)
  • Some persons infected with hepatitis B virus never fully recover and carry the virus for the rest of their lives. (cdc.gov)
  • Pregnant women who are infected with hepatitis B virus frequently transmit the disease to their babies. (cdc.gov)
  • All pregnant women should be tested early in pregnancy to determine if they are infected with hepatitis B virus. (cdc.gov)
  • New immunization strategies have been developed to eliminate the spread of the hepatitis B virus (HBV) and the hepatitis A virus (HAV) in the United States. (cdc.gov)
  • Circulation of other genotypes of hepatitis A virus in the Eastern Mediterranean Region presently remain unknown. (who.int)
  • The Hepatitis E virus has at least four different genotypes, of which two have been found only in humans. (who.int)
  • Hepatitis is most commonly caused by the virus hepatovirus A, B, C, D, and E. Other viruses can also cause liver inflammation, including cytomegalovirus, Epstein-Barr virus, and yellow fever virus. (wikipedia.org)
  • A variety of tools are available from the Immunization Action Coalition, including Guidance for Developing Admission Orders in Labor & Delivery and Newborn Units to Prevent Hepatitis B Virus Transmission and Labor & Delivery HBsAg Admission Checklist for Birthing Mother . (mass.gov)
  • Acute hepatitis C is a short-term illness that happens within 6 months of when a person is exposed to the virus. (kidshealth.org)
  • Chronic hepatitis C is when a person still has the virus in their body after 6 months. (kidshealth.org)
  • We also participate in nationwide studies investigating the way the body's immune system fights the hepatitis B virus with the goal of improving the treatment of chronic hepatitis B. (massgeneral.org)
  • We regularly assess each patient's response to antiviral medication to ensure the hepatitis B virus does not become resistant to the medications. (massgeneral.org)
  • Most cases of hepatitis are caused by a virus . (kidshealth.org)
  • Hepatitis A is contagious, and usually spreads through food, drink, or objects contaminated by feces (poop) containing the hepatitis A virus. (kidshealth.org)
  • This virus can cause severe symptoms, but unlike some other hepatitis viruses, it rarely leads to long-lasting liver damage. (kidshealth.org)
  • People recover from hepatitis A have immunity to the virus and won't get it again. (kidshealth.org)
  • The hepatitis B virus spreads from person to person through blood or other body fluids. (kidshealth.org)
  • The hepatitis C virus spreads from person to person through blood or other body fluids, and can lead to cirrhosis or liver cancer. (kidshealth.org)
  • The signs and symptoms of acute viral hepatitis result from damage to the liver and are similar regardless of the hepatitis virus responsible. (britannica.com)
  • The hepatitis E virus exists throughout the world. (medicinenet.com)
  • Even though hepatitis E virus is uncommon in the U.S., surveys have shown that up to 20% of Americans have antibodies to it and have probably been exposed. (medicinenet.com)
  • Hepatitis A usually spreads when a person unknowingly ingests the virus from objects, food, or drinks contaminated by small, undetected amounts of stool from an infected person. (longbeach.gov)
  • Hepatitis A is a liver disease caused by the hepatitis A virus. (longbeach.gov)
  • Hepatitis C can cause cirrhosis, but cirrhosis cannot cause hepatitis C. This is because a person must have exposure to the virus to get hepatitis C. (medicalnewstoday.com)
  • Hepatitis C is a virus that people contract when they come into contact with the blood of someone who has hepatitis C. (medicalnewstoday.com)
  • This is true in about 15 to 25 percent of people who contract the hepatitis C virus, according to the CDC. (medicalnewstoday.com)
  • Cirrhosis due to the hepatitis C virus usually takes decades to develop. (medicalnewstoday.com)
  • Hepatitis E is a virus that infects your liver . (webmd.com)
  • The hepatitis E virus spreads through poop . (webmd.com)
  • No vaccine can prevent the hepatitis E virus. (webmd.com)
  • Persons infected with hepatitis B can pass the virus to others through blood or body fluids. (medicinenet.com)
  • To avoid confusion , the term hepatitis B will be used to indicate liver disease and HBV will be used to designate the infecting virus. (medicinenet.com)
  • [ 1 , 2 ] It is caused by the hepatitis E virus (HEV) and is spread by fecally contaminated water within endemic areas or through the consumption of uncooked or undercooked meat. (medscape.com)
  • Hepatitis E has many similarities with hepatitis A . Hepatitis E has been associated with chronic hepatitis in solid-organ transplant recipients, patients infected by human immunodeficiency virus (HIV), and in an individual on rituximab treatment for non-Hodgkin lymphoma. (medscape.com)
  • The hepatitis E virus (HEV) genome contains three open reading frames (ORFs). (medscape.com)
  • Hepatitis A is a highly contagious virus that targets the liver. (healthline.com)
  • One specific type of viral hepatitis is hepatitis A, which is caused by the hepatitis A virus (HAV) and primarily transmitted through contaminated food or water. (healthline.com)
  • It's caused by the hepatitis A virus (HAV), which belongs to a family of viruses called picornaviruses. (healthline.com)
  • Hepatitis C virus (HCV) results in more lost years of life and more illness than any infectious disease in Ontario. (cmaj.ca)
  • Hepatitis C virus affects 250 000 to 400 000 Canadians and may lead to progressive liver fibrosis. (cmaj.ca)
  • Hepatitis E is hyperendemic in many developing countries in Asia and Africa, and is caused by hepatitis E virus (HEV) genotypes 1 and 2, which are spread via the faecal-oral route by contaminated water. (nature.com)
  • Figure 2: Brachial plexograms of eight patients with hepatitis E virus-associated neuralgic amyotrophy. (nature.com)
  • Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease. (nature.com)
  • The Hepatitis E Virus (HEV) is an emerging zoonotic pathogen in Europe that affects humans, doing damage to the liver and also to other organs, such as the kidney and the central nervous system. (eurekalert.org)
  • The results of the study confirmed that captive lynxes have a higher risk of exposure to Hepatitis E Virus than animals in the wild. (eurekalert.org)
  • While wild lynxes mainly consume wild rabbits, and previous studies carried out by this same group have shown that there is hardly any circulation of the Hepatitis E Virus in their populations, captive lynxes feed mainly on farm rabbits, and there are studies that have found virus circulation in these rabbits in Italy and France, although the presence of the virus in these animals in Spain has not yet been evaluated. (eurekalert.org)
  • Finally, the study has also discovered the presence of the genotype 3f of the hepatitis E virus in lynxes, which is the most frequent one in infected people in Spain. (eurekalert.org)
  • Adults should be tested for hepatitis B virus (HBV) at least once in their lifetime, according to updated guidelines from the Centers for Disease Control and Prevention (CDC). (medscape.com)
  • Scientists have identified a new immunotherapy to combat the hepatitis B virus (HBV), the most common cause of liver cancer in the world. (sciencedaily.com)
  • Hepatitis A (formerly known as ''infectious hepatitis'') is an acute infectious disease of the liver caused by the hepatitis A virus (HAV), which is most commonly transmitted by the fecal-oral route via contaminated food or drinking water. (news-medical.net)
  • Thermo Fisher Scientific, the world leader in serving science, today announced the availability of the Thermo Scientific MAS Omni Infectious Disease quality control sets for monitoring serological assays for analytes such as HIV 1&2, Hepatitis B & C virus, Syphilis and HTLV I/II. (news-medical.net)
  • This blood test also may be done if you were recently exposed to a hepatitis virus, even if you do not have symptoms. (healthlinkbc.ca)
  • Hepatitis B is transmitted when blood, semen, or another body fluid from a person infected with the virus enters the body of someone who is not infected. (health.mil)
  • Like Hepatitis A, this virus is commonly spread through "fecal-oral transmission," which occurs when a person eats or drinks something that has been contaminated with the feces of someone infected with HEV. (womens-health.co.uk)
  • If you've just been diagnosed with hepatitis C, you may wonder how you got it and worry about passing on the virus to a loved one. (webmd.com)
  • While the odds of passing on the hepatitis C virus are low, you should still tell anyone at risk that you have hepatitis C. You should tell sexual partners, spouses, and family members. (webmd.com)
  • According to the first, dogs could be the source of the hitherto unknown pathogen - a virus, most likely - responsible for the recent outbreak of "severe acute hepatitis" detected among pediatric patients from UK and other European (including Italy) and non-European (including USA) Countries. (bmj.com)
  • Viral Entry The envelope proteins of HCV form a heterodimer which helps binding the hepatitis C virus to the receptors present on the hepatocytes membrane. (bartleby.com)
  • This research paper is going to review today's silent killer, the Hepatitis C virus. (bartleby.com)
  • Hepatitis C virus (HCV) is from the virus family Flaviviridae with an RNA envelope serving as it's genetic material. (bartleby.com)
  • Hepatitis C is an enveloped virus, and the RNA also lacks a proofreading ability after replication, which results in mutations coding for many genotypes within the host. (bartleby.com)
  • There is a vaccine that can be administered to prevent catching the virus and hepatitis. (vetinfo.com)
  • Hepatitis in dogs can be prevented through the administration of the vaccine against the hepatitis virus. (vetinfo.com)
  • If you think you have been recently infected with hepatitis B, it can take up to 9 weeks before the virus will be detected in your blood. (hepb.org)
  • People become infected with hepatitis A by swallowing the virus. (nj.gov)
  • Hepatitis A is spread when traces of faecal matter containing the virus come in contact with hands, water or food and then enter a person's mouth. (theage.com.au)
  • The acute phase of hepatitis B is short-term and happens soon after a person has been exposed to the HBV virus. (disabled-world.com)
  • The HBV virus is one of the leading causes of infectious hepatitis. (disabled-world.com)
  • The average incubation period for hepatitis B is thirty to one-hundred and eighty days, although the HBV virus can be detected between thirty and sixty days after a person has become infected. (disabled-world.com)
  • Hepatitis B, Acute Acute hepatitis B is inflammation of the liver that is caused by the hepatitis B virus and that lasts from a few weeks up to 6 months. (msdmanuals.com)
  • Hepatitis A Acute hepatitis A is inflammation of the liver that is caused by the hepatitis A virus and that lasts less than 6 months. (msdmanuals.com)
  • However, if people who have been vaccinated are exposed to the virus, a doctor measures their antibody levels against hepatitis B. If the antibody levels are low, they may need another injection of hepatitis B vaccine. (msdmanuals.com)
  • McMahon BJ, Holck P, Bulkow L, Snowball M. Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus. (medscape.com)
  • Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis. (medscape.com)
  • Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. (medscape.com)
  • Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. (medscape.com)
  • Chisari FV, Ferrari C. Hepatitis B virus immunopathology. (medscape.com)
  • In 2018, 12,474 hepatitis A cases were reported in the United States, according to the Centers for Disease Control and Prevention (CDC) . (healthline.com)
  • After declining for two decades, new hepatitis C cases shot to an estimated 34,000 in 2015, nearly triple the number in 2010, according to a recent report from the U.S. Centers for Disease Control and Prevention. (startribune.com)
  • For more information, see the Centers for Disease Control and Prevention's (CDC) Hepatitis B vaccine information statement . (msdmanuals.com)
  • Vials are stored under appropriate frozen (-30°C) conditions until they are shipped to Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention for testing. (cdc.gov)
  • Number of facilities that are allocated to viral hepatitis prevention, care and Yes able to offer serological able to offer nucleic acid treatment? (who.int)
  • As with Hepatitis A, prevention efforts focus on raising awareness and maintaining safe water, proper sanitation, and proper hygiene. (who.int)
  • 204 infants born in 2021 were case managed by the Perinatal Hepatitis B Prevention Program (PHBPP). (mass.gov)
  • Unfortunately, there's no vaccine to protect against hepatitis C. Prevention means avoiding risky behaviors that can spread HCV, especially injecting drugs. (kidshealth.org)
  • The first-ever World Hepatitis Summit kicked off today in Glasgow, Scotland, where health officials are urging countries to develop national hepatitis treatment and prevention programs. (voanews.com)
  • World Hepatitis Day is observed each year on 28 July to raise awareness of viral hepatitis, an inflammation of the liver that causes severe liver disease and hepatocellular cancer. (bvsalud.org)
  • Chronic hepatitis can lead to complications such as cirrhosis (scarring of the liver), liver failure, and liver cancer . (medlineplus.gov)
  • Early diagnosis and treatment of chronic hepatitis may prevent these complications. (medlineplus.gov)
  • Gilead has countered that the cost of the drug is lower than the cost of complications associated with hepatitis C treatment, such as liver damage or liver failure. (genengnews.com)
  • It is caused by one of several viruses -- hepatitis viruses A , B , C , D, and E. In the United States, A, B, and C are the most common. (medlineplus.gov)
  • In addition, NHANES provides the means to better define the epidemiology of other hepatitis viruses. (cdc.gov)
  • DVH laboratory branch participates in outbreak investigations related to hepatitis viruses by performing routine and state of the art serologic and molecular methodologies on clinical samples collected from affected patients. (cdc.gov)
  • The three most common hepatitis viruses are hepatitis A , hepatitis B , and hepatitis C . (Hepatitis viruses D and E are rare in the United States. (kidshealth.org)
  • Infectious agents that cause hepatitis include viruses and parasites. (britannica.com)
  • and a number of hepatitis viruses. (britannica.com)
  • The term viral hepatitis , however, usually is applied only to those cases of liver disease caused by the hepatitis viruses. (britannica.com)
  • There are five different hepatitis viruses: A, B, C, D and E. All cause inflammation of the liver, but two strains, B and C, cause most deaths and are responsible for 80 percent of all liver cancer fatalities. (voanews.com)
  • Other tests look for antigens or the genetic material ( DNA or RNA ) of the viruses that cause hepatitis. (healthlinkbc.ca)
  • Epidemiology of hepatitis B and C viruses: a global overview. (medscape.com)
  • If a person has a hepatitis C diagnosis, they may first ask what treatments their doctor recommends. (medicalnewstoday.com)
  • Diagnosis and treatment for hepatitis A. (canada.ca)
  • Several factors explain why the risk of depression goes up following a hepatitis C diagnosis. (healthline.com)
  • It's common for people who learn that they have hepatitis C to experience a range of emotions about the diagnosis. (healthline.com)
  • hepatitis B antigens (HBsAg) can be detected as well as antibodies (anti-HBs) that are developed against hepatitis B antigens. (medicinenet.com)
  • Pregnant people who have already received timely triple panel screening for hepatitis B and who have no new HBV exposures only need HBsAg screening, the guidelines state. (medscape.com)
  • Hepatitis B surface antigen (HBsAg). (healthlinkbc.ca)
  • A safe and effective vaccine is available to prevent hepatitis A, which is a part of routine national children immunization programs in Saudi Arabia, Bahrain, and Iraq. (who.int)
  • There is no vaccine to prevent hepatitis C, but medical innovations in recent years mean that oral treatments can cure most people. (medicalnewstoday.com)
  • How to prevent hepatitis A. (canada.ca)
  • The best way to prevent Hepatitis A is to get vaccinated. (cabrillo.edu)
  • At least three people in Victoria, and two in NSW, who have eaten the frozen berries have since been diagnosed with hepatitis A. Symptoms include abdominal pain, nausea and fever as well as yellow skin and eyes, and anyone experiencing these symptoms is urged to see a doctor. (theage.com.au)
  • Yu MC, Yuan JM, Ross RK, Govindarajan S. Presence of antibodies to the hepatitis B surface antigen is associated with an excess risk for hepatocellular carcinoma among non-Asians in Los Angeles County, California. (medscape.com)
  • Hepatitis is inflammation of the liver . (medlineplus.gov)
  • Hepatitis is inflammation of the liver tissue. (wikipedia.org)
  • Chronic hepatitis presents similarly, but can manifest signs and symptoms specific to liver dysfunction with long-standing inflammation and damage to the organ. (wikipedia.org)
  • Cases of drug-induced hepatitis can manifest with systemic signs of an allergic reaction including rash, fever, serositis (inflammation of membranes lining certain organs), elevated eosinophils (a type of white blood cell), and suppression of bone marrow activity. (wikipedia.org)
  • Hepatitis (pronounced: hep-uh-TIE-tiss) is an inflammation of the liver. (kidshealth.org)
  • hepatitis , inflammation of the liver that results from a variety of causes, both infectious and noninfectious. (britannica.com)
  • Another complication is chronic hepatitis, which is characterized by liver cell death and inflammation over a period greater than six months. (britannica.com)
  • Hepatitis C is more common in adults than in children. (kidshealth.org)
  • Hepatitis C doesn't kill children or adults in the prime of life. (startribune.com)
  • Chronic hepatitis E is more common in most people with hepatitis C . However, hep E occurs less often than hep B , and very rarely, with hep E can become chronic in people whose immunity is suppressed by drugs given to prevent rejection of a transplanted organ. (medicinenet.com)
  • Perinatal HBV transmission can be prevented by identifying HBV positive pregnant persons and providing hepatitis B immune globulin and hepatitis B vaccine to their infants within 12 hours of birth. (mass.gov)
  • He says the approach should be similar to that taken for HIV/AIDS, to which Hepatitis shows similar roots of transmission. (voanews.com)
  • Hepatitis C transmission in medical settings is highly preventable and there are clear guidelines and standards to keep patients safe," says Dr. Defendorf. (eurekalert.org)
  • The consumption of products derived from infected animals is considered the main route for the transmission of Hepatitis E in humans, and has also been suggested for other animal species, including felines. (eurekalert.org)
  • Since the nature of transmission is fecal-oral, Hepatitis E tends to be seen more commonly in areas where there are poor sanitary conditions or where personal hygiene is not prevalent. (womens-health.co.uk)
  • You can't give blood if you currently have symptoms or have ever tested positive for hepatitis C. But you can probably donate organs or tissue, since risk of transmission is low and hepatitis C is curable. (webmd.com)
  • There are different ways to prevent or lower your risk for hepatitis, depending on the type of hepatitis. (medlineplus.gov)
  • Hepatitis C is the most serious type of hepatitis. (kidshealth.org)
  • People with hepatitis E should not (any type of hepatitis) drink alcohol . (medicinenet.com)
  • Who is at risk for hepatitis? (medlineplus.gov)
  • How great is the risk for hepatitis B? (cdc.gov)
  • If you engage in certain behaviors, your risk for hepatitis B may be much higher. (cdc.gov)
  • Because women of reproductive age are part of this group, experts worry that more newborns will be at risk for hepatitis C. (kidshealth.org)
  • Who's at Risk for Hepatitis C? (webmd.com)
  • Consumption of shellfish was implicated in an outbreak of hepatitis E on a cruise ship. (cdc.gov)
  • HCV guidance: Recommendations for testing, managing, and treating hepatitis C. Updated: May 24, 2018. (medscape.com)
  • The incubation period (from the time of exposure to HBV to symptom development) is long for hepatitis B - the average time to onset of symptoms is about 90, days but may range from 60-150 days. (medicinenet.com)
  • A person can only contract hepatitis C through exposure to certain bodily fluids, such as blood, of a person who is living with the condition. (healthline.com)
  • Hepatitis C is spread only through exposure to an infected person's blood. (webmd.com)
  • Hepatitis has a broad spectrum of presentations that range from a complete lack of symptoms to severe liver failure. (wikipedia.org)
  • Hepatitis in dogs can be acute or more severe. (vetinfo.com)
  • Acute hepatitis can be treated, while the severe form may be fatal. (vetinfo.com)
  • There is no treatment for hepatitis and if the dog has severe symptoms, he may die within 1 week. (vetinfo.com)
  • Why is hepatitis B so serious in pregnant women? (cdc.gov)
  • Hepatitis E can be very serious, especially for pregnant women. (medicinenet.com)
  • But hepatitis E can be dangerous for pregnant women or anyone with weak immune systems, including the elderly or people who are ill. (webmd.com)
  • If your chronic hepatitis leads to liver failure or liver cancer, you may need a liver transplant . (medlineplus.gov)
  • Acute hepatitis can resolve on its own, progress to chronic hepatitis, or (rarely) result in acute liver failure. (wikipedia.org)
  • Chronic hepatitis may progress to scarring of the liver (cirrhosis), liver failure, and liver cancer. (wikipedia.org)
  • Chronic viral hepatitis E can cause cirrhosis (liver scarring) over time that leads to liver failure. (medicinenet.com)
  • In 2014, the United States Food and Drug Administration (FDA) approved drug treatments called direct-acting antiviral medications that were available in oral form only to treat hepatitis C, according to the journal Open Forum Infectious Diseases . (medicalnewstoday.com)
  • Several medications to treat hepatitis C have met FDA approval since then. (medicalnewstoday.com)
  • There is no specific medication to treat hepatitis A and most people recover on their own. (nj.gov)
  • No specific treatment exists, although people who develop chronic hepatitis E benefit from antiviral treatment. (who.int)
  • Antiviral medications are recommended in all with chronic hepatitis C, except those with conditions that limit their life expectancy. (wikipedia.org)
  • Newer medications for hepatitis C, known as direct-acting antiviral drugs, have fewer common side effects than interferon. (healthline.com)
  • HALT-C (Hepatitis C Antiviral Long-term Treatment against Cirrhosis) trial website. (medscape.com)
  • Hepatitis D can only infect people already infected with hepatitis B. Hepatitis A, B, and D are preventable with immunization. (wikipedia.org)
  • Hospitals with a hepatitis B birth dose administration rate of ≥90% over a 12-month period can apply to be on the Immunization Action Coalition's Birth Dose Honor Roll . (mass.gov)
  • Hepatitis E does not cause chronic hepatitis except in some people with weak immune systems, especially after organ transplantation. (medicinenet.com)
  • During hepatitis E outbreaks, clinical attack rates are highest among people aged 15-49 years. (cdc.gov)
  • Although the actual burden of hepatitis A in the Eastern Mediterranean Region remains unknown but outbreaks have repeatedly occurred in displaced population and refugee settings of countries affected by crisis or humanitarian emergencies. (who.int)
  • CDC and partners ensure rapid and coordinated surveillance, detection, and response to hepatitis outbreaks. (cdc.gov)
  • Most outbreaks of hepatitis E occur in Southeast and East Asia. (medicinenet.com)
  • The new recommendations now contrast with the 2020 screening guidelines issued by the US Preventive Services Task Force (USPSTF) that recommend risk-based screening for hepatitis B. (medscape.com)
  • 3.3 million cases are symptomatic hepatitis E, and ≈70,000 deaths occur. (cdc.gov)
  • Hepatitis C is commonly spread through infected blood such as may occur during needle sharing by intravenous drug users. (wikipedia.org)
  • Hepatitis results in more than a million deaths a year, most of which occur indirectly from liver scarring or liver cancer. (wikipedia.org)
  • In the United States, hepatitis A is estimated to occur in about 2,500 people a year and results in about 75 deaths. (wikipedia.org)
  • Cirrhosis is scarring of the liver that can occur from hepatitis C and other conditions. (medicalnewstoday.com)
  • Emerging treatments for hepatitis C may help to reduce the likelihood that hepatitis C-related liver cirrhosis will occur. (medicalnewstoday.com)
  • Hepatitis C and depression are two separate health conditions that can occur at the same time. (healthline.com)
  • Babies born to HBV positive persons should receive HBIG and their first dose of hepatitis B vaccine within 12 hours of birth. (mass.gov)
  • All newborns, regardless of the birth parent's HBV status, should receive their first dose of hepatitis B vaccine within 24 hours of birth. (mass.gov)
  • Over 99% of these infants received treatment (HBIG and first dose of hepatitis B vaccine) at birth, 95% completed the vaccine series by 12 months of age, and 84% completed the vaccine series and received PVST by December 31, 2021. (mass.gov)
  • The first dose of hepatitis B vaccine is given at birth, with the three-dose series completed between 6 and 18 months of age. (health.mil)
  • The best way to be protected from hepatitis B is to be vaccinated with hepatitis B vaccine, which has been proven safe and effective. (cdc.gov)
  • Hepatitis B is a serious public health problem that affects people of all ages in the United States and around the world. (cdc.gov)
  • In the United States, NASH affects about 11 million people and alcoholic hepatitis affects about 5 million people. (wikipedia.org)
  • The fact that hepatitis C is a condition that affects millions of people should mean the drugs cost less. (medicalnewstoday.com)
  • The canine hepatitis is confused with the hepatitis B, which indeed affects humans. (vetinfo.com)
  • Viral hepatitis is a global public health problem that affects millions of people every year, causing disability and death. (bvsalud.org)
  • People who drink a lot over long periods of time are at risk for alcoholic hepatitis. (medlineplus.gov)
  • Some people with hepatitis do not have symptoms and do not know they are infected. (medlineplus.gov)
  • People who have alcoholic hepatitis need to stop drinking. (medlineplus.gov)
  • For most people, hepatitis E is a mild, self-limited disease. (cdc.gov)
  • An estimated 20 million people are infected with hepatitis E every year, leading to 3.3 million symptomatic cases. (who.int)
  • Worldwide in 2015, hepatitis A occurred in about 114 million people, chronic hepatitis B affected about 343 million people and chronic hepatitis C about 142 million people. (wikipedia.org)
  • Fever, when present, is most common in cases of hepatitis A and E. Late in this phase, people can experience liver-specific symptoms, including choluria (dark urine) and clay-colored stools. (wikipedia.org)
  • How Do People Get Hepatitis C? (kidshealth.org)
  • People with chronic hepatitis C might sometimes have vague general symptoms, like feeling very tired or depressed. (kidshealth.org)
  • Fortunately, medicines can now treat people with hepatitis C and cure them in most cases. (kidshealth.org)
  • Great progress has been made in treating and even curing hepatitis C. Oral medicines now can cure HCV for many people within 3 months. (kidshealth.org)
  • Health experts caution that people who had hepatitis C due to drug use should get counseling or further treatment to help them overcome their addiction. (kidshealth.org)
  • People also can get hepatitis C from unprotected sex with an infected partner. (kidshealth.org)
  • This article details information about hepatitis C medications, and how, under certain circumstances, people may be able to access help to pay for them. (medicalnewstoday.com)
  • Some insurance companies will pay for people whose hepatitis C has not responded to less-expensive treatments or for those who are already showing signs of liver damage . (medicalnewstoday.com)
  • Although rare, hepatitis A can cause death in some people. (longbeach.gov)
  • Again, according to the CDC, for every 100 people with hepatitis C, an estimated 10 to 20 will develop cirrhosis over the following 20 to 30 years. (medicalnewstoday.com)
  • People with hepatitis C and cirrhosis should talk to their doctor about strategies that can prevent further damage. (medicalnewstoday.com)
  • We really need governments, civil society, private companies to make people aware,' said Dr. Stefan Wiktor, the team leader of the WHO's Global Hepatitis Program, who attended the conference. (voanews.com)
  • There are about 240 million people with chronic Hepatitis B and between 130 and 150 million for Hepatitis C. (voanews.com)
  • Most people with hepatitis E get better within a few months. (webmd.com)
  • The irony is that now that people are starting to worry about drug users because they're entering the mainstream population, it's going to help hepatitis get the attention it deserves. (startribune.com)
  • When that recommendation was published, the Task Force was aligned with several other organizations, including the CDC, in supporting screening for hepatitis B in high-risk populations - and importantly, we're all still aligned in making sure that people get the care that they need," said Michael Barry, MD , chair of the USPSTF, in an emailed statement to Medscape Medical News . (medscape.com)
  • Several studies have shown that people who are diagnosed with a hepatitis C have higher rates of depression compared to other groups. (healthline.com)
  • In one report , researchers noted that someone with hepatitis C may be 1.4 to 4 times more likely to experience depression, compared to people with hepatitis B or the general population. (healthline.com)
  • They also suggest that about one-third of people with hepatitis C also have depression. (healthline.com)
  • Keep in mind, newer medications for hepatitis C completely cure the condition in more than 90 percent of people . (healthline.com)
  • One out of every one hundred people in the general population has Hepatitis C, but the ratio is higher in prisons. (bartleby.com)
  • Those countries account for more than 100 million people living with hepatitis C, representing 54% of the world's total infected population. (genengnews.com)
  • As per the existing stats and medical care, how long Hep c people can live health life? (medhelp.org)
  • Anyone can get hepatitis A. Some people at high-risk include men who have sex with men, people who travel to countries where hepatitis A is common, and people who use street drugs (injected or non-injected). (nj.gov)
  • Hepatitis A is found in the stool of infected people. (nj.gov)
  • Hepatitis A is usually spread when people ingest something that has. (msdmanuals.com)
  • In 5 to 10% of people, hepatitis B becomes chronic and can lead to cirrhosis and liver cancer. (msdmanuals.com)
  • The hepatitis B vaccine is recommended for all people up to age 59 who were not previously vaccinated. (msdmanuals.com)
  • Usually it doesn't lead to long-term illness or liver damage like some other forms of hepatitis do. (webmd.com)
  • With a person dying every 30 seconds from a hepatitis related illness - even in the current COVID-19 crisis - we can't wait to act on viral hepatitis. (bvsalud.org)
  • Hepatitis C. However, the majority of these notification events were discovered only after patients became acutely ill rather than through proactive reporting of violations of health safety protocols, according to a review in The Journal of the American Osteopathic Association . (eurekalert.org)
  • Not all patients with hepatitis B require treatment, which is generally used in more advanced diseases. (medicinenet.com)
  • In the meantime, we always encourage clinicians to use their judgment as they provide care for their patients - including those who may benefit from screening for hepatitis B - and to decide together with each patient which preventive services can best help them live a long and healthy life," Barry said. (medscape.com)
  • The combination is designed to interfere with HCV replication and be used as a treatment for hepatitis patients with genotypes 1a or 1b without PEG-interferon. (genengnews.com)
  • In doing so, countries can save lives and reduce the costs associated with long-term care for cirrhosis and liver cancer as a result of untreated hepatitis. (bvsalud.org)
  • Travel internationally to areas with a high prevalence of hepatitis B. (cdc.gov)
  • Hepatitis C is a contagious liver disease that is primarily spread through the blood of an infected person or, less commonly, through sexual contact. (eurekalert.org)
  • Treatment of chronic hepatitis C with recombinant interferon alfa. (medscape.com)
  • Hepatitis E. Lancet 379 , 2477-2488 (2012). (nature.com)
  • Molecular virology and pathogenesis of hepatitis B. Lancet . (medscape.com)